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ABSTRACT
A total of 411 G clone cell-dependent virus strains recently were isolated from 
nasal, trachea and lung samples in etiological investigations of acute respiratory tract 
diseases of vaccinated cattle, including shipping fever pneumonia. The virus infectivity 
titers reached up to 1.2 x 107 plaque forming units per gram of lung tissues of fatal 
cases. These viral agents were isolated in the 1st G clone cell passage without trypsin 
enhancement, and induced cell fusion. They have a restricted hemagglutination pattern, 
agglutinating only rat and mouse erythrocytes. Majority of them has receptor-destroying 
enzyme activities. They are round and enveloped with a diameter of 80 nm. Based on 
these features and the site of infections, these virus isolates were identified as 
respiratory bovine coronaviruses (RBCV). The RBCV were previously not recognized 
to be associated with acute respiratory tract diseases of cattle.
Tests on serum samples from RBCV-positive cattle during a shipping fever 
epizootic revealed characteristic primary immune responses with specific antibodies to 
hemagglutinin-esterase and spike. The RBCV-positive cattle that died had only IgM 
responses to RBCV infections. High level of opsonic and virus-neutralizing IgG2 
apparently protected cattle from RBCV infections and respiratory tract disease. These 
cattle entered this experiment with high antibodies against hemagglutinin-esterase and 
spike. The G clone cells had maximal susceptibility to RBCV infections from apical
xii
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domains. Asymmetric release of RBCV occurred through the apical surfaces of the 
cells. The RBCV-induced polykaryons had intact plasma membranes and degenerated 
nuclei, and resulted from expression of spike on cytoplasmic membrane and RBCV 
replication, indicating fusion from within. The purified RBCV particles showed higher 
acetylesterase activity at 37°C than at 39°C, while the purified enteropathogenic BCV 
(EBCV) particles retained full acetylesterase activity at both 37°C and 39°C. 
Transiently expressed hemagglutinin-esterase of RBCV exhibited a drastic reduction in 
acetylesterase activity after 40 min at 37°C, while the acetylesterase activity of the 
transiently expressed hemagglutinin-esterase of EBCV remained stable beyond the 40- 
min threshold. The deduced amino acid sequences of hemagglutinin-esterase specified 
by RBCV strains contained specific amino acid changes in comparison to the wild-type 
EBCV strain, which may be responsible for the observed enzymatic differences.
xiii
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CHAPTER 1 
INTRODUCTION
1.1 Statement of Problem and Hypothesis
We currently observed a newly emerging virus infections among young cattle with 
respiratory distress on winter pastures in the South, cattle transported to feedlots, and 
cattle that required veterinary care because they had respiratory tract disease signs 
during a livestock show in Louisiana (Storz et al., 1996; Storz, 1998; Storz et al., 1999; 
Storz et al., 2000a and b). These viral isolates were identified as coronaviruses and are 
referred to as respiratory bovine coronaviruses (RBCV) based on morphological 
features and cytopathic interaction with the G clone of human rectal tum or-18 
(HRT-18) cells. Their unique properties distinguished them from enteropathogenic 
bovine coronaviruses (EBCV). Distinguishing features are: (1) The RBCV were 
isolated in the 1st G clone cell passage without the use of trypsin enhancement. Trypsin 
activation was required for the isolation of EBCV (Storz et al., 1981). (2) The RBCV 
have unusually high cell-fusing activities for the G clone cells. (3) The RBCV have a 
restricted hemagglutination pattern. They agglutinate only mouse and rat, but not 
chicken red blood cells. Logically, questions arise whether RBCV and EBCV are 
antigenically or genetically different and whether specific tissue tropisms are the basis 
for such differences. Therefore, the properties of these newly isolated RBCV needed to
1
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be characterized and their pneumopathogenicity had to be defined. Our hypotheses are: 
(1) The RBCV emerged as an important viral pathogen with control of other respiratory 
virus infections through effective vaccination and immunization of the cattle 
population. (2) The RBCV infections were not detected in the past because proper 
technology was not available. (3) The RBCV developed specific pneumopathogenic 
properties based on structural and nonstructural genes. (4) The spike (S) and 
hemagglutinin-esterase (HE) glycoproteins are major determinants in the infectious 
process.
1.2 Research Objectives
The overall aims of investigations in our research group are to characterize the 
molecular properties and pneumopathogenicity of RBCV, newly isolated from cattle of 
this country, and to compare RBCV with EBCV. My specific aims of the research 
described in this dissertation were: (1) to study the unique properties of the newly 
emerging RBCV in comparison to EBCV, (2) to identify the antigenic properties of 
RBCV, and (3) to identify the genetic bases of acetylesterase (AE) activities in the 
emergence of BCV infecting the respiratory tracts of cattle. My specific research 
objectives were:
1. To assess the emergence and extend of respiratory coronavirus infections in cattle
from 1993 to 1998.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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2. To determine the antigenicity of RBCV structural proteins in inducing immune 
responses of market-stressed cattle during pathogenesis of a severe, naturally 
occurring shipping fever pneumonia epizootic of 1997.
3. To investigate the susceptibility of polarized epithelioid G clone cells to RBCV and 
EBCV.
4. To compare the dynamics of cell-fusion induction during the replication of RBCV 
and EBCV in the G clone cells, and to analyze the RBCV-induced polykaryons.
5. To relate the HE cDNA-predicted amino acid sequences for wild-type strains of 
RBCV and EBCV to the enzymatic activities of HE glycoproteins of RBCV and 
EBCV.
Scientific findings of these investigations are presented as 5 individual chapters,
most of which represent manuscripts published or submitted for publication to different
refereed journals. Their titles are:
1. Dynamics of Emergence of Respiratory Bovine Coronavirus Infections - A 
Catalogue of Virus Isolates from Major Epizootics.
2. “Antibody Responses to Respiratory Coronavirus Infections of Cattle during 
Shipping Fever Pathogenesis.” Submitted for publication to the “Archives of 
Virology.” Co-authored by K.L. O’Reilly, J. Storz, C.W. Purdy and R.W. Loan.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3. “Infection of Polarized Epithelial Cells with Respiratory and Enteric Tract Bovine 
Coronaviruses and Release of Virus Progeny.” Published by the “American Journal 
of Veterinary Research” (1997) 58: 1120-1124. Co-authored by K.L. O’Reilly and 
J. Storz.
4. “Comparison of Fusogenic Properties of Respiratory and Enteric Tract Bovine 
Coronaviruses.” Submitted for publication to the “Journal of Veterinary Medicine.” 
Co-authored by J. Storz.
5 . “Hemagglutinin-esterase Specified by Respiratory Bovine Coronaviruses Has 
Temperature-sensitive Acetylesterase Activity.” Submitted for publication to the 
“Journal of Medical Microbiology.” Co-authored by V.N. Chouljenko, K.G. 
Kousoulas and J. Storz.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2 
LITERATURE REVIEW
2.1 Pathogenic Potential of Coronaviruses
Coronaviruses emerge as increasingly important causes of human and animal 
diseases. These diseases include respiratory infections, gastroenteritis, hepatic and 
neurological disorders, immune-mediated disease such as feline infectious peritonitis, 
and persistent infections (Lai, 1990; Spaan et al., 1988). Bovine coronavirus (BCV) is 
the second most common cause of virus-induced severe enteritis or occasional 
pneumoenteritis in calves, and is referred to here as enteropathogenic BCV (EBCV) 
(Clark et al., 1993; Mebus et al., 1973). Winter dysentery in adult dairy cattle was also 
attributed to EBCV (Clark et al., 1993, Saif et al., 1988).
2.2 Coronavirus Infections of Cattle
2.2.1 Economic Losses Caused by Bovine Respiratory and Enteric Diseases
The beef and dairy cattle industries remain important economic activities in the 
United States of America. Over 15,000 family farms and agricultural businesses own 
almost 1 million cattle as a basis of their livelihood in Louisiana. Nationwide there were 
over 99 million beef and dairy cattle in 1997 (Weaber, 1998). Respiratory and enteric 
diseases of cattle represent the most costly diseases in animal agriculture in the U.S.A. 
It was released by the National Agricultural Statistics Service (NASS), Agricultural
5
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Statistics Board, U.S. Department of Agriculture in May 1996 that a total of 4.38 
million head of cattle and calves died from all causes with the total losses at $1.8 billion 
during 1995 in the United States. Respiratory problems led the other causes with 28% 
of the total deaths or 1.20 million head. The value of these losses was $478 million. The 
second leading other cause of deaths in cattle and calves was enteric problems with 20% 
of the total deaths or 0.86 million head. The value of these losses was $316 million. 
Coronaviruses are etiological factors in both respiratory and enteric diseases of cattle.
2.2.2 Enteric Diseases of Cattle and EBCV Infections
Severe enteritis (or calf scours) in newborn calves cause an estimated annual loss of 
over a quarter billion dollars in the U.S.A. and about 1.7 billion dollars worldwide 
(Ratafia, 1988). Scours and respiratory disease are the major causes of preweaned calf 
mortality. The EBCV is the second most common cause of viral enteritis in calves 
(Craig and Kapil, 1994). Although there is geographic variation, EBCV accounts for 
about 20-26% of the cases of calf scours, and causes acute and chronic diarrhea or 
pneumoenteritis in young calves (Clark, 1993; Mebus et al., 1973). The EBCV is also 
involved in winter dysentery in adult dairy cattle (Clark, 1993; Saif et al., 1988).
The primary mechanism of EBCV-induced disease was investigated through 
findings on ultrastructural features of the interaction of EBCV with the intestinal 
epithelial cells, early events in EBCV infections of cultured cells, viral protein
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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processing and cell fusion (Doughri et al., 1976; Storz and Zhang, 1991). The EBCV 
infection involved the villous epithelial cell lining and some cellular components of the 
lamina propria mucosae. The EBCV particles interacted with the glycocalyx and 
adsorbed to the microvilli of intestinal epithelial cells and intercellular membranes of 
neighboring enterocytes. The adsorbed virions were taken up through fusion of viral 
envelopes with the plasmalemma of microvilli at the apical surface of intestinal 
epithelial cells, and by entry into intercellular spaces and interaction with lateral cell 
membranes. This interaction resulted in alteration of lateral cellular membranes at the 
site of viral contact. The virus replicated predominantly in the differentiated absorptive 
epithelial cells and goblet cells of the villi. In the early phase of infection, the rough and 
smooth elements of the endoplasmic reticulum became distended with electron-dense 
granulofibrillar material which subsequently accumulated in the apical cytoplasm of 
infected cells, leading to the formation of viral factories. The viral cores were 
assembled by condensation of material in cytoplasmic viral factories, and within the 
distended cistemae of the rough endoplasmic reticulum. Following core condensation, 
viral envelopment was observed on membranes of cytoplasmic vacuoles, Golgi vesicles, 
or in association with smooth membrane of viral factories. Release of virus from 
infected cells occurred either by lysis of the apical plasmalemma and subsequent flow 
of the cytoplasm with its contents into the gut lumen, by digestion and lysis of extruded
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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infected cells, or through fusion of virus-containing vacuoles with apical plasmalemma 
and liberation of their contents.
2.2.3 Respiratory Disease Complex of Cattle and Emergence of RBCV
Bovine respiratory tract disease is recognized as one of the most economically 
significant concerns of feedlot managers. It is estimated the cattle industry loses $168 to 
$624 million a year to respiratory disease, with over $112 million of this loss from the 
feedlot industry (Perino, 1992). The bovine respiratory disease complex (BRDC) 
represents one of the most costly diseases in the cattle industry (Hoerlein, 1980). 
Shipping fever pneumonia represents the most serious component of the BRDC, and 
derives from primary infections with viruses such as bovine herpes virus (BHV-1), 
bovine parainfluenza virus-3 (PI-3), bovine respiratory syncytial virus (BRSV) or 
bovine viral diarrhea virus (BVDV) (Ciszewski et al., 1991; Madin et al., 1956; 
McKercher et al., 1957; Potgieter et al., 1984; Reisinger et al., 1959; Rosenquist et al., 
1974). However, secondary bacterial infections lead to deadly pneumonia. Even after 
years of research and tremendous progress in the development of needed vaccines and 
antibiotics, BRDC remains a challenging and expensive obstacle to the economically 
efficient production of cattle. Clearly, there is a continuing evolution of infectious 
agents and it is hypothesized that new infections may emerge as we achieve control of 
known virus-induced diseases. The potential of RBCV for causing acute respiratory 
disease among feedlot cattle was virtually unexpected until the fall of 1993 when Storz
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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and his colleagues at Louisiana State University (LSU) discovered a high rate of RBCV 
infections in cattle with respiratory disease on arrival in feedlots (Storz et al., 1996). 
Extensive investigations at LSU were made on cattle that originated from 11 different 
states in the U.S.A. during the last 5 years (Storz et al., 1996; Storz, 1998; Storz et al., 
1999; Storz et al., 2000a and b). Cattle of weaning age entering the next production 
system appear highly susceptible to RBCV infections. This surprising finding implies 
that coronaviruses appear to be a newly emerging factor in the epizootic of shipping 
fever that was previously not recognized because these viruses did not exist in the past 
or because they could not be detected by previously employed conventional diagnostic 
methods. Serological and antigen detection tests identified this type of virus as a 
potential cause of other forms of respiratory tract disease of cattle (Appel et al., 1992; 
Carman and Hazlett, 1992; Heckert et al., 1990; Herbst et al., 1989; Jimenez et al., 
1989; Mostl and Biirki, 1988). The use of the G clone cell cultures played a cardinal 
role in the isolation of newly recognized RBCV. Alternatively, successful vaccination 
programs to prevent known viral infections of cattle may create a shift in favor of this 
hitherto unrecognized RBCV infections.
2.3 Molecular Properties o f Bovine Coronavirus
2.3.1 Coronavirus Taxonomy
Coronaviruses, a genus in the family Coronaviridae, are large, enveloped positive- 
strand RNA viruses that are important causes of human and animal diseases (Lai, 1990;
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Spann et al., 1988; Wege et al., 1982). The viruses have the largest genomes of all RNA 
viruses. Three serologically distinct groups of coronaviruses have been identified. 
Bovine coronavirus belongs to the antigenic group II. Recently, toroviruses were 
classified as a genus within the Coronaviridae, and arteriviruses were also proposed as 
a new genus in this family (Cavanagh and Horzinek, 1993; den Boon et al., 1991; 
Snijder et al., 1991). Later, the International Committee on Taxonomy of Viruses in 
Jerusalem Meeting in 1996 created a new family, the family Arteriviridae, which 
contains a single genus arterivirus.
2.3.2 Structure of the BCV Virion
Bovine coronavirus is a round, enveloped panicle with a diameter of around 80 nm 
(Lai, 1990) (Fig. 2.1). The viral envelopes are formed by budding from intracellular 
membranes, and covered with a distinctive fringe of 20 nm long petal-shaped surface 
projections. The viral genome, is a single-stranded, positive-sense, RNA molecule with 
an estimated molecular weight of 8 x 106 dalton (Da) or 31 kilobases (kb). The viral 
RNA genome is associated with the nucleocapsid phosphoprotein, N, to form a long, 
flexible, helical nucleocapsid. There are 4 structural proteins on its lipoprotein 
envelope: (1) membrane glycoprotein (M, formerly called E l), (2) spike glycoprotein 
(S, formerly called E2), (3) hemagglutinin-esterase glycoprotein (HE, formerly called 
E3), and (4) recently identified envelope protein (E).







FIG. 2.1: Model of coronavirus structure.
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2.3.3 Viral Genome Structure and Organization
The 31 kb RNA genome of BCV is capped, polyadenylated, and can function as 
mRNAs (infectious) (Lai, 1990). The overall location and order of the known genes of 
BCV and other hemagglutinating (HA) coronaviruses is: 5-RNA pol-Ns (nonstructual) 
32-HE-S-Ns4.9-Ns4.8-Ns12.7-E-M-N-poly (A)-3' (Fig. 2.2). The first gene at the 5’ end 
of the genome is roughly 21 kb long and represents two-thirds of the entire genome 
(Lai, 1990, Spann et al., 1988). This large gene region consists of 2 overlapping open 
reading frames (ORFs, ORFla and ORFlb) that encode the viral RNA-dependent RNA 
polymerase, proteases, and other as yet uncharacterized proteins. However, the structure 
of this gene has not been determined. The terminal 3' end of the genomic RNA consists 
of approximately 9.5 kb and contains the genes for 5 major structural proteins (S, HE, 
E, M, N) and at least 4 other smaller proteins (Ns32, Ns4.9, Ns4.8, Ns12.7) which may 
play structural and nonstructural roles (Abraham et al., 1990, Cavanagh et al., 1990; 
Spaan et al, 1988).
2.3.4 Structures and Functions of Structural and Nonstructural Proteins 
Nucleocapsid protein: The BCV N protein is an internal non-glycosylated 50-52
kDa protein with a backbone of 448 amino acids (a.a.) and specific phosphorylation 
sites on serine residues, and it is rich in clusters of basic residues within the middle 
RNA-binding domains (Laude and Masters, 1995). This protein binds to virion RNA
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FIG. 2.2: Organization of eneteropathogenic bovine coronavirus genome.
HE gene: 1272 n.t. —» Hemagglutinin-esterase (HE) gp of 424 a.a.
S gene: 4092 n.t. —» Spike (S) gp of 1363 a.a.
M gene: 690 n.t. —» Matrix (M) gp of 230 a.a.
N gene: 1344 n.t. —» Nucleocapsid (N) protein of 448 a.a.
E gene: 252 n.t. —» Small envelope (E) protein of 84 a.a.
32-KDa ORF: 831 n.t. —» Ns 32KDa-protein of 277 a.a.
4.9-KDaORF: 129 n.t. —> Ns 4.9KDa-protein of 43 a.a.
4.8-KDa ORF: 135 n.t. —» Ns 4.8KDa-protein of 45 a.a.
12.7-KDa ORF: 327 n.t. —» Ns 12.7KDa-protein of 109 a.a
L: Leader sequence
POL: RNA polymerase
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genome, providing the structural basis for the long, flexible, helically symmetric 
nucleocapsid. Its major activity is involved in the process of viral RNA replication.
Membrane protein: The 26-32 kDa M glycoprotein contains 230 a.a., is derived 
from the 22 kDa protein backbone with 1 or 2 oligosaccharide side chains (2 kDa), and 
exists as a set of different protein species due to different levels of glycosylation 
(Rottier, 1995). It is the most abundant viral structural protein with a short N-terminai 
domain exposed on the exterior of the viral envelope, 3 hydrophobic a-helices spanning 
the lipid bilayer 3 times, and a large C-terminal domain located in the interior of the 
virus particle. The M protein of BCV is targeted to Golgi apparatus and does not appear 
on the plasma membrane (Machamer et al., 1990; Machamer and Rose, 1987; Swift and 
Machamer, 1991). This protein is essential for envelope formation, appears to play a 
key role in binding the helical nucleocapsid to the viral envelope during virus budding, 
and determining viral budding site on intracellular membranes. Monoclonal antibodies 
specific for the M protein of coronavirus do not neutralize virus infectivity. The M 
protein of coronaviruses is very closely related among virus strains of the same 
antigenic group, but differs largely from all the others (Rottier, 1995).
Hemagglutinin-esterase protein: The HE glycoprotein consists of 424 a.a. with an 
N-terminal signal region, a C-terminal anchorage region, and N-linked glycosylation 
sites, and is composed of 2 identical, disulfide-linked 65 kDa subunits (Deregt et al., 
1987; King et al., 1985). This glycoprotein is found only in the envelopes of certain
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species of coronviruses in antigenic group II, including BCV, porcine hemagglutinating 
encephalomyelitis virus (HEV), human respiratory coronavirus (HCV-OC43), turkey 
coronavirus (TCV) and some strains of mouse hepatitis virus (MHV). It forms short 
spikes on the viral envelope with molecular mass of 65 kDa and 140 kDa in its reduced 
and nonreduced forms, respectively. The bovine coronavirus HE genes have a.a. 
sequences homology with HE glycoprotein of influenza C virus and may have been 
derived by a recombination between an HE mRNA of influenza C virus and the 
genomic RNA of an ancestral coronavirus (Luytjes et al., 1988). The BCV HE has both 
hemagglutinating, receptor-binding and AE-mediated receptor-destroying functions 
which are similar to the influenza C virus. The HE glycoprotein of BCV binds to the 9- 
O-acetylated neuraminic acid residues of glycoproteins or glycolipids on the surfaces of 
erythrocytes and susceptible cells, which is considered to be the major receptor 
determinant of coronavirus (Herrler et al., 1985; Herrler et al., 1991; Vlasak et al., 
1988a). The AE activity of HE hydrolyzes an ester bond to cleave an acetyl group from 
the 9-O-position of the substrates, potentially eluting adsorbed virions and destroying 
the bond between HE and the glycans on the cell membrane. Inhibition of the AE 
activity of BCV HE by diisopropylfluorophosphate resulted in remarkable reduction of 
viral activity, indicating that binding of HE to 9-O-acetylated neuraminic acid residues 
can facilitate virus infection (Vlasak et al., 1988a). Enzymatic removal of the 9-0- 
acetylated neuraminic acid from cell membranes or treatment with HE-specific
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monoclonal antibodies inhibits BCV infections (Deregt et al., 1989; Schultze and 
Herrler, 1992). Furthermore, cells infected with a baculovirus recombinant expressing 
the BCV HE exhibited hemadsorption and esterase activities, both of which could be 
blocked by monoclonal antibodies which have infectivity neutralization activity 
(Parker et al., 1990a; Yoo et al., 1992).
Spike protein: The S protein of BCV is N-Iink glycosylated with a molecular mass 
of 185-190 kDa, and forms the longer peplomeric projections on the virion envelope 
(Cavanagh, 1990). This glycoprotein contains 1363 a.a. with an N-terminal signal 
sequence, a coil-to-coil structure, and a C-terminal hydrophobic membrane-anchoring 
domain. The S precursor is frequently cleaved into 2 functional subunits in BCV and 
some strains of MHV: the N-terminal 110 kDa SI and the C-terminal 100 kDa S2. 
Proteolytic cleavage of S preprotein is considered to enhance cell-fusing activity and/or 
plaque-forming activity for some host cells, but it is not absolutely required for 
induction of cell fusion for some MHV strains or mutants, feline infectious peritonitis 
virus (FIPV) and transmissible gastroenteritis virus (TGEV) which lack the protease 
motif (Cavanagh et al., 1990; St. Cyr-Coats et al., 1988b; Storz et al., 1981; Sturman et 
al., 1985). This protein of BCV is responsible for virus binding to 9-O-acetylated 
neuraminic acid-containing glycans on the target cells, initiation of infection, induction 
of cell-to-cell fusion after cell-surface expression (fusion from within), elicitation of 
neutralizing antibodies and cell-mediated immunity (Spaan et al., 1988). Furthermore,
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purified S protein was documented to exhibit higher hemagglutinating activities with 
rodent erythrocytes than purified HE protein (Schultze et al., 1991a and b). Although 
both S and HE glycoproteins of the BCV L9 strain were able to agglutinate rodent 
erythrocytes, only S could agglutinate chicken erythrocytes (Schultze et al., 1991a). 
The 9-O-acetylated neuraminic acid was identified as receptor determinant on 
susceptible cells for BCV to initiate infection, and was bound by both HE and S viral 
proteins. However, S glycoprotein of BCV was considered to be the major viral 
structural protein to bind to neuraminic acid-containing glycans (Schultze et al., 1991b). 
A porcine respiratory coronavirus was found with a deletion in the S gene region 
when compared with the TGEV (Rasschaert et al., 1990). This deletion was most likely 
responsible for the differences in tissue-tropism and pathogenicity of the 2 viral strains. 
Recently, 2 a.a. changes at the N-terminus of the TGEV S glycoprotein were reported to 
result in the loss of enteric tropism, which further suggested that the SI subunit is 
directly involved in the enteropathogenic potential of TGEV (Ballesteros et al., 1997). 
Further investigations of TGEV S 1 subunit with point mutations or a deletion of 4 a.a. 
within residues 145 to 155 lead to reduced enteropathogenicity and loss of 
hemagglutinating activity (Krempl et al., 1997)
Envelope protein: A small (9- to 12-kDa) integral hydrophobic protein E was 
recently identified in the viral envelope of BCV, and is encoded by a 9.5 kDa ORF 
which was previously believed to be a nonstructural gene, (Brown and Brierly, 1995).
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This protein was found in small amounts in infected cells and in the virion particles 
with its unknown function.
Nonstructural proteins: The 32 kDa nonstructural protein was documented to be a 
phosphoprotein that accumulates in the cytop'usm of infected cells (Cox et al., 1989; 
Cox et al., 1991). Between the S and M genes within the BCV genome, there are 3 
different ORFs encoding nonstructural proteins of 4.9, 4.8 and 12.7 kDa (Abraham et 
al., 1990a). The overall transcriptional pattern of this region is remarkably different 
between BCV and MHV (Lai, 1990). The 4.9 kDa ORF, most likely, is not translatable, 
while no information is available whether the 12.7 kDa and 4.8 kDa ORFs are 
expressed in infected cells (Hofmann et al., 1993). The functions of these gene products 
are unknown. It is also uncertain whether they play a role in virus pathogenesis.
2.3.5 Coronavirus Replication
Like other positive-strand RNA viruses, BCV does not contain any RNA-dependent 
RNA polymerase in their virions. The virus replicates in cytoplasm of infected cells by 
a unique mechanism that results in a high frequency of recombination (Lai, 1990) 
(Fig. 2.3).
Attachment and penetration: Upon infection, the BCV binds to the plasma 
membrane of target cells by the interaction of S glycoprotein with its specific receptor 
glycoprotein, 9-O-acetylated neuraminic acid moieties on membrane macromolecules

















FIG. 2.3: Model of coronavirus replication.
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(Schultze et al., 1991a and b; Schultze and Herrler, 1992). Binding of HE glycoprotein 
in the short peplomeres to 9-O-acetylated neuraminic acid residues on the cell surface 
may function as a second viral attachment protein besides the S protein. The virus 
penetrates through fusion of the viral envelope with the plasma membrane that is 
mediated by the S2 subunit of S protein.
Primary translation: Following entry of viral genome into the cytoplasm, the 
positive-strand genomic RNA is First translated to form a macromolecule (>800 kDa) 
which is co- or posttranslationally processed by viral and cellular proteases to produce 
multiple proteins that serve as a virus-specific, RNA-dependent RNA polymerase. 
Although p28, p290, p50, p240 and several other cleavage products were found in 
MHV-infected cells, the primary gene product has not been clearly identified (Baker et 
al., 1989; Baker et al., 1993; Denison et al., 1991; Denison et al., 1992; Denison and 
Perlman, 1986; Denison and Perlman, 1987)
Transcription of viral RNA: The polymerase then transcribes positive-strand 
genomic RNA into a full-length negative-strand RNA, which is subsequently used as a 
template for synthesis of new positive-strand viral genomic RNA and mRNAs which 
are capped and polyadenylated (Sawicki and Sawicki, 1990).
The RNA polymerase must recognize specific signals that control the initiation of 
positive- and negative-stranded RNA synthesis. Deletion mapping of different defective
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interfering RNAs (DIs) demonstrated that sequences comprising both the 3’-terminal 
and the 5’-terminal of viral genomes are required for viral replication, but the sizes of 
these regions were different for different DIs (Van der Most and Spaan, 1995).
The mRNA: All the mRNAs are co-nested on the 3’ ends. Although each of the 
mRNAs except the smallest is polycistronic, only the unique 5’-end ORF of each 
mRNA, which is not present in the next smaller mRNA, is translated into a protein 
(Leibowitz et al., 1982; Siddell, 1983). Subgenomic negative-strand RNAs are also 
synthesized in double-stranded forms during viral replication (Sawicki and Sawicki, 
1990; Sethna et al., 1989). Both subgenomic and genomic-length negative-strand RNAs 
serve as templates for subgenomic mRNA synthesis. Eight virus-specific mRNAs were 
detected in cells infected with bovine coronavirus (BCV) and other hemagglutinating 
(HA) coronaviruses indicating the existence of 8 subgenomic mRNAs.
The subgenomic mRNAs of coronaviruses not only form a 3’-co-terminal nested set 
but also are characteristically 5’-co-terminal. All subgenomic mRNAs of BCV contain a 
common 5’ end of a leader sequence about 65 nucleotides (n.t.) long which is encoded 
by the 3’ end of the negative-strand template and derived from the 5’ end of the 
genomic RNA (Hofmann et al., 1993). This leader sequence is not found elsewhere in 
the genome, but between each ORF on the genome there is a short intergenic sequence 
(IS) that contains a 5-11 n.t. sequence homologous with a sequence near the 3’ end of
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the BCV leader RNA (Hofmann et al., 1993; Shieh et al., 1987). It is not clear how the 
5’ terminally encoded leader recombines with the 3’ co-terminal subgenomic mRNAs.
Models for coronavirus mRNA synthesis: There are 3 models for coronavirus 
mRNA synthesis. Leader-primed transcriptional mechanism is a model which is most 
popularly accepted (Lai, 1990) (Fig. 2.4A). Transcription of leader RNA would begin at 
the 3’ end of the full-length, negative-strand template RNA and terminate with the 
dissociation of the leader from the template, either alone or with attached polymerase 
protein(s). The leader would then recognizes its complementary promoter at ISs 
downstream on the negative-strand template and function as the primer for mRNA 
transcription. The leader sequences can function in cis and in trans and can serve as 
primers for positive-stranded RNA synthesis (Lai, 1990). In this model, the ISs serve as 
promoters for mRNA transcription. A second model for coronavirus RNA synthesis is 
called discontinuous transcription mechanism (Sawicki and Sawicki, 1990) (Fig. 2.4B). 
During negative-strand RNA synthesis, the polymerase would stop at one of the ISs and 
then jump to the 3’ end of the leader sequence near the 5’ end of the genomic RNA 
template, generating subgenomic negative-strand RNA with an antisense leader 
sequence at its 3 ’ end. These subgenomic negative-strand RNAs and a full-length 
negative strand could serve as templates for continuous transcription of positive-strand 
mRNAs and genomic RNA. In this model, the IS functions as transcriptional 
termination sequence and/or as a sequence that interacts with leader RNA to permit
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FIG. 2.4: Models for transcription of coronavirus subgenomic mRNAs.
(A) Leader-primed transcription during (+) strand synthesis, (B) Discontinuous 
transcription during (-) strand synthesis.
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polymerase jumping during negative-strand RNA synthesis. A third model proposes 
that, following the penetration of virus, the positive-strand subgenomic mRNAs are 
used directly as templates for transcription of the negative-strand subgenomic RNAs, 
which are subsequently used as templates for synthesis of additional subgenomic 
mRNAs (Sethna et al., 1989; Sethna et al., 1991).
Replication o f viral genomic RNA: Production of full-length, positive-strand 
genomic RNA requires continuous synthesis with the full-length, negative-strand 
template. Studies of cloned DI RNA of MHV virus indicated that around 400 n.t. at 
both the 3’ and 5’ ends of viral genome, and an internal sequence of about 135 n.t. were 
required for replication of DI RNA (Kim et al., 1993; Lin and Lai, 1993; Masters et al., 
1994). Furthermore, a free leader sequence of the DI RNA was suggested to be involved 
in RNA replication (Makino and Lai, 1989). However, the precise mechanism of viral 
RNA replication remains unknown.
Translation, processing and intracellular transport of viral proteins: Huge 
amounts of N protein are translated on free polysomes from mRNA 7, and rapidly 
phosphorylated in the cytosol (Stohlman et al., 1983). The HE, S, and M glycoproteins 
are encoded by mRNAs 2-1, 3, and 6, respectively, and translated on membrane-bound 
polysomes on the rough endoplasmic reticulum (Sturman and Holmes, 1983). The S 
glycoprotein is cotranslationally inserted into the RER and glycosylated at asparagine 
residues (N-linked), oligomerized into noncovalently linked homotrimers, and
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transported through the Golgi apparatus, where the S2 subunit is fatty-acylated, and the 
high mannose oligosaccharides are trimmed with addition of terminal sugars (Delmas 
and Haude, 1990; Opstelten et al., 1993; Schmidt, 1982; Sturman et al., 1985). The S 
protein may be proteolytically cleaved to form two 100-110 kDa subunits (Abraham et 
al., 1990b; Deregt et al., 1987). Excess S protein that is not incorporated into virions is 
transported to the plasma membrane, where it plays a role in cell-cell fusion (Griffiths 
and Rottier, 1992; Vennema et al., 1990). The matrix glycoprotein M is transported to 
the Golgi apparatus, where it accumulates and may be glycosylated at serine or 
threonine residues (O-linked), but M is not transported to the plasma membrane (Locker 
et al., 1992). The HE protein is also cotranslationally glycosylated at asparagine 
residues (N-linked) in the RER. Subsequently the processed HE is transported to the 
Golgi when the N-linked glycans are removed (Yokomori et al., 1989), and then to the 
plasma membrane, where it can cause hemadsorption (Kienzel et al., 1990).
Assembly and release of virions: The newly formed positive-strand genomic 
RNAs and N proteins assemble in the cytoplasm to form helical nucleocapsids (Sturman 
and Holmes, 1983). The N protein binds to RNA in both sequence- and non-sequence- 
specific manners with a preferred binding site within the leader RNA (Robbins et al., 
1986; Stohlman et al., 1988). Packaging of genomic RNA needs a specific signal in 
genomic RNA which consists of a stretch of 61 nt in the 3 ’ end of gene 1, 
approximately 20kb from the 5’ end of the genome (Fosmire et al., 1992; van der Most
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et al., 1991). Virions mature by budding of nucleocapsids from the membranes of the 
Golgi apparatus or endoplasmic reticulum that contain M protein (Dubois-Dalcq et al., 
1982; Tooze et al., 1984; Tooze and Tooze, 1985). The unique large and small 
peplomeres formed by S and HE, respectively, are incorporated into virions at the time 
of budding. It is still unknown whether Golgi-associated posttranslational processing of 
viral structural glycoproteins occurs before or after their incorporation into virions.
Following budding, virions accumulate in large, smooth-walled vesicles and are 
released from the cell cytoplasm presumably by fusion of the virion-containing vesicles 
with the plasma membrane (Griffiths and Rottier, 1992).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 3
DYNAMICS OF EMERGENCE OF RESPIRATORY BOVINE 
CORONAVIRUS INFECTIONS-A CATALOGUE OF VIRUS 
ISOLATES FROM MAJOR EPIZOOTICS
3.1 Introduction
Bovine respiratory and enteric tract diseases represent the most costly diseases in 
the cattle industry of the United States. The role of coronavirus in causing severe 
diarrhea in neonatal calves was initially explored in the seventies (Doughri et al., 1976; 
Mebus et al., 1973). Coronavirus might also be involved in winter dysentery of adult 
cattle as reported by Saif and co-workers in 1988. Mebus and co-workers (1973) 
succeeded in adapting the enteropathogenic coronavirus strains L9 (EBCV-L9) through 
inoculation of a diarrhea specimen into a specific culture of bovine fetal kidney cells 
through multiple passages. Adaptation of other wild-type EBCV agent to cultured 
bovine cells remained unsuccessful in numerous instances in which electron 
microscopic examination revealed the presence of intestinal coronavirus infections. 
However, wild-type EBCV strains could be isolated and propagated in the HRT-18 cell 
line, which was derived from human rectal adenocarcinoma (Laporte et al., 1979; 
Tompkins et al., 1974). This process was enhanced by addition of trypsin to the culture 
medium (St. Cyr-Coats et al., 1988a). The EBCV are among the better characterized 
hemagglutinating coronaviruses which also include human coronavirus strain OC43,
27
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hemagglutinating encephalomyelitis virus of swine, the turkey coronavirus, and mouse 
hepatitis virus strain JHM (Spaan et al., 1988; Storz et al., 1992).
Shipping fever pneumonia is an acute respiratory tract disease, and remains a 
serious problem in beef cattle recently transported to feedlots. This disease is commonly 
considered to be induced by multiple factors whereby stressful conditions, such as 
transport and assembly, favor primary respiratory tract infections with viruses which 
become further complicated by secondary bacterial infections with Pasteurella (P.) 
haem olytica  or other bacterial species (Hoerlein, 1980; Yates, 1982). Viruses 
traditionally associated with shipping fever pneumonia include BHV-1 (McKercher et 
al., 1957), bovine PI-3 virus (Baldwin et al., 1967; Reisinger et al., 1959), bovine 
pneumovirus or BRSV (Rosenquist, 1974) and pestivirus of BVDV (Potgieter et al., 
1984). Bovine herpesvirus-1 was isolated by Jensen and co-workers (1976) from 
respiratory tract samples in 18% of 354 cases of shipping fever pneumonia among cattle 
in Colorado feed yards. However, dynamics of any of these virus infections have not 
been explored in naturally evolving shipping fever epizootics (Yates, 1982).
European reports on serological and epidemiological investigation indicate that 
coronaviruses may play an etiological role in respiratory tract disease of young calves 
(Herbst et al., 1989; Jiminez et al., 1989; McNulty et al., 1984; Most! and Burki, 1988). 
Little information exists on the prevalence and epidemiology of respiratory coronavirus 
infections in adult cattle of the United States (Carman and Hazlett, 1992; Heckert et al.,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
29
1990). However, all these investigations provided serologic and other indirect evidence 
for respiratory coronavirus infection in cattle. The wild-type RBCV was not isolated 
previously from feedlot or other adult cattle by conventional cell culture techniques. 
Therefore, RBCV have neither been characterized nor compared with the known EBCV 
because reliable isolates were not available.
In 1993, one investigation was conducted in the U.S.A. to assess prevailing viral 
respiratory infections of cattle (Storz et al., 1996). This experiment involved 100 cattle 
in Kansas and Arizona feedlots. A high percentage of cattle arriving at feedlots yielded 
isolates of an “emerging” RBCV. These viruses were recovered from nasal swab 
samples collected from cattle experiencing acute respiratory distress following shipping. 
A novel isolation scheme was employed which included the G clone cells and 2 cell 
types of cultured bovine cells with specific ranges of permissiveness for all known 
respiratory viruses of cattle including RBCV. This approach resulted in the first 
successful isolation of RBCV at high rates from nasal swab samples of cattle arriving at 
feed yards with respiratory distress, and provided the first evidence for an etiological 
role of this virus in naturally occurring shipping fever pneumonia. This virus was also 
isolated at high rates from young cattle of a livestock show and stocker cattle on 
pastures during fall and winter months in the southern United States (Storz, 1998; Storz 
et al., 1999).
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During the fall of 1997 and 1998, 2 prospectively designed investigation were 
conducted on 105 and 120 cattle, respectively, which experienced severe epizootics of 
naturally occurring shipping fever pneumonia and were subjected to sequential 
sampling and bacteriological, virological and serological testing (Storz et al., 1999, 
Storz et al., 2000a and b). These experiments generated excellent samples for 
virological studies on naturally-infected cattle. Again, a surprisingly high rate of RBCV 
infections and virtually no other bovine respiratory viruses were detected from nasal 
swab and lung samples of sick or dead cattle at the beginning of these shipping fever 
epizootics.
The epizootic dimensions of this RBCV infection of beef and dairy cattle are 
documented by isolation of this newly emerging virus from cattle with acute respiratory 
tract diseases in 11 different states of this country. This finding implies that RBCV 
appears to be a new factor in the BRDC that was previously not recognized. It is 
possible that this virus infection was missed in past investigations because sensitive 
tests were not applied, but a more likely hypothesis is that we are dealing with an 
emerging virus infection in a cattle population that is protected through effective 
modem vaccination against other known virus infections. The major objectives of this 
investigation were to assess the dynamics of currently prevailing respiratory virus 
infections of cattle with acute respiratory tract diseases, including shipping fever 
pneumonia, and to catalogue virus isolates with features of cytopathic expression of
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RBCV in G clone cells, and to identify hemagglutinating and receptor-destroying 
properties.
3.2 Materials and Methods
3.2.1 Experimental Design and Collection of Samples from Cattle
1993 Epizootic: One hundred cattle of 6 to 9 months old were involved in the 1993 
experiment. Fifty beef cattle had originated from farms and ranches in Oklahoma, Texas 
and Arkansas, has passed through sale yards, then were transported to a feedlot in 
Kansas. Another 50 young cattle originated from dairy herds in California and were 
transported to a feedlot in Arizona. These cattle showed respiratory signs and fever on 
arrival at the 2 feedlots when clinical examinations were performed and nasal swab 
samples were taken. However, ensuing respiratory tract diseases of these cattle was not 
monitored. Duplicate nasal swab samples were obtained and placed in separate tubes 
containing 3 ml of transport medium (phosphate buffered saline [PBS] with 5% fetal 
calf serum), and were then frozen at -70°C until they were tested. One set of these 
samples was tested at our laboratories in Louisiana State University while another set 
was assayed at a laboratory in Kansas.
Cases from Louisiana State University livestock show and clinics: Twenty-nine 
nasal swab samples were obtained from cattle in the 1994 Louisiana State University 
Livestock Show (LSU-LSS). These calves showed signs of acute respiratory distress 
and required special veterinary services. From 1995 to 1997, 16 nasal swab samples
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were supplied from clinical cases of LSU Department of Veterinary Clinical Sciences 
and Veterinary Medical Diagnostic Laboratory and from clinical cases of Mississippi 
State University Veterinary Clinical Sciences.
Cases from cattle on winter pastures: Fifteen nasal swab samples were obtained 
on November 25, 1996 from cattle of the Lawton Ranch Herd which had acute 
respiratory tract disease and were provided by Dr. Michael Meaux at Rhode Veterinary 
Hospital, Inc. These cattle presented with mucopurulent nasal discharge and 
temperature of 41°C. Lung sounds were greatly increased with crackles and wheezes 
present. The animals were treated with Micotil. The herd consisted of 900 head of 
purebred Charolais cattle which originated from Texas, and were divided into several 
pastures located just west of Sulphur, Louisiana. This herd was closed with the only 
new additions to the herd being Charolais, Limosine and Beefmaster bulls and 3 
Charolais cows with calves a year and a half earlier. At weaning, these cattle 
subcutaneously were given a vaccine containing killed IBR, BVD, PI-3, BRSV virus 
antigens as well as a 5-way lepto and a 8-way Clostridium vaccines. They were 
dewormed and heifers were brucellosis vaccinated.
One set of trachea and lung samples of 3 dead calves was provided by Dr. Jeffrey 
Anderson from a farm in the Northwest Louisiana during March of 1998. This 3-month 
old calf was from a herd of 150 beef cows, 125 calves, and 23 cow-calf pairs which 
experienced a severe respiratory disease episode with over 20% of the 125 calves
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affected. The affected calves had pneumonia with mucopurulent nasal discharge, 
increased respiratory rates, and rectal temperature above 40°C. They had been 
vaccinated with “Cattlemaster 4+VL5 (BHV-1, BVDV, PI-3, BRSV, leptospira and 
Campylobacter antigens), 1 shot of Pasteurella  vaccine, and Scour-guard K/C 
(coronavirus, rotavirus, and Escherichia coli) about 2 weeks before the onset of 
pneumonia epizootic. In November, 1998, another 2 sets of trachea and lung samples 
from 2 dead calves were provided by Dr. Anderson. The calves were 6 months old and 
from a herd of 200 cows and 200 yearling cattle. Clinical features and vaccine histories 
were the same as described before. All trachea and lung samples were frozen at -70°C 
until they were tested.
1997 and 1998 epizootics of shipping fever among market-stressed cattle: 
Prospective, carefully designed experiments of 1997 and 1998 included 105 and 120 
cattle of 6 to 8 months old, respectively. The cattle were assembled at an order-buyer 
bam (OBB) from 3 different local auctions in eastern Tennessee. Each calf was eartag- 
identified, and clinically examined on their arrival at the OBB, that is day 0 post-arrival 
at OBB. After nasal swab and blood samples had been collected, the cattle were 
vaccinated with commercially available modified-live vaccines against BHV-1 and PI-3 
in 1997 (Prevail, Rhone Merieux, Inc., Athens, Ga.)and BHV-1 only in 1998 (Reliant, 
Rhone Merieux, Inc., Athens, Ga.). A 7-way clostridial vaccine (Electroid 7, 
Mallinckrodt Veterinary, Inc., Mundelein, II.) and Ivomec (Merck Agriculture and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
34
Veterinary Division, Merck and Co., Inc., Rahway, N.J.) were given to all cattle and an 
experimental bacterin-toxoid of P. haemolytica was given to the odd-numbered cattle 
(Loan et al., 1988). After a 4-day rest at the OBB, the cattle were transported 1932 
kilometers to a feed yard jointly operated by the Agricultural Research Service (ARS) 
and the Texas Agricultural Experiment Station in Bushland, Texas where clinical 
assessments were continued. Nasal specimens were taken on days 7, 14, and 21 post- 
arrival at OBB, while blood specimens were taken on days 7, 14, 21, 28 and 35 post­
arrival at OBB. Nasal swab samples were collected in duplicates using cotton swabs 
that were inserted deeply into the ventral meatus of the nostrils, placed into test tubes 
with 1 ml transport medium, and frozen at -70°C  until they were subjected to 
virological and bacteriological tests while blood samples were obtained for serum 
harvest.
Ten and 16 cattle died during the 1997 and 1998 investigations, respectively. The 
dead cattle were taken to the Texas Veterinary Diagnostic Laboratory in Amarillo, 
Texas, where necropsies were performed and lung samples were collected. Aliquots of 
lung samples were frozen at —70°C for isolation, identification and quantitation of 
bacteria and viruses.
3.2.2 Processing of Nasal Swab Samples
The samples were thawed, and 1 ml of cold Dulbecco’s modified minimal essential 
medium (DMEM, Sigma Chemical Co., St. Louis, Mo.) with 4.5 g/1 of glucose buffered
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with 44 mM NaKC03 and supplemented with penicillin (100 units/ml) - streptomycin 
(100 pg/ml) (Sigma Chemical Co.) was added to each sample. The tubes were stirred 
for 2 min. Aliquots of fluids were taken for centrifugation at 1,500 x g for 20 min. 
Supernatant fluids were withdrawn and filtered through 0.45 pm Millipore filters 
(Acrodisc™ syringe filters, Gelman Sciences, Ann Arbor, Mich.). The filtrates were 
used to inoculate the cell cultures.
3.2.3 Processing of Trachea and Lung Samples
Virus isolation and titration: Tracheal mucosa and lung tissues were cut from 
frozen specimens and minced with scissors into small pieces, while surface mucus 
membranes of trachea were scrapped off with scissors. Tissues were homogenized by 
grinding with Ten Broeck devices in the appropriate volume of cold DMEM to make 
5% (g/v) suspensions. The homogenates were centrifuged at 1,500 x g for 20 min. The 
top half of the supernatant was withdrawn, diluted 1:1 with cold DMEM and subjected 
to a second cycle of centrifugation. Then, the top half of this supernatant was 
withdrawn, and filtered as described and used for virus isolation and RBCV infectivity 
titration.
Immunocytochemical examinations: A small piece of lung tissue was cut from 
each thawed sample and used to make exfoliative cytological preparations on glass 
slides for immunofluoresecent tests.
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Bacterial identification and quantitation: Tests were performed according to 
Weaver and Frank (Frank and Wessman, 1978; Weaver and Hollins, 1980). Briefly, the 
lung specimens were thawed, surfaces were seared with a hot spatula, and 1 gram of 
tissue was removed from the center of each sample. The cut tissue was minced with 
scissors, homogenized with a Ten Broeck device, and subjected to a serial 10-fold 
dilution in PBS. Aliquots of 0.1 ml of the dilutions were plated in duplicate on tryptose 
agar plates fortified with 5% citrated bovine blood, and spread over the media with a 
spreader bar. The culture plates were kept in a 37°C incubator with 5% C 0 2 for 24 h. 
Bacterial colonies were counted and the numbers of the 2 replicates were averaged. 
Colonies of P. haemolytica and P. multocida were identified by colony morphology, 
Gram staining, biochemical reactions and specific serotyping.
3.2.4 Virus Isolation Scheme for Known Respiratory Bovine Viruses
The virus isolation scheme included 3 different cell types: the G clone of human 
rectal tumor-18 (HRT-18) (Lin et al„ 1997b; Storz et al., 1996; Storz, 1998; Storz et al., 
1999; Storz et al., 2000a and b; Tompkins et al., 1974), Georgia bovine kidney (GBK) 
and bovine turbinate (BT) cells. These cell types were specifically permissive for all 
known respiratory bovine viruses. The BT cells are particularly permissive for BRSV 
(Rosenquist, 1974; Storz et al., 1996), while either BT or GBK cells are sensitive to 
other viruses, such as PI-3, BHV-1, cytopathogenic BVDV and bovine adenovirus 
(Storz et al., 1996). Importantly, RBCV can only replicate in the G clone cells and not
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in currently available cultured bovine cells (Storz et al., 1996). Virus replication and 
related cytopathic changes in these cell culture systems were tested with the Cooper 
strain of BHV-1, the 72-P-1096 strain of PI-3, the NADL strain of BVDV, the FS1-1 
strain of BRSV, and the LSU-LSS-218 strain of bovine adenovirus.
Different cell types were propagated in sets of 24-well plates (Becton-Dickinson 
Labware, Franklin Lakes, N.J.) with DMEM at 37°C until confluent monolayers were 
formed. Medium supplemented with 5% fetal bovine serum (FBS, Sigma Chemical Co.) 
was used for cell propagation, and serum-free medium was used during virus 
propagation. Confluent monolayers were washed 2 times with serum-free Dulbecco's 
PBS (calcium and magnesium free, Sigma Chemical Co.) before inocula were added. 
Each prepared sample was diluted to 10'1 and 10'2, and 0.5 ml of each dilution was 
added to each well in duplicates. Five samples were tested to 5 rows of 4 wells of each 
plate, leaving the 6th row of 4 wells as uninoculated cell control. Following inoculation, 
the cell cultures were incubated at 37°C and examined daily with an inverted 
microscope for evidence of cytopathic changes for 6 days. Then, they were subjected to 
1 cycle of freezing at -70°C and thawing at room temperature. The media of cell 
cultures in the 4 wells inoculated with the same test samples or the control wells were 
pooled for hemagglutinin (HA) and receptor-destroying enzyme (RDE) assays. Media 
of G clone cell cultures that developed characteristic cytopathic changes and positive
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HA and RDE activities were pooled for stock preparations or subpassages. Media of BT 
or GBK cell cultures that developed any cytopathic changes were collected and 
subjected to 2nd or 3rd subpassages in the homologous cell culture systems to detect 
other respiratory bovine viruses. Media of uninoculated control cell cultures were 
similarly tested. The result of virus isolation was considered as negative when neither 
cytopathic changes nor HA and RDE activities were detected in the 3rd subpassage.
3.2.5 Identification of RBCV and Other Respiratory Bovine Virus Isolates
As reported (Storz et al., 1999), the virus isolates were initially identified by the 
characteristic cytopathic changes in the specifically permissive cell types. Additional 
differentiation tests involved: (1) assays for HA titers and RDE activities, a 
characteristic of RBCV, with rat red blood cells (RBC); (2) Cells infected with selected 
RBCV isolates that evidenced high fusogenic activity in the first passage were analyzed 
ultrastructurally. Fluids of such cultures also were examined by negative-contrast 
electron microscopy; (3) tests for HA activities of PI-3 with bovine and chicken RBC; 
(4) HA inhibition (HAI) tests with specific antisera for PI-3 and other virus isolates with 
bovine and chicken RBC; (5) virus infectivity neutralization tests with monospecific, 
polyclonal antiserum  against BHV-1 which was diluted at 1:5; and (6) 
Immunofluorescence assay with fluorescent antibodies specific for BHV-1, PI-3, 
BVDV and BRSV.
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3.2.6 Tests for HA Antigens and RDE
As reported (Storz et al., 1999; Storz et al., 2000b), washed rat, chicken or bovine 
RBC were prepared to 0.5% with PBS pH7.4, containing 0.05% bovine serum albumin 
(BSA). Fifty pi of each test samples was used and prepared as serial 2-fold dilutions in 
96-well V-bottom microtiter plates (Costar, Cambridge, Mass.) with a volume of 50 pi. 
The prepared RBC suspensions were added in a volume of 50 pi. The plates were 
shaken to disperse the RBC suspensions and incubated at 6°C for 2 h. The HA titers 
were determined as the highest dilutions with complete aggregation of the RBC. The 
plates were then shifted to a 37°C incubator and placed there for 2 h. The RDE 
activities were considered as the highest dilutions with complete elution of adsorbed 
virions, that is the deaggregation of existing virus-erythrocyte complexes.
3.2.7 Hemagglutinin Inhibition Assay
As reported (Storz et al., 2000b), specific antisera for BCV (serum 1745) (Storz and 
Rott, 1980; Storz and Rott, 1981), PI-3 (serum 70P-1096) and other virus isolates were 
diluted at 1:4 in PBS, and then diluted in a serial 2-fold steps as 50 pi aliquots. Aliquots 
of media of cell cultures infected with sbspected PI-3 or other virus isolates were 
collected, prepared to 16 HA units in PBS pH7.4 containing 0.05% BSA and used as 
antigens. The prepared antigens were added in a volume of 50 pi to each serum dilution. 
Following 30 min-reaction of serum and antigen mixtures at room temperature, 50 pi of
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rat, chicken or bovine RBC suspensions were added as described above. The plates 
were kept at 6°C for 2 h, and the HAI titers were determined as the highest dilutions 
with complete inhibition of the aggregation of RBC.
3.2.8 Plaque Titration of RBCV in Lung Tissues
The plaque assay was performed according to recently published procedure (Lin et 
al., 1997b), using 6-well flat-bottom tissue culture plates (Becton-Dickinson, Lincoln 
Park, N.J.) with G clone confluent monolayers. Briefly, ceils were maintained in 
DMEM supplemented with 5% FBS. Confluent monolayers were washed 2 times with 
serum-free Dulbecco's PBS (calcium and magnesium free) before inocula were added. 
Dilutions of test samples in 10-fold sequential steps were prepared in serum-free 
DMEM. Cell monolayers were inoculated with 0.5 ml of the appropriate dilutions and 
incubated for 1 h at 37°C. Following excessive inocula had been removed, the 
monolayers were overlayed with 0.5% agarose (Ultrapure DNA Grade Agarose, Bio- 
Rad Laboratories, Richmond, Calif.) in trypsin- and serum-free DMEM. After the 
overlay medium had solidified at room temperature, plates were incubated at 37°C in a 
5% CO; incubator for 2 to 4 days until cytopathic changes were observed and plaques 
were formed. Cells were then stained with 0.05% neutral red (Sigma Chemical Co.) in 
serum-free Dulbecco's PBS (calcium and magnesium free), and fixed with 4% (v/v)
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formalin (J.T. Baker Chemical Co, Phillipsburg, N.J.) in PBS for plaque quantitation. 
Uninoculated cell cultures were used as negative controls.
3.2.9 Virus Infectivity Neutralization Tests
The neutralization tests were performed in 24-well plates (Becton-Dickinson 
Labware) with confluent monolayers of GBK cells. Cultures of cells were maintained in 
MEM (Sigma Chemical Co.) supplemented with 10% FBS. The media of BT or GBK 
cell cultures with specific features of cytopathic changes were pooled for stock 
preparations and subjected to a sequential 10-fold dilution in serum-free MEM. A 
volume of 0.1 ml of the appropriate viral dilutions was mixed with 0.1 ml of 
monospecific, polyclonal antiserum 4897-IBR-NBF against BHV-1 which was diluted 
at 1:5 in serum-free MEM, and the mixture reacted at room temperature for 30 min. 
Cell monolayers were inoculated as described and overlayed with 2% methylcellulose 
(Sigma Chemical Co.) in MEM buffered with 25 mM Hepes (Sigma Chemical Co.) and 
supplemented with 2% FBS and penicillin (100 units/ml) - streptomycin (100 pg/ml). 
Plates were incubated at 37°C in a 5% C 0 2 incubator for 2 to 4 days until cytopathic 
changes were observed and plaques were formed. The monolayers were then fixed with 
a prepared solution (76% ethanol, 5% formaline, 5% glacial acetic acid). After the 
overlayers were removed, the cells were stained with Gram Crystal Violet (DIFCO 
Laboratories, Detroit, Mich.) for plaque counting. Infectivity titration in the presence of 
MEM alone and uninoculated cell cultures with or without serum were used as controls.
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3.2.10 Indirect Immunofluorescence Assay
Indirect immunofluorescence assay (IFA) was performed according to standard 
methods. Briefly, exfoliative cytological preparations on glass slides were air-dried, and 
fixed with methanol for 20 min at room temperature and incubated with respiratory 
bovine virus-specific antisera (diluted at 1:50 in PBS) at 37°C for 1 h, then washed with 
PBS and stained with fluorescein isothiocyanate (FITC)-Iabeled affinity purified goat 
anti-bovine IgG (diluted 1:50, Kirkegaard & Perry Laboratories Inc. Gaithersburg, Md.) 
at 37°C for 1 h. The cytologic preparations were then counter stained with Evans blue, 
and examined with a UV microscope (Olympus AH-2, Olympus Optical Co. LTD, 
Japan).
3.2.11 Virus Purification and Negative-contrast Electron Microscopy
The virus purification procedure was performed according to Zhang et al. (Zhang et 
al., 1994). Briefly, infected G clone cultures with approximately 90% of the cells 
showing cytopathic expression were subjected to 3 cycles of freezing and thawing, and 
sonicating 4 times for 15 s at a power setting of 4 (Branson Sonifier cell disruptor 200, 
Branson Ultrasonics Co, Danbury, Conn.) and centrifugation at 1,500 x g for 30 min. 
Supernatant fluids were collected, and precipitated overnight at 4°C with 10% (w/v) 
polyethylene glycol 8,000 and 0.5 M NaCl in TNE buffer (100 mM Tris, 10 mM NaCl,
1 mM EDTA, pH 7.4), and harvested by centrifugation at 1,500 x g. A drop of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
43
concentrated sample was stained with 2% phosphotunstic acid in PBS on a formvar- 
coated copper grid and examined with a ZEIS EM 10 electron microscope at 60 to 
80 kv.
3 3  Results
3.3.1 Clinical Observations
The 100 cattle in the 1993 experiment exhibited respiratory signs, including cough 
or mild-to-moderate dyspnea or nasal discharge on their arrival at the feedlot. Nine of 
them had all of these signs. Rectal temperatures ranged from 38.4°C to 40.8°C and 
39.8°C to 40.9°C for cattle in Kansas feedlot and Arizona feedlot, respectively. Another 
63 cattle from the 1994 LSU Livestock show, clinics and winter pastures of Southern 
and Northwest Louisiana also displayed clinical signs of acute respiratory distress, 
increased respiratory rates, mucupurulent nasal discharge and fever.
The 105 calves of the 1997 experiment appeared clinically normal on their arrival 
and during their stay at the OBB. Three days after arrival at the ARS feedlot following a 
transport over a distance of 1932 kilometer, 93 of them developed nasal and eye 
discharges and fever with rectal temperatures ranging from 40°C to 45°C. Ten calves 
died 1 to 5 days after arrival at the feedlot that were 7 to 11 days post-arrival at the 
OBB. Seventy-nine of the remaining 83 sick cattle were treated vigorously with
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antibiotics. Twelve of the 105 calves did not exhibit adverse clinical signs of respiratory 
tract diseases, therefore were not treated.
During the 1998 investigation, 39 of the 120 cattle showed evident respiratory signs 
with rectal temperatures of above 40°C on their arrival at the OBB. A total of 107 
calves developed adverse signs of respiratory tract diseases after arrival the ARS feedlot 
and therefore treated with antibiotics while 16 of them died 1 to 32 days later that were 
7 to 38 days post-arrival at the OBB. The remaining 13 calves appeared clinically 
normal.
3.3.2 Shedding of Viruses in Nasal Secretions of Cattle and Properties o f RBCV 
Isolates
The 1993 experiment: Of the 100 cattle involved in the 1993 experiment, 42 
nasally shed viruses as detected through the characteristic cytopathic changes in the 3 
different cell culture systems (Table 3.1). Of these 42 viral isolates, 38 were G clone 
cell-dependent, and were not detected in GBK or BT cell cultures. Of 50 cattle in the 
Kansas feedlot, 32 yielded this unique G clone cell-dependent viral agent, while of 50 
cattle in the Arizona feedlot, 6 had viral isolate cultured from nasal swab samples that 
multiplied only in G clone cells.
Nasal swab samples from 4 cattle in the Arizona feedlot also contained a viral agent 
that induced cytopathic changes, mainly cell fusion, in BT cells. These viral isolates 
exhibited activities in agglutination of chicken and bovine RBC which were inhibited
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Table 3.1: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle
in Kansas Feedlot and Arizona Feedlot
State of ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent*Viruses
Origin Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
K Feedlot
Oklahoma OK-2793 + F >256 <2 - - - - -
OK-2482 - <2 <2 - - - - -
OK-1986 - <2 <2 - - - - -
OK-3484 + F >256 <2 - - - - -
OK-0543 + F >256 64(2) - - - - -
OK-0105 + F >256 <2 - - - - -
OK-0286 + F(2) >256 (2) 32 (2) - - - - -
OK-0481 + F(2) >256 (2) 8(2) - - - - -
OK-3845 + F >256 <2 - - - - -
OK-0099 + F >256 <2 - - - - -
OK-1910 - <2 <2 - - - - -
OK-2077 - <2 <2 - - - - -
OK-0518 + F >256 <2 - - - - -
OK-0357 + F >256 <2 - - - - -
OK-0519 + F >256 <2 - - - - -
OK-3683 - <2 <2 - - - - -
OK-0471 - <2 <2 - - - - -
OK-1595 - <2 <2 - - - - -
OK-2480 + F >256 <2 - - - - -
OK-0251 + F >256 <2 - - - - -
OK-2I20 - <2 <2 - _ . _ _
Table 3.1: contd.
Samples were provided by Dr. Stine from Immtech Biologies, Bucyrus, KS; K: 
Kansas; A: Arizona; BT: bovine turbinate cells; GBK: Georgia bovine kidney cells; 
CPE: the cytopathic expression; +: have CPE; no CPE; F; fusion; HC: honeycomb 
formation; Number in brackets indicates the number of subpassage in which (1) CPE 
was first detected and RBCV was isolated, otherwise, RBCV was isolated in the 1st G 
clone cell passage; (2) HA and RDE titers were recorded, otherwise, they were 
recorded with RBCV in the 1st G clone cell passage; HA: hemagglutinin; RDE: 
receptor-destroying enzyme; RBCV: respiratory bovine coronavirus; BHV-1: bovine 
herpes virus-1; BAV: bovine adenovirus; cpBVDV: cytopathogenic bovine viral 
diarrhea virus; PI-3: parainfluenza virus-3; BRSV: bovine respiratory syncytial virus.
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S ta te  o f ID  o f G  Clone Cell D ependen t-R B C V BT o r  G B K  C ell D ependent-V iruses
O rig in C a ttle C PE HA T ite r R D E  T ite r BHV-1 PI-3 cpB V D V  BAV BRSV
Oklahoma OK-2081 + F, HC (2) >256 (2) 32 (2) .
OK-3258 + F >256 <2 .
OK-3176 + F >256 <2 .
OK-0725 + F >256 <2 .
OK-3771 - <2 <2
OK-0687 - <2 <2 .
OK-0142 - <2 <2 .
OK-0358 + F >256 <2
OK-3568 + F >256 <2 .
OK-NT - <2 <2 -
OK-0926 +- F >256 <2 -
OK-05I4 + F >256 64(3) .
Texas TX-956 - <2 <2 .
TX-671 + F >256 128 (2)
TX-I335
TX-1594




- - - - -
TX-284 + F >256 64(2) -
TX-911 + F(2) >256 (2) 4(3) -
TX-1533 + F >256 32 (2) .
TX-187 - <2 <2 -
TX-I395 + F 64 <2
TX-2385 + F >256 64(2) .
TX-I456 - <2 <2 - -
Arkansas AR-1356 + F >256 64(3) .
AR-7ET-65 - <2 <2 .
AR-NT1 + F >256 <2
AR-NT2 + F(2) >256 (2) 64(2) -
AR-NT3 + F >256 <2 .
A Feedlot
AR-NT4 - <2 <2 -
California AZ-000098 - <2 <2 -
AZ-19085 - <2 <2 -
AZ-19522 - <2 <2 -
AZ-19529 - <2 <2 -
AZ-19548 - <2 <2 -
AZ-19692 - <2 <2 -
AZ-19766 + F 128 64(2) -
Table 3.1: contd.
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State of ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent*Viruses
Origin Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
California AZ-19906 - <2 <2 - - - - -
AZ-I9937 - <2 <2 - - - - -
AZ-19963 - <2 <2 - - - - -
AZ-19972 - <2 <2 - - - - -
AZ-19990 - <2 <2 - - - - -
AZ-24366 - <2 <2 - - - - -
AZ-23509 - <2 <2 - - - - -
AZ-23559 - <2 <2 - - - - -
AZ-23584 - <2 <2 - - - - -
AZ-20898 - <2 <2 - - - - -
AZ-23481 - <2 <2 - + - - -
AZ-24316 - <2 <2 - - - - -
AZ-24444 - <2 <2 - + - - -
AZ-24362 + F(2) >256 (2) 32 (2) - - - - -
AZ-24646 - <2 <2 - - - - -
AZ-25357 - <2 <2 - - - - -
AZ-26525 - <2 <2 - - - - -
AZ-26787 - <2 <2 - - - - -
AZ-28256 - <2 <2 - - - - -
AZ-28410 + F 16, >256 (2) 64(2) - - - - -
AZ-24619 + F 128 64(2) - - - - -
AZ-23489 - <2 <2 - - - - -
AZ-19996 - <2 <2 - - - - -
AZ-000997 - <2 <2 - - - -
AZ-24239 - <2 <2 - - - - -
AZ-24382 - <2 <2 - - - - -
AZ-24337 - <2 <2 - - - - -
AZ-19847 - <2 <2 - - - - -
AZ-26649 + F >256 64(2) - - - - -
AZ-19884 - <2 <2 - - - - -
AZ-26337 + F >256 8(2) - - - - -
AZ-28414 - <2 <2 - - - - -
AZ-23170 - <2 <2 - - - - -
AZ-20641 - <2 <2 - + - - -
AZ-20899 - <2 <2 - - - - -
AZ-22913 - <2 <2 - - - - -
AZ-26532 - <2 <2 - _ _ _
Table 3.1: contd.
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State of ID or G Clone Cell Dependent-RBCV BT or GBK Cell Dependent*Viruses
Origin Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
California AZ-23586 - <2 <2
AZ-19958 <2 <2 . . .  .
AZ-19948 <2 <2 . . .  . .
AZ-000996 <2 <2 . . .  . .
AZ-25I20 <2 <2 . . .  . .
AZ-19902 - <2 <2 . . .  . .
Total 38/100 0/100 4/100 0/100 0/100 0/100
Table 3.1.
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by antiserum against PI-3. The BT cells infected with these viral isolates also adsorbed 
chicken and bovine RBC, and fluorescence-stained with antibodies specific for PI-3, but 
not with antibodies specific for BHV-1, BVDV or BRSV. All these findings reflected 
properties of PI-3.
Properties of RBCV isolates: The majority of these G clone cell-dependent viral 
isolates induced abundant and extensive polykaryons in the 1st passage in G clone cells 
without the enhancement of trypsin, and fused cells detached rapidly from the 
monolayers as soon as fusion was formed. Therefore, large granular clumps of cellular 
floats were created in the cell culture medium. Additional HA assays indicated that 16 
to >256 HA units could be detected from the media of cell cultures infected with these 
viral agents, only with mouse and rat RBC. The hemagglutination activities could be 
inhibited by bovine antiserum 1745 specific to BCV. The associated characteristic RDE 
functions were measured at titers ranging from <2 to 128. Furthermore, negative- 
contrast electron microscopic analysis of infected G clone cells indicated the presence 
of round and enveloped virions that had the diameter of 70 to 80 nm, and contained 
electron-dense cores and club-shaped projections of 12 to 17 nm in length (Fig. 3.1). 
Therefore, these viruses were identified as respiratory bovine coronaviruses (RBCV).
Nasal swab samples from show cattle, clinical cases, and cattle on winter 
pastures: Of the 29 cattle in the 1994 Louisiana State University Livestock show, 4 
nasally shed G clone cell-dependent RBCV isolates, while 2 had BHV-1 isolates that
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FIG. 3.1: Negatively stained viral particles of RBCV OK-0514-2.
Petal-shaped projections and short peplomeres are evident. Internal structures are not 
detectable (x 680,000); bar = 20pm.
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multiplied in BT cells and formed pronounced grape-like aggregation of rounded cells 
(Table 3.2). These BHV-1 isolates were also identified by virus infectivity 
neutralization test and IFA with antisera specific to BHV-1. These calves had mixed 
infections with RBCV and BHV-1. One calf yielded bovine adenovirus in nasal swab 
samples through the characteristic cytopathic changes in BT cell cultures consisting of 
slow development of highly refractile swollen cells that gradually detached and lysed. 
This viral isolate is further identified by (1) virus infectivity neutralization test; (2) the 
presence of large, irregular intranuclear inclusion with varying halos while infected BT 
cells were stained with the Giemsa or hematoxylin-eosin; (3) lattice arrangement of 
circular viral capsid of 60 to 70 nm in diamer as indicated by ultrastructure analysis; 
and (4) absence of HA titers with rat and mouse RBC.
Of the 16 nasal swab samples provided by the clinicians of Louisiana State 
University and Mississippi State University, 2 contained G clone cell-dependent RBCV, 
while BHV-1 was detected once (Table 3.3).
Of the 15 cattle on the winter pasture of Southern Louisiana, 4 had RBCV isolates 
that multiplied only in the G clone cells, while 1 shed BHV-1 in nasal secretions (Table 
3.4).
The 1997 shipping fever experiment: Of the 105 cattle, 64 nasally shed viruses 
dependent on G clone cells for replication on their arrival at the OBB, while BHV-1 
was detected from 2 cattle which also had RBCV infection (Table 3.5). These G clone
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Table 3.2: Respiratory Bovine Virus Isolation from Nasal Swab Samples o f Cattle
in the 1994 Louisiana State University Livestock Show
G Clone Cell Dependent-RBCV BT or GBK Cell Dependent-Viruses
ID of Cattle CPE HA Titer ROE Titer BHV-1 PI-3 cpBVDV BAV BRSV
LSU-94LSS-035-1 - <2 <2 - - - - -
LSU-94LSS-040-1 - <2 <2 - - - - -
LSU-94LSS-048-1 - <2 <2 - - - - -
LSU-94LSS-050-1 - <2 <2 - - - - -
LSU-94LSS-051-1 + F >256 32 (3) - - - - -
LSU-94LSS-052-1 - <2 <2 - - - - -
LSU-94LSS-058-1 + F >256 32 (2) - - - - -
LSU-94LSS-05B-1 - <2 <2 - - - - -
LSU-94LSS-063-1 - <2 <2 - - - - -
LSU-94LSS-062-I - <2 <2 - - - - -
LSU-94LSS-081 - 1 - <2 <2 - - - - -
LSU-94LSS-082-1 - <2 <2 - - - - -
LSU-94LSS-094-1 - <2 <2 - - - - -
LSU-94LSS-092-1 - <2 <2 - - - - -
LSU-94LSS-091-1 - <2 <2 - - - - -
LSU-94LSS-095-1 - <2 <2 - - - - -
LSU-94LSS-099-1 - <2 <2 - - - - -
LSU-94LSS-112-1 - <2 <2 - - - - -
LSU-94LSS-114-1 - <2 <2 - - - - -
LSU-94LSS-119-1 - <2 <2 - - - - -
LSU-94LSS-128-1 - <2 <2 - - - - -
LSU-94LSS-141-1 - <2 <2 - - - - -
LSU-94LSS-142-1 - <2 <2 - - - - -
LSU-94LSS-143-1 - <2 <2 - - - - -
LSU-94LSS-144-1 + F >256 <2 + - - - -
LS U-94LSS-168-1 - <2 <2 - - - - -
LSU-94LSS-136-1 - <2 <2 - - - - -







Notes as table 3.1.
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Table 3.3: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle
in Clinical Cases
ID of Cattle G Clone Cell Dependent-RBCV BT or GBK Dependent-Viruses
CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
MS-VCS-249 - <2 <2 - - - - -
MS-VCS-124 - <2 <2 - - - - -
MS-VCS-18859 - <2 <2 - - - - -
MS-VCS-18911 - <2 <2 - - - - -
MS-VCS-33177 - <2 <2 - - - - -
MS-VCS-37108 - <2 <2 - - - - -
MS-VCS-125 + F >256 128 (2) - - - - -
MS-VCS-3 - <2 <2 - - - - -
MS-VCS-13 - <2 <2 - - - - -
MS-VCS-20 - <2 <2 - - - -
MS-VCS-23 - <2 <2 - - - - -
MS-VCS-123 - <2 <2 - - - - -
LSU-VCS-6622698 + F, HC >256 32 (2) - - - - -
LSU-VCS-625142 - <2 <2 - - - - -
LS U-VMDL-625546 - <2 <2 - - - - -
LSU-VMDL-96-2124 - <2 <2 - - - - -
Total 2/16 1/16 0/16 0/16 0/16 0/16
MS-VCS: samples provided by Dr. Hoyt and Dr. Paulson from Department of 
Veterinary Clinical Sciences at Mississippi State University; LSU-VCS: samples 
provided by Dr. Angel from Department of Veterinary Clinical Sciences at Louisiana 
State University; LSU-VMDL: samples provided by Dr. Gill from Veterinary Medical 
Diagnostic Laboratory at Louisiana State University; Other notes as table 3.1.
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Table 3.4: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle of
the Lawton Ranch Herd
ID ot Cattle G Clone Cell Dependent-RBCV BT or GBK Cell Dependent-Viruses
CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
96LR-I + F 32 <2 - - - - -
96LR-2 - <2 <2 - - - - -
96LR-3 - <2 <2 - - - - -
96LR-4 - <2 <2 - - - - -
96LR-5 + F 64. 256 (3) <2(3) - - - - -
96LR-6 +• F 32. 128 (3) 32 (3) - - - - -
96LR-7 + F 32 32 - - - - -
96LR-8 - <2 <2 - - - - -
96LR-9 - <2 <2 - - - - -
96LR-10 - <2 <2 - - - - -
96LR-11 - <2 <2 - - - - -
96LR-12 - <2 <2 - - - - -
96LR-I3 - <2 <2 - - - - -
96LR-14 - <2 <2 - - - - -
96LR-15 - <2 <2 + - - - -
Total 4/15 1/15 0/15 0/15 0/15 0/15
Samples were provided by Dr. Michael Meaux, Rhodes Veterinary Hospital, Inc., 
Sulphur, LA; LR: Lawton ranch; Other notes as table 3.1.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
55
Table 3.5: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle 
at the Order-buyer Barn during the 1997 Shipping Fever Epizootic
i d  o r G  C lone Cell D ependent-RBCV B T  o r  G B K  Cell D ependent-V iruses
CatUe C P E HA T ite r RD E T ite r BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-1 - <2 <2 - - .
97TXSF-2 - <2 <2 - - .
97TXSF-3 - <2 <2 - - .
97TXSF-4 - <2 <2 - - .
97TXSF-5 + F 32 4 - - .
97TXSF-6 -t-F 64 4 - - .
97TXSF-7 - <2 <2 - -
97TXSF-8 -t-F. HC 64 4 - - .
97TXSF-9 - <2 <2 - - .
97TXSF-10 + F. HC 128 4 - - .
97TXSF-1I + F 64 4 - -
97TXSF-12 + F 64 4 - - .
97TXSF-13 + F 64 4 - - .
97TXSF-I4 + F 64 4 - - .
97TXSF-15 + F 64 4 - - .
97TXSF-16 - <2 <2 - - .
97TXSF-17 - <2 <2 - - .
97TXSF-18 + F 64 <2 - - .
97TXSF-19 + F. HC 32 2 - -
97TXSF-20 + F. HC 32 4 - - .
97TXSF-2I + F 32 2 - - .
97TXSF-22 + F. HC 32 2 - - .
97TXSF-23 - <2 <2 - - .
97TXSF-24 + F 32 <2 - - .
97TXSF-25 + F 128 4 - - .
97TXSF-26 - <2 <2 - - .
97TXSF-27 - <2 <2 - - .
97TXSF-28 + F >256 >256 - - .
97TXSF-29 - <2 <2 - - -
Table 3.5: contd.
Samples were supplied by Dr. Purdy at United States Department of Agriculture- 
Agriculture Research Service in Bushland, Texas. 97TXSF: nasal swab sample 
collected from cattle under investigation of shipping fever (SF) pneumonia at Texas 
(TX) in 1997 (97); Other notes as table 3.1.
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ID of G Clone Cell Dependent-RBCV BT or GBK Dependent*Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-30 + F 64 64 - - - - -
97TXSF-31 + F. HC 128 64 - - - - -
97TXSF-32 - <2 <2 - - - - -
97TXSF-33 + F. HC 128 128 - - - - -
97TXSF-34 - <2 <2 - - - - -
97TXSF-35 - <2 <2 - - - - -
97TXSF-36 + F. HC 128 128 - - - - -
97TXSF-37 + F >256 >256 - - - - -
97TXSF-38 + F >256 >256 - - - - -
97TXSF-39 + F 64 64 - - - - -
97TXSF-40 + F 64 64 - - - - -
97TXSF-41 - <2 <2 - - - - -
97TXSF-42 + F. HC 16 16 - - - - -
97TXSF-43 + F, HC 32 32 - - - - -
97TXSF-44 + F 16 16 - - - - -
97TXSF-45 + F 32 32 - - - - -
97TXSF-46 + F 16 <2 - - - - -
97TXSF-47 + F.HC 64 64 - - - - -
97TXSF-48 + F. HC 128 128 - - - - -
97TXSF-49 + F 128 128 - - - - -
97TXSF-50 - <2 <2 - - - - -
97TXSF-51 - <2 <2 - - - - -
97TXSF-52 - <2 <2 - - - - -
97TXSF-53 - <2 <2 - - - - -
97TXSF-54 + F.HC 64 64 - - - - -
97TXSF-55 - <2 <2 - - - - -
97TXSF-56 - <2 <2 - - - - -
97TXSF-57 - <2 <2 - - - - -
97TXSF-58 + F. HC 64 64 - - - - -
97TXSF-59 + F
00rj 128 - - - - -
97TXSF-60 - <2 <2 - - - - -
97TXSF-61 - <2 <2 - - - - -
97TXSF-62 - <2 <2 - - - - -
97TXSF-63 - <2 <2 - - - - -
97TXSF-64 + F 128 128 - - - - -
97TXSF-65 + F.HC 64 64 - - - - -
97TXSF-66 - <2 <2 - _ _ . .
Table 3.5: contd.
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id  or G Clone Cell Dependent-RBCV BT or GBK Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-67 + F. HC 32 32 - - - - *
97TXSF-68 - <2 <2 - - - - -
97TXSF-69 - <2 <2 - - - - -
97TXSF-70 + F 64 64 + - - - -
97TXSF-71 + F. HC >256 >256 - - - - -
97TXSF-72 - <2 <2 - - - - -
97TXSF-73 + F. HC >256 >256 + - * - -
97TXSF-74 + F. HC 128 128 - - - - -
97TXSF-75 - <2 <2 - - - - -
97TXSF-76 + F 64 64 - - - - -
97TXSF-77 + F, HC 64 64 - - - - -
97TXSF-78 - <2 <2 - - - - -
97TXSF-79 + F 128 128 - - - - -
97TXSF-80 + F 128 128 - - - - -
97TXSF-81 + F 32 32 - - - - -
97TXSF-82 - <2 <2 - - - - -
97TXSF-83 - <2 <2 - - - - -
97TXSF-84 + F 64 64 - - - - -
97TXSF-85 + F 128 128 - - - - -
97TXSF-86 - <2 <2 - - - - -
97TXSF-87 + F 32 32 - - - - -
97TXSF-88 - <2 <2 - - - - -
97TXSF-89 + F. HC 64 64 - - - - -
97TXSF-90 + F 32 32 - - - - -
97TXSF-91 - <2 <2 - - - - -
97TXSF-92 + F 64 64 - - - - -
97TXSF-93 + F 8 8 - - - - -
97TXSF-94 + F 64 64 - - - - -
97TXSF-95 + F >256 >256 - - - - -
97TXSF-96 + F 128 128 - - - - -
97TXSF-97 + F >256 >256 - - - - -
97TXSF-98 - <2 <2 - - - - -
97TXSF-99 + F 64 64 - - - - -
97TXSF-100 + F 32 32 - - - - -
97TXSF-10I + F 32 32 - - - - -
97TXSF-I02 + F 32 32 - - - - -
97TXSF-I03 + F 128 128 _ .
Table 3.5: contd.
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ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-104 - <2 <2 - - - -
97TXSF-105 - <2 <2 - - - -
Total 64/105 2/105 0/105 0/105 0/105 0/105
Table 3.5.
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cell-dependent RBCV strains were isolated in the 1st attempt after inoculating the cells 
with clinical specimens. During transport to the ARS feed yard, 14 discontinued 
shedding RBCV while an additional 22 cattle contracted RBCV infection during 
transport to the ARS feed yard (Table 3.6). Therefore, 72 cattle contained RBCV in 
nasal secretions right after their arrived at the feed yard, which was 7 days post-arrival 
at the OBB, when the calves exhibited severe clinical signs of respiratory tract diseases. 
Meanwhile, no other respiratory bovine viruses were detected in the cattle. A total of 86 
cattle experienced RBCV infection during the first week of this epizootic. Of the 
remaining 95 surviving cattle, the numbers of cattle nasally shedding RBCV 
dramatically reduced to 5 and 4 on days 14 and 21 post-arrival at the OBB, respectively, 
when adverse clinical signs were not evident (Tables 3.7 and 3.8). The single BHV-1 
infections were detected from nasal swab samples of 4 cattle on day 14 post-arrival at 
the OBB, while 1 and 4 cattle shed BHV-1 only and PI-3 only, respectively, on day 21 
post-arrival at the OBB. The BRSV, cytopathogenic BVDV and bovine adenovirus 
could not be detected from all nasal swab samples collected during the 1997 epizootic.
The 1998 shipping fever experiment: O f the 120 cattle, 89 contained RBCV 
isolates in nasal secretions on their arrival at the OBB, when adverse clinical signs were 
already pronounced, and aggressive antibiotic treatment was applied (Table 3.9). Only 1 
cattle had BHV-1 infection at this time. During transport to the ARS feed yard, 2 calves 
became infected with RBCV while 24 calves stopped shedding this virus (Table 3.10).
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Table 3.6: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle 
On Day 7 Post-arrival at the Order-buyer Barn during the 1997 Shipping Fever
Epizootic
ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-1 - <2 <2 - - - - -
97TXSF-2 - <2 <2 - - - - -
97TXSF-3 + F. HC 16 <2 - - - - -
97TXSF-4 - <2 <2 - - - - -
97TXSF-S + F. HC 64 <2 - - - - -
97TXSF-6 + F. HC 64 <2 - - - - -
97TXSF-7 - <2 <2 - - - - -
97TXSF-8 + F, HC 128 8 - - - - -
97TXSF-9 - <2 <2 - - - - -
97TXSF-10 + F. HC 16 16 - - - - -
97TXSF-11 + F, HC 128 128 - - - - -
97TXSF-I2 - <2 <2 - - - - -
97TXSF-13 + F 64 2 - - - - -
97TXSF-14 + F, HC 64 <2 - - - - -
97TXSF-15 + F 64 <2 - - - - -
97TXSF-I6 - <2 <2 - - - - -
97TXSF-17 + F 32 32 - - - - -
97TXSF-I8 - <2 <2 - - - - -
97TXSF-19 + F 128 <2 - - - - -
97TXSF-20 + F 64 <2 - - - - -
97TXSF-21 + F 64 <2 - - - - -
97TXSF-22 - <2 <2 - - - - -
97TXSF-23 - <2 <2 - - - - -
97TXSF-24 - <2 <2 - - - - -
97TXSF-25 + F 64 <2 - - - - -
97TXSF-26 + F.HC 64 64 - - - - -
97TXSF-27 - <2 <2 - - - - -
97TXSF-28 + F. HC 64 4 - - - - -
97TXSF-29 - <2 <2 - - - - -
97TXSF-30 - <2 <2 - - - - -
97TXSF-31 + F. HC 64 16 . _ _ _
Table 3.6: contd. 
Notes as table 3.5.
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id  or G Clone Cell Dependent* RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-32 - <2 <2 - - - - -
97TXSF-33 - <2 <2 - - - - -
97TXSF-34 - <2 <2 - - - - -
97TXSF-35 - <2 <2 - - - - -
97TXSF-36 + F, HC 128 128 - - - - -
97TXSF-37 - <2 <2 - - - - -
97TXSF-38 + F. HC 64 2 - - - - -
97TXSF-39 - <2 <2 - - - - -
97TXSF-40 + F 16 2 - - - - -
97TXSF-41 - <2 <2 - - - - -
97TXSF-42 + F 32 4 - - - - -
97TXSF-43 + F 32 <2 - - - - -
97TXSF-44 + F 64 64 - - - - -
97TXSF-45 - <2 <2 - - - - -
97TXSF-46 - <2 <2 - - - - -
97TXSF-47 + F, HC 64 <2 - - - - -
97TXSF-48 - <2 <2 - - - - -
97TXSF-49 - <2 <2 - - - - -
97TXSF-50 + F 64 8 - - - - -
97TXSF-5I + F 64 4 - - - - -
97TXSF-52 + F. HC 32 <2 - - - - -
97TXSF-53 + F.HC 32 4 - - - - -
97TXSF-54 + F 64 64 - - - - -
97TXSF-55 - <2 <2 - - - - -
97TXSF-56 + F. HC 64 <2 - - - - -
97TXSF-57 + F 64 64 - - - - -
97TXSF-58 + F, HC 128 <2 - - - - -
97TXSF-59 + F. HC 64 <2 - - - - -
97TXSF-60 + F. HC 64 <2 - - - - -
97TXSF-61 + F. HC 16 16 - - - - -
97TXSF-62 + F. HC 128 128 - - - - -
97TXSF-63 - <2 <2 - - - - -
97TXSF-64 + F. HC 128 <2 - - - - -
97TXSF-65 + F 64 64 - - - - -
97TXSF-66 + F. HC 128 8 - - - - -
97TXSF-67 + F 32 <2 - - - - -
97TXSF-68 + F 32 32 _ _ . _
Table 3.6: contd.
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ID  of 
C attle
G  C lone Cell D ependent- RBCV B T  o r  G B K  Cell D ependen t-V iruses
C P E HA T ite r  RDE T ite r BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-69 - <2 <2 - - - - -
97TXSF-70 + F 32 <2 - - - - -
97TXSF-71 + F 64 <2 - - - - -
97TXSF-72 - <2 <2 - - - - -
97TXSF-73 + F. HC 64 <2 - - - - -
97TXSF-74 - <2 <2 - - - - -
97TXSF-75 + F 32 <2 - - - - -
97TXSF-76 + F. HC 64 64 - - - - -
97TXSF-77 + F, HC 128 2 - - - - -
97TXSF-78 + F 128 <2 - - - - -
97TXSF-79 + F 32 32 - - - - -
97TXSF-80 + F 64 64 - - - - -
97TXSF-81 + F 64 2 - - - - -
97TXSF-82 + F 64 64 - - - - -
97TXSF-83 + F 64 64 - - - - -
97TXSF-84 + F 32 <2 - - - - -
97TXSF-85 + F 32 <2 - - - - -
97TXSF-86 - <2 <2 - - - - -
97TXSF-87 + F 128 2 - - - - -
97TXSF-88 - <2 <2 - - - - -
97TXSF-89 + F 128 8 - - - - -
97TXSF-90 - <2 <2 - - - - -
97TXSF-91 + F 64 64 - - - - -
97TXSF-92 + F 64 4 - - - - -
97TXSF-93 + F, HC 64 64 - - - - -
97TXSF-94 + F 64 4 - - - - -
97TXSF-95 + F, HC 32 <2 - - - - -
97TXSF-96 + F 16 2 - - - - -
97TXSF-97 + F. HC 64 2 - - - - -
97TXSF-98 + F, HC 64 64 - - - - -
97TXSF-99 + F 64 2 - - - - -
97TXSF-100 + F. HC 64 8 - - - - -
97TXSF-101 + F 64 4 - - - - -
97TXSF-102 + F, HC 32 4 - - - - -
97TXSF-103 + F.HC 64 4 - - - - -
97TXSF-I04 + F, HC 32 4 - - - - -
97TXSF-105 + F 128 4 - - - - -
Total 72/105 0/105 0/105 0/105 0/105 0/105
Table 3.6.
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Table 3.7: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle 
On Day 14 Post-arrival at the Order-buyer Barn during the 1997 Shipping Fever
Epizootic
ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-1 - <2 <2 - - .
97TXSF-2 - <2 <2 - - .
97TXSF-3 - <2 <2 - -
97TXSF-4 - <2 <2 + - .
97TXSF-5 Died
97TXSF-6 + F(2> 128 <2 - - .
97TXSF-7 - <2 <2 - - .
97TXSF-8 - <2 <2 - - .
97TXSF-9 - <2 <2 - .
97TXSF-10 - <2 <2 - - .
97TXSF-11 - <2 <2 - - .
97TXSF-I2 - <2 <2 - - .
97TXSF-13 - <2 <2 - - .
97TXSF-14 - <2 <2 - - .
97TXSF-15 Died
97TXSF-16 - <2 <2 - - .
97TXSF-17 - <2 <2 + - .
97TXSF-18 - <2 <2 - - .
97TXSF-19 Died
97TXSF-20 - <2 <2 - - .
97TXSF-21 - <2 <2 - - .
97TXSF-22 - <2 <2 - - .
97TXSF-23 - <2 <2 - - .
97TXSF-24 - <2 <2 - - .
97TXSF-25 - <2 <2 - - .
97TXSF-26 - <2 <2 - - .
97TXSF-27 - <2 <2 - - .
97TXSF-28 - <2 <2 - - .
97TXSF-29 - <2 <2 - - .
97TXSF-30 - <2 <2 - - .
97TXSF-31 - <2 <2 - -
97TXSF-32 - <2 <2 - - -
Table 3.7: contd.
Notes as table 3.5.
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ID of G Clone Cell Dependent- RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-33 + F (2) 32. >256 (2) <2 - .
97TXSF-34 - <2 <2 - .
97TXSF-35 - <2 <2 - .
97TXSF-36 + F, HC 16 4 - .
97TXSF-37 - <2 <2 -
97TXSF-38 - <2 <2 - .
97TXSF-39 - <2 <2 - .
97TXSF-40 - <2 <2 - .
97TXSF-41 - <2 <2 - .





97TXSF-45 + F 64 4 - .
97TXSF-46 - <2 <2 - .
97TXSF-47 - <2 <2 - .
97TXSF-48 - <2 <2 - .
97TXSF-49 - <2 <2 - .
97TXSF-50 - <2 <2 - .




+ F >256 >256
97TXSF-54 - <2 <2 - .
97TXSF-55 - <2 <2 - .
97TXSF-56 - <2 <2 - .





97TXSF-60 - <2 <2 - .







97TXSF-65 - <2 <2 .
97TXSF-66 - <2 <2 - .
97TXSF-67 - <2 <2 -
97TXSF-68 - <2 <2 - .
97TXSF-69 - <2 <2 - .
Table 3.7: contd.
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ID of G Clone Cell Dependent* RBCV BT or GBK Cell Dependent*Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-70 - <2 <2 - - .
97TXSF-71 - <2 <2 - - -
97TXSF-72 - <2 <2 - - -
97TXSF-73 - <2 <2 - - -
97TXSF-74 - <2 <2 - - -
97TXSF-75 Died
97TXSF-76 - <2 <2 - - -
97TXSF-77 - <2 <2 - - -
97TXSF-78 - <2 <2 - - -
97TXSF-79 - <2 <2 - - -
97TXSF-80 - <2 <2 * - .
97TXSF-81 - <2 <2 - - .
97TXSF-82 - <2 <2 - - -
97TXSF-83 - <2 <2 - - .
97TXSF-84 - <2 <2 - - .
97TXSF-85 - <2 <2 - - .
97TXSF-86 - <2 <2 - - .
97TXSF-87 - <2 <2 - - .
97TXSF-88 - <2 <2 - - .
97TXSF-89 - <2 <2 - - .
97TXSF-90 - <2 <2 - - .
97TXSF-9I - <2 <2 - - .
97TXSF-92 - <2 <2 - - .
97TXSF-93 - <2 <2 - - .
97TXSF-94 - <2 <2 - - .
97TXSF-95 - <2 <2 - - .
97TXSF-96 Died
97TXSF-97 - <2 <2 - - .
97TXSF-98 - <2 <2 - - .
97TXSF-99 - <2 <2 - - .
97TXSF-I00 - <2 <2 - -
97TXSF-101 - <2 <2 - - .
97TXSF-102 - <2 <2 - - .
97TXSF-I03 - <2 <2 - - .
97TXSF-104 - <2 <2 - - .
97TXSF-105 - <2 <2 - - .
Total 5/95 4/95 0/95 0/95 0/95 0/95
Table 3.7.
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Table 3.8: Respiratory Bovine Virus Isolation from Nasal Swab Samples o f Cattle 
On Day 21 Post-arrival at the Order-buyer Barn during the 1997 Shipping Fever
Epizootic
ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
97TXSF-I - <2 <2 - .
97TXSF-2 - <2 <2 - .
97TXSF-3 - <2 <2 - .
97TXSF-4
97TXSF-5 Died
<2 <2 - -
97TXSF-6 - <2 <2 -
97TXSF-7 - <2 <2 - .
97TXSF-8 - <2 <2 - .
97TXSF-9 - <2 <2 - .
97TXSF-I0 - <2 <2 - .
97TXSF-11 - <2 <2 - .
97TXSF-12 - <2 <2 - .
97TXSF-I3 - <2 <2 -
97TXSF-14
97TXSF-15 Died
<2 <2 - -
97TXSF-16 - <2 <2 - .
97TXSF-I7 - <2 <2 -
97TXSF-18
97TXSF-I9 Died
<2 <2 - -
97TXSF-20 - <2 <2 - .
97TXSF-21 - <2 <2 - .
97TXSF-22 - <2 <2 + .
97TXSF-23 - <2 <2 - .
97TXSF-24 - <2 <2 - .
97TXSF-25 - <2 <2 - .
97TXSF-26 - <2 <2 - .
97TXSF-27 - <2 <2 - .
97TXSF-28 + F. HC 256 <2 - .
97TXSF-29 - <2 <2 + .
97TXSF-30 - <2 <2 - .
97TXSF-3I - <2 <2 - .
97TXSF-32 - <2 <2 - -
Table 3.8: contd.
Notes as table 3.5.
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ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent*Viruses
Cattle CPE HA Titer RDE Titer BHV-l PI-3 cpBVDV BAV BRSV
97TXSF-33 - <2 <2 - - -
97TXSF-34 - <2 <2 - - .
97TXSF-35 - <2 <2 - - -
97TXSF-36 - <2 <2 - - -
97TXSF-37 - <2 <2 - - -
97TXSF-38 - <2 <2 - - -
97TXSF-39 - <2 <2 - - -
97TXSF-40 - <2 <2 - - -
97TXSF-41 - <2 <2 - + -
97TXSF-42 - <2 <2 - - -
97TXSF-43 Died
97TXSF-44 - <2 <2 - - -
97TXSF-45 - <2 <2 - - .
97TXSF-46 - <2 <2 - - -
97TXSF-47 - <2 <2 - - -
97TXSF-48 - <2 <2 - - -
97TXSF-49 - <2 <2 - - -
97TXSF-50 - <2 <2 - - -
97TXSF-51 - <2 <2 - - -
97TXSF-52 Died
97TXSF-53 - <2 <2 - - -
97TXSF-54 - <2 <2 + - .
97TXSF-55 - <2 <2 - - -
97TXSF-56 - <2 <2 - - -
97TXSF-57 - <2 <2 - - .
97TXSF-58 Died
97TXSF-59 - <2 <2 - - .
97TXSF-60 - <2 <2 - - -
97TXSF-6I - <2 <2 - - -
97TXSF-62 Died
97TXSF-63 Died
97TXSF-64 - <2 <2 - - -
97TXSF-65 + F. HC 4 <2 - -
97TXSF-66 - <2 <2 - - .
97TXSF-67 - <2 <2 - - .
97TXSF-68 - <2 <2 - - .
97TXSF-69 - <2 <2 - - -
Table 3.8: contd.
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ID of G Clone Cell Dependent-RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-I PI-3 cpBVDV BAV BRSV
97TXSF-70 - <2 <2 - -
97TXSF-7I - <2 <2 - - .
97TXSF-72 - <2 <2 - - .
97TXSF-73 - <2 <2 - - .
97TXSF-74 - <2 <2 - - .
97TXSF-75 Died
97TXSF-76 - <2 <2 - - .
97TXSF-77 - <2 <2 - - .
97TXSF-78 - <2 <2 - - .
97TXSF-79 - <2 <2 - - .
97TXSF-80 - <2 <2 - - .
97TXSF-81 + F 64 <2 - - .
97TXSF-82 -t-F, HC 64 4 - - .
97TXSF-83 - <2 <2 - - .
97TXSF-84 - <2 <2 - - .
97TXSF-85 - <2 <2 - + .
97TXSF-86 - <2 <2 - - .
97TXSF-87 - <2 <2 - - .
97TXSF-88 - <2 <2 - - .
97TXSF-89 - <2 <2 - - .
97TXSF-90 - <2 <2 - - .
97TXSF-91 - <2 <2 - - .
97TXSF-92 - <2 <2 - - .
97TXSF-93 - <2 <2 - -
97TXSF-94 - <2 <2 - - .
97TXSF-95 - <2 <2 - - .
97TXSF-96 Died
97TXSF-97 - <2 <2 - - .
97TXSF-98 - <2 <2 - - .
97TXSF-99 - <2 <2 - - .
97TXSF-100 - <2 <2 - - .
97TXSF-101 - <2 <2 - - .
97TXSF-102 - <2 <2 - - .
97TXSF-103 - <2 <2 - - .
97TXSF-I04 - <2 <2 - - .
97TXSF-105 - <2 <2 - - .
Total 4/95 1/95 4/95 0/95 0/95 0/95
Table 3.8.
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Table 3.9: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle 
at the Order-buyer Barn during the 1998 Shipping Fever Epizootic
ID of G  C lone Cell Dependent* RBCV B T o r  G B K  Cell D ependent-V iruses
C attle C P E HA T ite r RD E T ite r BHV-1 PI-3 cpBV D V  BAV BRSV
98TXSF-1 + F >256 <2 - -
98TXSF-2 - <2 <2 - - .
98TXSF-3 - <2 <2 - - .
98TXSF-4 + F >256 >256 - - .
98TXSF-5 + F >256 >256 - - .
98TXSF-6 + F >256 2 - - .
98TXSF-7 + F >256 >256 - - .
98TXSF-8 + F >256 <2 - - .
98TXSF-9 + F >256 <2 - -
98TXSF-10 + F >256 128 - - .
98TXSF-11 + F >256 64 - - .
98TXSF-12 + F >256 2 - - .
98TXSF-I3 + F >256 64 - - .
98TXSF-14 + F 128 128 - - .
98TXSF-15 + F >256 128 - - .
98TXSF-16 + F >256 8 - -
98TXSF-17 + F >256 <2 - - .
98TXSF-18 + F >256 <2 - - .
98TXSF-I9 + F >256 32 - - .
98TXSF-20 + F >256 <2 - - .
98TXSF-21 + F >256 <2 - - .
98TXSF-22 - <2 <2 - - .
98TXSF-23 + F >256 <2 - -
98TXSF-24 + F >256 <2 - - .
98TXSF-25 + F >256 >256 - - .
98TXSF-26 + F >256 64 - - .
98TXSF-27 - <2 <2 - - .
98TXSF-28 + F >256 >256 - - .
98TXSF-29 + F >256 32 - - -
Table 3.9: contd.
Samples were supplied by Dr. Purdy at United States Department of Agriculture- 
Agriculture Research Service in Bushland, Texas. 98TXSF: nasal swab sample 
collected from cattle under investigation of shipping fever (SF) pneumonia at Texas 
(TX) in 1998 (98); N/A: not available; Other notes as table 3.1.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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ID of G Clone Cell Dependent* RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BIIV-1 PI-3 cpBVDV BAV BRSV
98TXSF-30 - <2 <2 - - - - -
98TXSF-31 + F >256 <2 - - - - -
98TXSF-32 - <2 <2 - - - - -
98TXSF-33 + F >256 <2 - - - - -
98TXSF-34 - <2 <2 - - - - -
98TXSF-35 + F >256 <2 - - - - -
98TXSF-36 + F >256 32 - - - - -
98TXSF-37 + F >256 <2 - - - - -
98TXSF-38 - <2 <2 - - - - -
98TXSF-39 + F >256 >256 - - - - -
98TXSF-40 + F >256 <2 - - * - -
98TXSF-41 - <2 <2 - - - - -
98TXSF-42 + F >256 <2 - - - - -
98TXSF-43 + F >256 <2 - - - - -
98TXSF-44 - <2 <2 - - - - -
98TXSF-45 + F >256 <2 - - - - -
98TXSF-46 + F >256 <2 - - - - -
98TXSF-47 - <2 <2 - - - - -
98TXSF-48 + F >256 >256 - - - - -
98TXSF-49 + F >256 <2 - - - - -
98TXSF-50 + F >256 <2 - - - - -
98TXSF-51 + F >256 <2 - - - - -
98TXSF-52 - <2 <2 - - - - -
98TXSF-53 + F >256 <2 - - - - -
98TXSF-54 + F >256 <2 - - - - -
98TXSF-55 +■ F >256 >256 - - - - -
98TXSF-56 + F >256 <2 - - - - -
98TXSF-57 + F >256 <2 - - - - -
98TXSF-58 - <2 <2 - - - - -
98TXSF-59 + F >256 <2 - - - - -
98TXSF-60 + F >256 <2 - - - - -
98TXSF-61 +F >256 <2 - - - - -
98TXSF-62 - <2 <2 - - - - -




+ F >256 >256
98TXSF-66 + F >256 >256 _ _ . .
Table 3.9: contd.
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ID of G Clone Cell Dependent- RBCV BT or GBK Ceil Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 Pi-3 cpBVDV BAV BRSV
98TXSF-67 + F >256 >256 - - - - -
98TXSF-68 + F >256 >256 - - - - -
98TXSF-69 + F >256 >256 - - - - -
98TXSF-70 - <2 <2 - - - - -
98TXSF-7I + F >256 >256 - - - - -
98TXSF-72 + F >256 >256 - - - - -
98TXSF-73 + F >256 >256 - - - - -
98TXSF-74 - <2 <2 - - - - -
98TXSF-75 + F >256 >256 - - - - -
98TXSF-76 + F >256 >256 - - - - -
98TXSF-77 + F >256 >256 - - - - -
98TXSF-78 - <2 <2 - - - - -
98TXSF-79 +■ F >256 >256 - - - - -
98TXSF-80 + F >256 >256 - - - - -
98TXSF-81 + F >256 16 - - - - -
98TXSF-82 + F >256 >256 - - - - -
98TXSF-83 + F >256 >256 - - - - -
98TXSF-84 - <2 <2 - - - - -
98TXSF-85 - <2 <2 - - - - -
98TXSF-86 - <2 <2 - - - - -
98TXSF-87 - <2 <2 - - - - -
98TXSF-88 - <2 <2 - - - - -
98TXSF-89 + F .H C >256 >256 - - - - -
98TXSF-90 - <2 <2 - - - - -
98TXSF-91 + F >256 >256 - - - - -
98TXSF-92 + F >256 >256 - - - - -
98TXSF-93 - <2 <2 - - - - -
98TXSF-94 - <2 <2 + - - - -
98TXSF-95 - <2 <2 - - - - -
98TXSF-96 + F. HC >256 >256 - - - - -
98TXSF-97 + F >256 >256 - - - - -
98TXSF-98 - <2 <2 - - - - -
98TXSF-99 + F 256 256 - - - - -
98TXSF-100 + F >256 >256 - - - - -
98TXSF-I01 + F >256 >256 - - - - -
98TXSF-I02 + F >256 >256 - - - - -
98TXSF-I03 + F >256 >256 - - - - -
98TXSF-I04 + F 256 256 . - _ - -
Table 3.9: contd.




G Clone Cell Dependent* RBCV BT or GBK Cell Dependent*Viruses
CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
98TXSF-105 + F >256 >256 - - - - -
98TXSF-I06 + F >256 >256 - - - - -
98TXSF-107 + F >256 >256 - - - - -
98TXSF-108 + F >256 >256 - - - - -
98TXSF-109 +■ F >256 >256 - - - - -
98TXSF-110 + F >256 >256 - - - - -
98TXSF-111 + F 256 256 - - - - -
98TXSF-112 - <2 <2 - - - - -
98TXSF-113 + F 256 16 - - - - -
98TXSF-114 + F >256 >256 - - - - -
98TXSF-U5 + F >256 >256 - - - - -
98TXSF-116 + F >256 >256 - - - - -
98TXSF-117 + F >256 >256 - - - - -
98TXSF-118 - <2 <2 - - - - -
98TXSF-119 - <2 <2 - - - - -
98TXSF-120 + F >256 >256 - - - - -
Total 89/120 1/120 0/120 0/120 0/120 0/120
Table 3.9.
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Table 3.10: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle 
On Day 7 Post-arrival at the Order-buyer Barn during the 1998 Shipping Fever 
Epizootic
ID of G Clone Cell Dependent- RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-i PI-3 cpBVDV BAY BRSV
98TXSF-1 - <2 <2 - - - - -
98TXSF-2 - <2 <2 - - - - -
9STXSF-3 - <2 <2 - - - - -
98TXSF-4 + F >256 <2 - - - - -
98TXSF-5 - <2 <2 - - - - -
98TXSF-6 - <2 <2 - - - - -
98TXSF-7 + F >256 <2 - - - - -
98TXSF-8 + F >256 <2 - - - - -
98TXSF-9 + F >256 <2 - - - - -
98TXSF-10 + F >256 >256 - - - - -
98TXSF-11 + F >256 >256 - - - - -
98TXSF-12 + F >256 <2 - - - - -
98TXSF-13 + F >256 <2 - - - - -
98TXSF-I4 + F >256 >256 - - - - -
98TXSF-15 + F >256 32 - - - - -
98TXSF-16 - <2 <2 - - - - -
98TXSF-I7 - <2 <2 - - - - -
98TXSF-18 + F >256 <2 - - - - -
98TXSF-I9 + F >256 <2 - - - - -
98TXSF-20 - <2 <2 - - - - -
98TXSF-2I - <2 <2 - - - - -
98TXSF-22 - <2 <2 - - - - -
98TXSF-23 - <2 <2 - - - - -
98TXSF-24 - <2 <2 - - - - -
98TXSF-25 - <2 <2 - - - - -
98TXSF-26 + F >256 <2 - - - - -
98TXSF-27 - <2 <2 + - - - -
98TXSF-28 + F >256 <2 - - - - -
98TXSF-29 - <2 <2 - - - - -
98TXSF-30 - <2 <2 - - - - -
98TXSF-31 - <2 <2 . . _ . _
Table 3.10: contd.
Notes as table 3.9.
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ID of G Clone Cell Dependent- RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-I PI-3 cpBVDV BAV BRSV
98TXSF-32 - <2 <2 - - - - -
98TXSF-33 - <2 <2 - - - - -
98TXSF-34 - <2 <2 - - - - -
98TXSF-35 - <2 <2 - - - - -
98TXSF-36 - <2 <2 - - - - -
98TXSF-37 + F >256 <2 - - - - -
98TXSF-38 - <2 <2 - - - - -
98TXSF-39 + F >256 <2 - - - - -
98TXSF-40 + F >256 <2 - - - - -
98TXSF-41 - <2 <2 - - - - -
98TXSF-42 + F >256 <2 - - - - -
98TXSF-43 + F >256 <2 - - - - -
98TXSF-44 - <2 <2 - - - - -
98TXSF-45 + F >256 - - - - -
98TXSF-46 - <2 <2 - - - - -
98TXSF-47 - <2 <2 - - - - -
98TXSF-48 +• F >256 <2 - - - - -
98TXSF-49 + F >256 <2 - - - - -
98TXSF-50 + F >256 <2 - - - - -
98TXSF-51 + F >256 - - - - -
98TXSF-52 - <2 <2 - - - - -
98TXSF-53 - <2 <2 - - - - -
9STXSF-54 -t-F >256 <2 - - - - -
98TXSF-55 + F >256 <2 - - - - -
98TXSF-56 + F >256 <2 - - - - -
98TXSF-57 + F >256 <2 - - - - -
98TXSF-58 - <2 <2 - + - - -
98TXSF-59 + F >256 <2 - - - - -
98TXSF-60 + F >256 <2 - - - - -
98TXSF-61 + F >256 <2 - - - - -
98TXSF-62 - <2 <2 - - - - -
98TXSF-63 + F >256 <2 - - - - -
98TXSF-64 - <2 <2 - - - - -
98TXSF-65 - <2 <2 - - - - -
98TXSF-66 - <2 <2 - - - - -
98TXSF-67 + F >256 <2 - - - - -
98TXSF-68 + F >256 <2 _ . - . .
Table 3.10: contd.
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ID o f G  C lone  C ell Dependent* R B C V B T  o r  G B K  Cell D ependent*V iruses
C attle C P E H A  T ite r R D E T ite r BH V -1 PI-3 cpBV D V  B A V  BRSV
98TXSF-69 + F >256 <2 - - .
98TXSF-70 - <2 <2 - - .
98TXSF-71 + F >256 >256 - -
98TXSF-72 + F >256 >256 - - .
98TXSF-73 - <2 <2 - - .
98TXSF-74 - <2 <2 - - .
98TXSF-75 + F >256 <2 - - .
98TXSF-76 + F >256 >256 - - .
98TXSF-77 + F >256 <2 - - .
98TXSF-78 - <2 <2 - -
98TXSF-79 + F >256 <2 - - .
98TXSF-80 + F >256 <2 - - .
98TXSF-81 - <2 <2 - - .
98TXSF-82 - <2 <2 - - .
98TXSF-83 + F >256 <2 - - .
98TXSF-S4 - <2 <2 - - .
98TXSF-85 + F >256 (Oct. 5) 32 - - .
98TXSF-86 - <2 <2 - - .
9STXSF-87 - <2 <2 - - .
98TXSF-88 - <2 <2 - - .
98TXSF-89 +• F >256 <2 - - .
98TXSF-90 + F >256 <2 - - .
98TXSF-91 + F >256 >256 - - .
98TXSF-92 +• F >256 <2 - - .
98TXSF-93 - <2 <2 - - .
98TXSF-94 - <2 <2 - - .
98TXSF-95 - <2 <2 - - .
98TXSF-96 + F >256 <2 - - .
98TXSF-97 + F >256 <2 - - .
98TXSF-98 - <2 <2 - - .
98TXSF-99 + F >256 <2 - - .
98TXSF-I00 -t-F >256 4 - - .
98TXSF-101 + F >256 <2 - - .
98TXSF-I02 + F >256 128 - - .
98TXSF-103 + F >256 <2 - - .
98TXSF-104 + F >256 <2 - - .
98TXSF-105 - <2 <2 - - .
98TXSF-106 + F >256 >256 - - .
Table 3.10: contd.
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ID of G Clone Ceil Dependent* RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
98TXSF-107 + F >256 <2 - - .
98TXSF-I08 - <2 <2 - - .
98TXSF-109 +■ F >256 <2 - - -
98TXSF-110 + F >256 >256 - - -
98TXSF-111 + F >256 <2 - - -
98TXSF-112 - <2 <2 - - .
98TXSF-113 + F >256 16 - - .
98TXSF-114 +• F >256 >256 - - -
98TXSF-115 + F >256 4 - - -
98TXSF-116 + F >256 8 - - -
98TXSF-H7 + F >256 <2 - - -
98TXSF-118 - <2 <2 - - -
98TXSF-1I9 - <2 <2 - - -
98TXSF-120 +■ F >256 <2 - - .
Total 67/120 1/120 1/120 0/120 0/120 0/120
Table 3.10.
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Therefore, 67 cattle contained RBCV in nasal secretions right after their arrived at the 
feed yard, when adverse clinical signs of respiratory tract diseases were still evident. At 
the same time, 1 cattle had BHV-1 only and 1 cattle shed PI-3 only. Of the 120 cattle, 
91 cattle experienced RBCV infection during the first week of this investigation. Only 6 
and 4 cattle still nasally shed RBCV on days 14 and 21 post-arrival at the OBB, 
respectively (Tables 3.11 and 3.12). However, on day 14 post-arrival at the OBB, of the 
remaining 109 cattle, 4 cattle shed BHV-1 only, 1 cattle had mixed infections of BHV-1 
and RBCV, and 6 cattle became PI-3-infected. On day 21 post-arrival at the OBB, of 
the surviving 107 cattle, 2 cattle had BHV-1 only while 13 cattle shed PI-3, and 1 of 
them had simultaneously RBCV infection. Again, sequential nasal swab samples 
remained BRSV, cytopathogenic BVDV and bovine adenovirus-negative during the 
1998 epizootic.
3.3.3 Virological Findings in Fatal Cases
The 1997 shipping fever experiment: Ten cattle died on days 7 to 11 post-arrival 
at the OBB that were 1 to 5 days after they arrived at the ARS feed yard. Virus isolation 
attempts with nasal swab samples indicated that 6 of them shed RBCV on their arrival 
at OBB, 3 more contracted this infection during transport (Table 3.13), and no other 
respiratory viruses were detected before these calves died. Further analysis of 10 
pneumonic lung samples revealed that 9 were RBCV-positive, no other viruses were
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Table 3.11: Respiratory Bovine Virus Isolation from Nasal Swab Samples o f Cattle 
On Day 14 Post-arrival at the Order-buyer Barn during the 1998 Shipping Fever
Epizootic
ID of G Clone Cell Dependent- RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
98TXSF-1 - <2 <2 - - - - -
98TXSF-2 - <2 <2 - - - - -
98TXSF-3 - <2 <2 - + - - -
98TXSF-4 - <2 <2 - - - - -
98TXSF-5 - <2 <2 - + - - -
98TXSF-6 - <2 <2 - - - - -
9STXSF-7 + F >256 <2 - - - - -
98TXSF-8 - <2 <2 - - - - -
98TXSF-9 - <2 <2 - - - - -
98TXSF-10 Died
98TXSF-I1 Died
98TXSF-I2 + F 128 <2 - - - - -
98TXSF-13 - <2 <2 - - - - -
98TXSF-I4 Died
98TXSF-15 - <2 <2 + - - - -
98TXSF-16 - <2 <2 - - - - -
98TXSF-17 - <2 <2 - - - - -
98TXSF-18 - <2 <2 - - - - -
98TXSF-19 - <2 <2 - - - - -
98TXSF-20 - <2 <2 - - - - -
98TXSF-21 - <2 <2 - - - - -
98TXSF-22 - <2 <2 - - - - -
98TXSF-23 - <2 <2 - - - - -
98TXSF-24 - <2 <2 - - - - -
98TXSF-25 - <2 <2 - - - - -
98TXSF-26 - <2 <2 - - - - -
98TXSF-27 - <2 <2 - - - - -
98TXSF-28 - <2 <2 - - - - -
98TXSF-29 - <2 <2 - - - - -
98TXSF-30 - <2 <2 - - - - -
98TXSF-3I <2 <2 _ _ _ _ _
Table 3.11: contd.
Notes as table 3.9.
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ID of G  C lo n e  Cell Dependent* RBCV B T  o r  G B K  Cell D ependent-V iruses
Cattle C P E HA T ite r R D E  T ite r BHV-1 PI-3 cpBV D V  BAV BRSV
98TXSF-32 - <2 <2 - + .
98TXSF-33 - <2 <2 - - .
98TXSF-34 - <2 <2 - - .
98TXSF-35 - <2 <2 - - .
98TXSF-36 - <2 <2 - - .
98TXSF-37 - <2 <2 - -
98TXSF-38 - <2 <2 - - .
98TXSF-39 - <2 <2 - - .
98TXSF-40 - <2 <2 - - .
98TXSF-41 - <2 <2 - - .
98TXSF-42 + F, HC >256 <2 - - .
98TXSF-43 - <2 <2 - - .
98TXSF-44 - <2 <2 - - .
98TXSF-45 - <2 <2 - - .
98TXSF-46 - <2 <2 - - .
98TXSF-47 - <2 <2 - - .
98TXSF-48 - <2 <2 - + .
9STXSF-49 - <2 <2 - - .
98TXSF-50 - <2 <2 - - .
98TXSF-51 - <2 <2 - - .
98TXSF-52 - <2 <2 - - .
98TXSF-53 - <2 <2 - - .
98TXSF-54 - <2 <2 - - .
98TXSF-55 - <2 <2 - - .
98TXSF-56 - <2 <2 - - .
98TXSF-57 - <2 <2 - + .
98TXSF-58 - <2 <2 - - .
98TXSF-59 - <2 <2 - - .
98TXSF-60 - <2 <2 - -
98TXSF-61 + F >256 <2 - - .
98TXSF-62 - <2 <2 - + .
98TXSF-63 - <2 <2 - -
98TXSF-64 - <2 <2 - - .
98TXSF-65 - <2 <2 - -
98TXSF-66 - <2 <2 - - .
98TXSF-67 - <2 <2 - - .
9STXSF-68 - <2 <2 - - .
98TXSF-69 - <2 <2 - - -
Table 3.11: contd.
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ID of G Clone Cell Dependent- RBCV BT or GBK Cell Dependent-Viruses
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ID  o f G  C lone C ell D ependent- RBCV B T  o r  G B K  Cell D ependent-V uruses
C attle C P E H A  T ite r I R D E  T ite r BHV-1 PI-3 cpBVDV BAV B R SV
98TXSF-108 - <2 <2 - - .
98TXSF-I09 - <2 <2 - - .
98TXSF-110 Died
98TXSF-111 - <2 <2 - -
98TXSF-112 - <2 <2 - - .
98TXSF-113 - <2 <2 - - .
98TXSF-114 Died
98TXSF-115 + F >256 <2 + - .
98TXSF-116 - <2 <2 - - .
98TXSF-117 - <2 <2 - - .
98TXSF-118 - <2 <2 - - .
98TXSF-119 - <2 <2 - - .
98TXSF-120 - <2 <2 - - .
Total 6/109 5/109 6/109 0/109 0/109 0/109
Table 3.11.
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Table 3.12: Respiratory Bovine Virus Isolation from Nasal Swab Samples of Cattle 
On Day 21 Post-arrival at the Order-buyer Barn during the 1998 Shipping Fever
Epizootic
i d  o r G  C lone Cell D ependent- R B C V BT o r  G B K  Cell D ependen t-V iruses
C attle C P E HA T ite r R D E  T ite r BHV-1 PI-3 cpB V D V  BAV BRSV
98TXSF-I - <2 <2 - - .
98TXSF-2 - <2 <2 - - .
98TXSF-3 - <2 <2 - -
98TXSF-4 - <2 <2 - - .
98TXSF-5 - <2 <2 - - .
98TXSF-6 - <2 <2 - - .
98TXSF-7 - <2 <2 - - .
98TXSF-8 - <2 <2 - - .
98TXSF-9 - <2 <2 - - .
98TXSF-10 Died
98TXSF-11 Died
98TXSF-12 - <2 <2 - - .
98TXSF-13 - <2 <2 - - .
98TXSF-14 Died
98TXSF-15 - <2 <2 -t- -
98TXSF-16 - <2 <2 - - .
98TXSF-17 - <2 <2 - - .
98TXSF-I8 - <2 <2 - - .
98TXSF-19 - <2 <2 - - .
98TXSF-20 - <2 <2 - - .
98TXSF-21 - <2 <2 - - .
98TXSF-22 - <2 <2 - +
98TXSF-23 - <2 <2 - - .
98TXSF-24 - <2 <2 - - .
98TXSF-25 - <2 <2 - -t- .
98TXSF-26 + F 64 64 - + .
98TXSF-27 - <2 <2 - - .
98TXSF-28 - <2 <2 - - .
98TXSF-29 - <2 <2 - - .
98TXSF-30 - <2 <2 - +
98TXSF-31 - <2 <2 - - -
Table 3.12: contd.
Notes as table 3.9.
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id  or G Clone Cell Dependent* RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-I PI-3 cpBVDV BAV BRSV
98TXSF-32 - <2 <2 - + .
98TXSF-33 - <2 <2 - - .
98TXSF-34 - <2 <2 - - .
98TXSF-35 - <2 <2 - - -
98TXSF-36 - <2 <2 - - .
98TXSF-37 - <2 <2 - - -
98TXSF-38 - <2 <2 - - -
98TXSF-39 - <2 <2 - - -
98TXSF-40 - <2 <2 - - -
98TXSF-4I - <2 <2 - - .
98TXSF-42 - <2 <2 - + .
98TXSF-43 + F 16 16 - - .
9STXSF-44 - <2 <2 - - -
98TXSF-45 + F(3) 16. >256 (3) 16 - - .
98TXSF-46 - <2 <2 - - -
98TXSF-47 - <2 <2 - - -
98TXSF-48 - <2 <2 - - .
98TXSF-49 - <2 <2 - - -
98TXSF-50 - <2 <2 - - -
98TXSF-51 - <2 <2 - - -
98TXSF-52 - <2 <2 - + -
98TXSF-53 - <2 <2 - - .
98TXSF-54 - <2 <2 - - -
98TXSF-55 - <2 <2 - - .
98TXSF-56 - <2 <2 - - -
98TXSF-57 - <2 <2 - - -
98TXSF-58 - <2 <2 - - -
98TXSF-59 - <2 <2 - - -
98TXSF-60 - <2 <2 - + -
98TXSF-61 - <2 <2 - - -
98TXSF-62 - <2 <2 - - .
98TXSF-63 - <2 <2 - - -
98TXSF-64 - <2 <2 - - -
98TXSF-65 - <2 <2 - - -
98TXSF-66 - <2 <2 - + .
98TXSF-67 - <2 <2 - - -
98TXSF-68 - <2 <2 - - -
98TXSF-69 - <2 <2 - - -
Table 3.12: contd.
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ID of G Clone Cell Dependent* RBCV BT or GBK Cell Dependent*Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
98TXSF-70 - <2 <2 - + - - -
98TXSF-71 Died
98TXSF-72 Died
98TXSF-73 - <2 <2 - - - - -
98TXSF-74 - <2 <2 - - - - -
98TXSF-75 - <2 <2 - - - - -
98TXSF-76 - <2 <2 - - - - -
98TXSF-77 - <2 <2 - - - - -
98TXSF-78 - <2 <2 - - - - -
98TXSF-79 - <2 <2 - - - - -
98TXSF-80 - <2 <2 - - - - -
98TXSF-81 - <2 <2 - - - - -
98TXSF-82 - <2 <2 - + - - -
98TXSF-83 - <2 <2 - - - - -
98TXSF-84 - <2 <2 - - - - -
98TXSF-85 Died
98TXSF-86 - <2 <2 - - - - -
98TXSF-87 - <2 <2 - - - - -
98TXSF-88 - <2 <2 - - - - -
98TXSF-89 - <2 <2 - - - - -
98TXSF-90 - <2 <2 - - - - -
98TXSF-91 Died
98TXSF-92 - <2 <2 - - - - -
98TXSF-93 - <2 <2 - + - - -
98TXSF-94 - <2 <2 - - - - -
98TXSF-95 - <2 <2 - - - - -
98TXSF-96 - <2 <2 - - - - -
98TXSF-97 - <2 <2 - - - - -
98TXSF-98 - <2 <2 - - - - -
98TXSF-99 - <2 <2 - - - - -
98TXSF-100 - <2 <2 + - - - -
98TXSF-101 - <2 <2 - - - - -
98TXSF-102 Died
98TXSF-103 + F 64 <2 - - - - -
98TXSF-104 Died
98TXSF-105 - <2 <2 - - - - -
98TXSF-106 Died
98TXSF-I07 . <2 <2 _ . . . _
Table 3.12: contd.
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ID of G Clone Cell Dependent* RBCV BT or GBK Cell Dependent-Viruses
Cattle CPE HA Titer RDE Titer BHV-1 PI-3 cpBVDV BAV BRSV
98TXSF-108 - <2 <2 - .
98TXSF-109 - <2 <2 - .
98TXSF-110 Died
98TXSF-111 - <2 <2 -
98TXSF-112 - <2 <2 - .
98TXSF-113 - <2 <2 - .
98TXSF-I14 Died
98TXSF-115 Died
98TXSF-116 - <2 <2 - .
98TXSF-117 - <2 <2 - .
98TXSF-118 - <2 <2 +
98TXSF-119 - <2 <2 -
98TXSF-120 - <2 <2 - .
Total 4/107 2/107 13/107 0/107 0/107 0/107
Table 3.12.
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Table 3.13: Isolation of Respiratory Bovine Viruses and Pasteurella spp. from
Nasal and Lung Samples of Cattle that Died in the 1997 Shipping Fever Epizootic




RBCV/OV Isolated from Nasal Samples Lung Samples
OBB Day 7 RBCV/OV Pasteurella spp.
97TXSF-52 7 -/- +/- +/- PhA l.Pm
97TXSF-5 8 +/- +/- + / - PhAl
97TXSF-I5 8 +/- +/- + / - PhA6
97TXSF-19 8 +/- +/- +/- PhAl
97TXSF-43 8 +/- +/- +/- PhAl
97TXSF-62 8 -/- +/- +/- PhAl
97TXSF-75 8 -/- +/- + / - PhAl
97TXSF-96 8 +/- +/- +/- PhAl
97TXSF-58 9 +/- +/- + / - PhAl
97TXSF-63 11 -/- -/- -/- PhAl
Total 6/0 9/0 9/0 10
Samples were supplied by Dr. Purdy at United States Department of Agriculture- 
Agriculture Research Service in Bushland, Texas. 97TXSF: nasal swab/lung samples 
collected from cattle under investigation of shipping fever (SF) pneumonia at Texas 
(TX) in 1997 (97); Day X: X days post-arrival at the order-buyer bam; OBB: on arrival 
at the order-buyer bam; RBCV: respiratory bovine coronavirus; OV: other viruses; +: 
virus was isolated; vims was not isolated; PhAl: Pasteurella haemolytica type Al; 
PhA6: Pasteurella haemolytica type A6; Pm: Pasteurella multocida.
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isolated. The RBCV plaque forming units (PFU) per gram of lung tissues ranged from
8.0 x 103 to 5.0 x  106 (Table 3.14).
The 1998 shipping fever experiment: Sixteen cattle died on days 7 to 38 post­
arrival at the OBB that were 1 to 32 days after they arrived at the ARS feed yard. 
Fifteen of them nasally shed RBCV when they arrived at the OBB, and all of them did 
so after they arrived at the ARS feed yard (Table 3.15). Again, no other respiratory 
bovine viruses were detected from nasal samples during the 1st week of experiment. On 
day 14, of the remaining 5 cattle, 1 calf was nasally both RBCV- and BHV-l-positive, 
and 2 had BHV-1 infection only. On day 21, of the 3 survived cattle, 2 shed BHV-1, 
and 1 of them continued to shed BHV-1 along with PI-3 a week later. On day 35, only 1 
calf was left, nasally shedding PI-3 only. Virus isolation on 15 available lung samples 
indicated that 9 lung samples from cattle that died between days 7 and 9 post-arrival at 
the OBB were RBCV-positive, while the lung samples from the remaining cattle that 
died between days 13 to 38 days post-arrival at the OBB were RBCV-negative, but 
BHV-1 and PI-3 were detected once and twice. Lung tissues did not yield BRSV, 
cytopathogenic BVDV, or bovine adenovirus. The RBCV plaque-forming units (PFU) 
per gram of lung tissues ranged from 1.0 x 103 to 1.2 x 107 (Table 3.16).
The 1998 winter pasture pneumonia: Of the 3 cattle that died of acute winter 
pasture pneumonia in the Northwest Louisiana during 1998, RBCV were isolated from
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Table 3.14: Loads of Respiratory Bovine Coronaviruses and Pasteurella spp. in
Lungs of Cattle that Died in the 1997 Shipping Fever Epizootic
ID of Cattle Death on Day X RBCV (PFU/g) Pasteurella spp. (CFU/g)
97TXSF-52 7 5.0 x 106 1.0 x  106(a), 1.6 x 107(b)
97TXSF-5 8 1.2 x 105 7.0 x 108
97TXSF-15 8 3.0 x  106 4.8 x 10s
97TXSF-19 8 8.0 x  104 1.4 x 109
97TXSF-43 8 8.0 x  103 3.4 x 108
97TXSF-62 8 1.0 x 105 8.2 x 108
97TXSF-75 8 1.4 x 106 1.5 x 107
97TXSF-96 8 3.4 x  106 1.1 x 107
97TXSF-58 9 2.0 x  105 1.9 x 106
97TXSF-63 11 - 2.8 x 106
PFU/g: plaque forming units per gram of lung tissue; CFU/g: colony forming units per 
gram of lung tissue; (a): for PhAl; (b): for Pm; other notes as table 3.13.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
89
Table 3.15: Isolation o f Respiratory Bovine Viruses and Pasterurella spp. from




RBCV/OV isolated from nasal samples Lung samples
OBB Day 7 Day 14 Day 21 Day 28 Day 35 RBCV/OV Pasteurella spp.
98TXSF-85* 7 -/- +/- +/- Pm
9STXSF-10 8 +/- +/- +/- PhAl.Pm
98TXSF-11 8 +/- +/- +/- PhAl
98TXSF-I4 8 +/- +/- +/- Pm
98TXSF-91 8 +/- +/- +/- PhAl,Pm
98TXSF-110 8 +/- +/- +/- Pm
98TXSF-71 9 +/- +/- +/- PhAl. Pm
98TXSF-72** 9 +/- +/- +/- PhAl.Pm
9STXSF-106** 9 +/- +/- +/- PhAl
98TXSF-114** 9 +/- +/- NA/NA PhAl
98TXSF-102** 13 +/- +/- -/- PhA2
98TXSF-104** 15 +/- +/- -/- -/- PhAl
98TXSF-115** 16 +/- +/- +/BHV-1 -/BHV-1 PhAl
98TXSF-36** 29 +/- +/- -/- -/- -/- Pm
98TXSF-15** 33 +/- +/- -/BHV-1 -/BHV-I PI-3/BHV-1 -/PI-3 -
98TXSF-100** 38 +/- +/- -/BHV-1 -/BHV-1 -/- -/PI-3 -/PI-3 Pm
Samples were supplied by Dr. Purdy at United States Department of Agriculture- 
Agriculture Research Service in Bushland, Texas. 98TXSF: nasal swab/lung samples 
collected from cattle under investigation of shipping fever (SF) pneumonia at Texas (TX) 
in 1998 (98); *: Calves with odd numbers were vaccinated with an experimental bacterin- 
toxoid of P. haemolytica; **: Calves with 40°C or higher temperatures were treated with 
Micotif or Liquamycin LA200; Other notes as table 3.13.
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Table 3.16: Loads o f Respiratory Bovine Corona viruses and Pasteurella spp. in 
Lungs of Cattle that Died in the 1998 Shipping Fever Epizootic
ID of Cattle Death on Day X RBCV (PFU/g) Pasteurella spp. (CFU/g)
98TXSF-85* 7 6.0 x 104 6.0 x 105
98TXSF-10 8 1.0 x 105 3.3 x 108 (a), 2.5 x  106(b)
98TXSF-11 8 6.0 x 106 6.3 x 108
98TXSF-14 8 1.0 x 103 2.4 x 108
98TXSF-91 8 1.2 x 107 4.0 x 107 (a), 1.4 x 108(b)
98TXSF-110 8 2.4 x 106 2.3 x 109
98TXSF-71 9 4.0 x 105 3.0 x 108 (a), 4.1 x 108 (b)
98TXSF-72** 9 2.0 x 104 3.1 x 108 (a), 2.1 x 108 (b)
98TXSF-106** 9 2.0 x 104 2.5 x 106
98TXSF-114** 9 NA/NA 8.0 x 106
98TXSF-102** 13 9.5 x 105
98TXSF-104** 15 2.9 x 106
98TXSF-115** 16 4.0 x 105
98TXSF-36** 29 1.1 x 108
98TXSF-15** 33 -
98TXSF-100** 38 7.5 x 107
Notes as tables 3.14 and 3.15.
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both trachea and lung samples, and, again, no other respiratory bovine viruses were 
detected (Table 3.17).
3.3.4 Bacteriological Findings in Fatal Cases
The 1997 shipping fever experiment: Pasteurella haemolytica was isolated from 
all 10 lung samples (Table 3.13). One calf had a pure culture of P. haemolytica A6, 
while the other 9 calves had P. haemolytica A1 infetions, and 1 of them also had P. 
multocida infection. Loads of Pasterurella spp. ranged from 1.0 x 106 to 1.4 x 109 
colony forming units (CFU) per gram of lung tissue (Table 3.14).
The 1998 shipping fever experiment: Pasteurella spp. was cultivated from 15 of 
the 16 lung samples (Table 3.15). Five calf had only P. multocida infection, 1 calf had 
only P. haemolytica A2 isolate in the lung, and 4 calves had mixed infections of P. 
haemolytica A1 and P. multocida. The bacterial isolates from the remaining 5 lung 
samples were identified as P. haemolytica Al. Loads of Pasterurella spp. ranged from
4.0 x 105 to 2.3 x 109 CFU per gram of lung tissue (Table 3.16).
The 1998 winter pasture pneumonia: Interestingly, no Pasterurella spp. were 
detected from either lung or trachea samples of 3 cattle that died of winter pasture 
pneumonia (Table 3.17).
3.3.5 Correlation between RBCV Infection and Respiratory Tract Diseases
A correlation existed between the number of cattle which developed respiratory 
tract diseases, including fatal outcomes, and frequency of RBCV detection as presented
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Table 3.17: Isolation of Respiratory Bovine Viruses and Pasterurella spp. from
Trachea and Lung Samples o f Cattle that Died in the Winter Pasture
ID of Samples RBCV Other Viruses PasteureUa spp.
985987-trachea + (64 HAU) - -
985987-lung + (64 HAU) - -
880-trachea + (>256 HAU) - -
880-lung + (>256 HAU) - -
881-trachea + (>256 HAU) - -
881-lung + (>256 HAU) - -
Samples were provided by Dr. Jeffrey Anderson; +: infectious agents were detected;
no infectious agents were detected; HAU: hemagglutinin units; other notes as table
3.13.
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in Table 3.18 and 3.19. The RBCV was successfully isolated from 81 of the 93 
clinically sick or dead cattle in the 1997 investigation, while the 1998 experiment 
included 89 RBCV-positive cattle of the 107 sick or dead ones. Twelve and 18 cattle 
exhibited adverse clinical signs of respiratory tract disease but did not shed RBCV 
during the 1997 and 1998 epizootics, respectively. Five cattle of the 1997 and 2 cattle of 
the 1998 had RBCV infections but remained clinically normal. Seven and 11 cattle were 
RBCV isolation-negative, and had no adverse respiratory signs of disease throughout 
the 1997 and 1998 experiment periods, respectively. Statistically, the sensitivity and 
specificity of RBCV isolations compared with respiratory tract diseases of cattle were 
87% and 58%, respectively, for the 1997 epizootic, and 83% and 85%, respectively, for 
the 1998 experiment.
3.4 Discussion
During 1993 and 1998, we investigated 388 cattle from 11 different states. A viral 
agent exclusively multiplying in G clone cell cultures was successfully isolated from 
nasal swab samples of 225 cattle and from trachea and lung samples of 20 cattle during 
the early phase of respiratory tract infections (Tables 3.20 and 3.21). Investigated cattle 
included those with acute respiratory distress after shipping, during shipping fever 
epizootic, in a livestock show, and from stocker cattle on winter pastures in the 
Southern U.S.A. This viral agent was identified as coronavirus and is referred to as
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Table 3.18: Correlation between Respiratory Bovine Coronavirus Infection and 
Signs of Respiratory Tact Diseases of Cattle in the 1997 Shipping Fever Epizootic.
Isolation of RBCV Sick or Dead Clinical Normal Total
RBCV(+) 81 5 86
RBCV(-) 12 7 19
Total 93 12 105
RBCV(+): respiratory bovine coronavirus isolated in the G clone cells; RBCV(-): 
respiratory bovine coronavirus not isolated in the G clone cells; other notes as table
3.13.
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Table 3.19: Correlation between Respiratory Bovine Coronavirus Infection and 
Signs of Respiratory Tact Diseases of Cattle in the 1998 Shipping Fever Epizootic.
Isolation of RBCV Sick or Dead Clinical Normal Total
RBCV(+) 89 2 91
RBCV(-) 18 11 29
Total 107 13 120
Notes as table 3.18.
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Table 3.20: Frequency of Virus Isolations from Nasal Secretions of Cattle with
Acute Respiratory Tract Diseases
Disease Episodes
Viruses Detected in Nasal Swab Samples
RBCV BHV-1 PI-3 cpBVDV BAV BRSV
1993 Kansas feedyard 32/50 0/50 0/50 0/50 0/50 0/50
1993 Arizona feedyard 6/50 0/50 4/50 0/50 0/50 0/50
1997 TXSF epizootic 86/105 7/105 4/105 0/105 0/105 0/105
1998 TXSF epizootic 91/120 7/120 19/120 0/120 0/120 0/120
LSU livestock show 4/29 2/29 0/29 0/29 1/29 0/29
Hospital cases 2/16 1/16 0/16 0/16 0/16 0/16
Winter pastures 4/15 1/15 0/15 0/15 0/15 0/15
Positive/total 225/385 18/385 27/385 0/385 1/385 0/385
Notes as tables 3.1, 3.5, and 3.9.
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Table 3.21: Frequency of Virus Isolations from Lungs of Cattle with Fatal
Pneumonia
Disease Episodes
Viruses Detected in Lung Samples
RBCV BHV-1 PI-3 cpBVDV BAV BRSV
1997 TXSF epizootic 9/10 0/10 0/10 0/10 0/10 0/10
1998 TXSF epizootic 8/15 1/15 2/15 0/15 0/15 0/15
Winter pasture pneumonia 3/3 0/3 0/3 0/3 0/3 0/3
Positive/total 20/28 1/28 2/28 0/28 0/28 0/28
Notes as tables 3.1, 3.5, and 3.9.
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RBCV on the basis of site of isolation, clinical signs of affected cattle, presence of HA 
and specific receptor-destroying functions, cell fusion and other cytopathic properties in 
G clone cells as well as ultrastructural features. The use of G clone cells, which has a 
homogeneous epithelial cell population, played an important role in the isolation of 
RBCV. The parent HRT-18 cell cultures have properties of polarized epithelial cells, 
and contain a rather heterogeneous cell population (Payne and Storz, 1990; Tompkins et 
al„ 1974).
The RBCV isolates have unique properties that distinguished them from wild-type, 
hemagglutinating EBCV. Distinguishing features are: (1) The RBCV were isolated in 
the first G clone cell passage without trypsin enhancement. Trypsin activation was 
required for the isolation of EBCV (Storz et al., 1981). (2) The RBCV have unusually 
high cell-fusing activities for the G clone cells. (3) The RBCV have a restricted 
hemagglutination pattern. They agglutinate only mouse and rat, but not chicken and 
bovine RBC. (4) Comparison of nucleotide and predicted amino acid sequences of all 
genes encoded by the 3’ genomic portion (9.5kb) of RBCV and EBCV defined pinpoint 
RBCV-specific mutations that are suggested to be associated with pneumopathogenicity 
and other features of RBCV (Chouljenko et al., 1998a and b). (5) The hemaggiutinin- 
esterase of selected wild-type RBCV and EBCV strains differed in AE kinetic activities 
at 37°C and 39°C (Lin et al., 1997a). The high degree of nucleotide conservation among 
all RBCV isolates indicated that all these viruses evolved from a common prototypic
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ancestral genome (Chouljenko et al., 1998a; Storz et al., 2000a). The dynamic evolution 
of new viral genotypes containing single nucleotide changes at specific genomic loci 
was evident within the same calf at different time points of disease progression 
(Chouljenko et al., 1998a; Storz et al., 2000a).
The high rate of RBCV isolation and virtual absence of other respiratory virus 
infections during the early stages of the investigated respiratory tract disease epizootics 
indicated that RBCV played a causative role in shipping fever pneumonia and winter 
pasture pneumonia. Although serological and antigen detection tests identified a 
corona-like agent as a potential cause of respiratory disease of cattle, isolation of wild- 
type RBCV had not been successful (Appel et al., 1992; Carman and Hazlett, 1992; 
Heckert et al., 1991; Herbst et al., 1989; Jimenez et al., 1989; Mostl and Biirki, 1988). 
Remarkably, the involvement of RBCV in epizootics of shipping fever pneumonia was 
not suspected in the past (Yates, 1982).
The novel virus isolation techniques allow us to exclude other respiratory bovine 
viruses as major viral causes associated with these episodes of acute respiratory tract 
diseases. Almost all the investigated cattle had been vaccinated with a modified-live 
virus vaccine containing BHV-1 and PI-3. Successful vaccination programs 
theoretically reduce the frequency of the respective infections. These BHV-1 or PI-3 
vaccinations did not have a modulating influence on the pathogenesis of RBCV 
infections. The surprisingly low rate of BHV-1, PI-3, and other respiratory viruses
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among these vaccinated cattle contrasts with the high frequency of RBCV isolations in 
these respiratory tract disease episodes under investigation (Tables 3.20 and 3.21). This 
finding may suggest that RBCV is establishing itself as a currently prevailing 
respiratory virus in the cattle population because of the immune pressure of successful 
modem vaccination programs, which are reducing infection with other known viral 
causes of BRDC.
The predominant bacterial species cultivated from pneumonic lung samples of dead 
cattle were P. haemolytica. The upper respiratory tracts but not lungs of clinically 
normal cattle may harbor P. haemolytica and other bacteria considered as potential 
contributing causes of shipping fever (Briggs et al., 1998; Frank et al., 1986; Frank and 
Briggs, 1992; Frank and Smith, 1983; Magwood et al., 1969). Certainly, P. haemolytica 
infections played a role in the pathogenesis of the severe pneumonia of the calves 
whose respiratory tract defenses were weakened by the high level of RBCV infection 
during the early phase of respiratory tract disease episodes of our investigations. The 
HE glycoprotein of BCV binds to the 9-O-acetylated neuraminic acid residues of 
glycoproteins or glycolipids on the surfaces of erythrocytes and susceptible cells, which 
is considered to be the major receptor determinant of coronavirus (Herrler et al., 1985; 
Herrler et al., 1991; Vlasak et al., 1988a and b). The AE activity of HE hydrolyzes an 
ester bond to cleave an acetyl group from the 9-O-position of the substrates, potentially 
eluting adsorbed virions and destroying the HE-binding activity of the glycans on the
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cell membrane. The process of binding to 9-O-acetylated receptors, followed by 
cleavage and rebinding to intact receptors, could theoretically result in virus migration 
through a mucus layer and weakness of mucosal resistance barrier and thereby facilitate 
not only the virus infection, release and spread but also adhesion of P. haemolytica.
It is a widely accepted hypothesis that bovine shipping fever pneumonia is resulting 
from multiple causes such as stressful conditions of crowding and transport and viral 
and bacterial infections (Hoerlein, 1980; Yates, 1982). Numerous repeated attempts to 
reproduce typical shipping fever pneumonia with stress alone, with virus infections 
alone, or with bacterial infections alone were unsuccessful, unless P. haemolytica 
infections were introduced directly into the lungs (Baldwin et al., 1967; Briggs et al., 
1998; Collier, 1968; Friend et al., 1977; Hoerlein et al., 1961; Whitely et al., 1992; 
Yates, 1982). Stressful conditions are usually created at weaning, under auction 
conditions, during transport and adjustment to the feedlot environment. Identification of 
etiological infectious agents and their mechanisms of pathogenesis had been studied for 
decades. However, shipping fever pneumonia, a fatal acute respiratory tract disease, is 
still particularly prevalent among 6- to 8-month-old beef cattle after transport and entry 
into feed yards (Hoerlein, 1980; Martin, 1985; Storz et al., 1996; Storz, 1998; Storz et 
al., 1999; Storz et al., 2000a and b; Yates, 1982).
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ANTIBODY RESPONSES TO RESPIRATORY CORONAVIRUS 
INFECTIONS OF CATTLE DURING SHIPPING FEVER
PATHOGENESIS
4.1 Introduction
Coronaviruses, a genus in the family Coronaviridae, are enveloped positive-strand 
RNA viruses that emerge as increasingly important causes of human and animal 
diseases (Lai, 1990). These diseases include respiratory infections, gastroenteritis, 
hepatic and neurological disorders, immune-mediated disease such as feline infectious 
peritonitis, and persistent infections (Lai, 1990; Spaan et al., 1988; Wege et al., 1982). 
Bovine coronavirus (BCV) is the second most common cause of virus-induced severe 
enteritis or occasional pneumoenteritis in calves, and is referred to here as 
enteropathogenic BCV (EBCV) (Clark, 1993; Mebus et al., 1973). Winter dysentery in 
adult dairy cattle was also attributed to EBCV (Clark, 1993; Saif et al., 1988).
Recently, high rates of coronavirus infections were detected in respiratory tract 
samples of cattle with acute respiratory distress including shipping fever pneumonia 
(Storz et al., 1996; Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b). Shipping 
fever pneumonia is an acute respiratory tract disease, particularly prevalent among 6- to 
8-month-old cattle after transport and entry into feed yards in Northern America 
(Hoerlein, 1980; Yates, 1982). The role of respiratory bovine coronavirus (RBCV) in
102
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shipping fever pneumonia was previously not recognized. A refined virus isolation 
scheme was applied in recent etiological investigations. It included the G clone of 
human rectal tumor-18 (HRT-18) cells and Georgia bovine kidney (GBK) and bovine 
turbinate (BT) cells with specific permissiveness for currently known respiratory 
viruses of cattle including RBCV (Storz et al., 1996; Storz, 1998; Storz et al., 1999; 
Storz et al., 2000a and b). This approach led to the first successful isolation of wild-type 
RBCV at high rates from nasal swab samples of cattle arriving at feed yards with 
respiratory distress, and provided the initial evidence of a potential etiological role of 
RBCV in shipping fever pneumonia.
The genome of EBCV consists of a single, positive-stranded RNA molecule of 
about 31 kilobases (kb) (Clark, 1993; Lai, 1990; Spaan et al., 1988; Wege et al., 1982). 
The 3’ end of the genomic RNA consists of approximately 9.5kb and contains the genes 
for 5 structural proteins: (1) a longer peplomeric 190 kilodalton (kDa) spike 
glycoprotein (S) with a proteolytic cleavage site where proteases split S into 110-kDa 
Si and 100-kDa S2 subunits, (2) a short peplomeric 140-kDa hemagglutinin-esterase 
glycoprotein (HE) which is a disulfide-linked dimer of 2 identical 65-kDa subunits, (3) 
a 26-kDa integral membrane glycoprotein (M), (4) a 9.5-kDa envelope protein (E), and 
(5) an internal phosphorylated 50-kDa nucleocapsid protein (N) (Brown and Brierly, 
1995; Deregt et al., 1987; Hogue et al., 1989). Comparative nucleotide and amino acid 
sequence analysis of the 3’ genomic portion (9.5kb) of wild-type RBCV and EBCV
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strains revealed that RBCV-specific nucleotide and amino acid changes were 
disproportionally concentrated within the HE gene, the S gene and the genomic region 
between the S and E genes (Chouljenko et al., 1998b).
Immunoglobulin (Ig) G predominates over other classes in serum of cattle and 
accounts for around 90% of the total serum Ig (Duncan et al., 1972; McGuire et al., 
1976; Williams and Spooner; 1975). The 2 major subclasses of IgG in cattle are IgGl 
and IgG2 (Butler, 1969). Although IgGl and IgG2 occur in relatively equal amounts in 
serum and secretions, IgGl is the predominant isotype in colostrum and milk instead. 
Bovine IgGl and IgG2 fix bovine complement, but IgG2 does not bind heterologous 
complement (McGuire et al., 1979; McGuire and Musoke, 1980). The antibody 
responses to EBCV structural proteins were first studied by Heckert et al (Heckert et al., 
1991) in experimentally-exposed, colostrum-deprived, 20- to 30-hour-old calves that 
were inoculated orally and intranasally at birth and challenge exposed 3 weeks after 
inoculation. About 2 to 3 days postinoculation, these calves developed enteric disease 
signs, and virus shedding was detected in their feces and nasal swab samples for 4 to 9 
days and 6 to 9 days, respectively. These calves first developed serum IgM to N and HE 
at postinoculation week (PIW) 1, and then they responded with IgGl directed to N and 
S, and with moderate and slower IgG2 response to N and S antigens at PIW 2 and 3. 
After challenge of the immunity of these calves by EBCV inoculation, virus shedding 
was not detected, and calves did not become ill. An increase in IgM to N, in IgGl
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antibody reactions to S, HE, M and N, and in IgG2 responses to S and HE was detected. 
The S and HE antigens elicited virus infectivity-neutralizing antibodies.
Previously, extensive investigations on the kinetics of antibody responses of cattle 
to respiratory viruses other than RBCV demonstrated a crucial role of Ig isotypes in 
disease development and protection (Hoerlein, 1980; Kimman et al., 1989a and b; 
LeJan and Asso, 1980; Potgieter, 1975; Rossi and Kiesel, 1976; Yates, 1982). We 
hypothesized that differences in either immune response to RBCV or RBCV-specificity 
of antibody reaction would effect the clinical outcome of shipping fever pneumonia. 
Consequently, we monitored these parameters of RBCV infections during a severe 
epizootic of shipping fever pneumonia which was prospectively designed, and included 
sequential examinations and samplings. These cattle were studied clinically, 
virologically and immunologically from the initial phases of infection to recovery or 
fatal outcomes. The investigation facilitated the first comprehensive assessment of 
currently prevailing respiratory virus infections of market-stressed cattle during a 
naturally occurring epizootic. A surprisingly high rate of RBCV infections in the virtual 
absence of other respiratory bovine viruses was detected in the early stage of this 
epizootic (Storz et al., 1999; Storz et al., 2000a and b). The specific objectives of this 
investigation were to assess the kinetics of total antibody responses of immunologically 
mature cattle to RBCV infections during a naturally occurring epizootic of shipping 
fever pneumonia, to define the immunoisotype responses and the antigenic reactivities
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of the S, HE, M, N structural proteins of RBCV, and to relate these findings with 
isolation of RBCV from nasal swab and lung samples and development of respiratory 
tract disease.
4.2 Materials and Methods
4.2.1 Experimental Design
One hundred and five 6- to 8-month-old cattle were included in this naturally 
evolving and prospectively monitored epizootic which occurred in 1997. The mixed- 
breed cattle were assembled on day 0 at an order-buyer bam (OBB), identified by ear 
tags and clinically examined. Nasal swab and blood samples were collected, followed 
by vaccination with commercially available modified-live vaccines against BHV-1 and 
PI-3 (Prevail, Rhone Merieux Inc., Athens, Ga.), and a 7-way clostridial vaccine 
(Electroid 7, Mallinckrodt Veterinary Inc., Mundelein, II.). After a stay at OBB, the 
cattle were transported 1932 kilometers to the feed yard jointly operated by the 
Agricultural Research Service and the Texas Agricultural Experimental Station in 
Bushland, Texas. Nasal swab samples were taken on days 7, 14, and 21, and blood for 
serum harvest was collected on days 7, 14, 21, 28 and 35.
Clinical signs of respiratory tract diseases and results of RBCV isolation assigned 
these cattle into 5 response groups based on results reported elsewhere (Table 4.1) 
(Storz et al., 1999; Storz et al., 2000a and b). Response group 1 included 72 cattle that 
exhibited clinical signs of respiratory tract disease, and were shedding RBCV on day 0,
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day 7 or both. Seven animals were randomly chosen from each shedding pattern for 
testing in this study. Response group 2 contained 5 test cattle that secreted RBCV in 
nasal discharges without adverse respiratory signs. The 10 cattle of response group 3 
developed severe pneumonia, and died on days 7 to 11, and 9 that nasally shed RBCV 
were selected. Eighteen cattle remained RBCV isolation-negative. Eleven of them were 
included in response group 4 because they had fever and other respiratory signs, while 
the remaining 7 calves (response group 5) maintained clinically healthy during the 5- 
week investigation. Samples of 7 representative cattle from response groups 4 and 5 
were serologically analyzed. Test results of 49 cattle on sequential serum samples were 
included in this report.
4.2.2 Cell Line and Virus Isolate
A wild-type strain of RBCV (RBCV-97TXSF-Lul5-2) was isolated from the lung 
tissue of calf 97TXSF-15 as described (Storz et al., 1999; Storz et al., 2000a and b), 
propagated in the G clone of HRT-18 cells, and used at its 2nd passage for antigen 
preparation.
4.2.3 Virus Purification
Virus purification was performed according to Zhang et al. (Zhang et al., 1994). 
Infected G clone cell cultures with approximately 90% of the cells showing cytopathic 
expression were subjected to 3 cycles of freezing and thawing, and sonicating 4 times 
for 15 s at a power setting of 4 (Branson Sonifier cell disruptor 200, Branson
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Table 4.1: Respiratory Coronavirus Isolations and Clinical Signs o f Cattle in
Response Groups of the 1997 Shipping Fever Epizootic
Response No. of No. o f RBCV Isolation-Positive Cattle Clinical Signs No. of
Group Cattle Day 0 Day 7 Day 14 Day 21 RTD Death Ab-Tested Cattle
la 12 12 0 I 0 Yes No 7
lb 44 44 44 2 3 Yes No 7
lc 16 0 16 I 1 Yes No 7
2 5 2 3 1 0 No No 5
3 10* 6 9 Yes Yes 9
4 11 0 0 0 0 Yes No 7
5 7 0 0 0 0 No No 7
Total 105 64 72 5 4 49
RBCV: respiratory bovine coronavirus; RTD: clinical signs of respiratory tract disease; 
*cattle died on days 7 to 11.
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Ultrasonics Co, Danbury, Conn.), and centrifugation at 1,500 x g for 30 min.
Supernatant fluids were collected, and precipitated overnight at 4°C with 10% (w/v)
polyethylene glycol 8,000 and 0.5 M NaCl in TNE buffer (100 mM Tris, 10 mM NaCl,
1 mM EDTA pH 7.4), and harvested by centrifugation at 1,500 x g. Suspensions of
precipitates were loaded onto a 20% sucrose cushion prepared in TNE buffer,
centrifuged at 90,000 x g for 2 h. The sediments were collected and purified by
centrifugation at 200,000 x g for 16 h through a 20-60% sucrose gradient prepared in
TNE buffer. Isopycnic bands were collected, and the sucrose was removed through
TNE buffer dilution and centrifugation at 200,000 x g for 1.5 h. The purified virus
preparations were resuspended in TNE buffer and stored at -70°C.
4.2.4 Antibody Detection Using Indirect Enzyme-linked Immunosorbent Assay 
(ELISA)
The purified RBCV-97TXSF-Lul5-2 stock was diluted to 1 pg protein/ml in 0.1 M 
carbonate buffer, pH 9.6, and used to coat Microtitration ELISA plates (Immulon-2, 
Fisher Scientific, Pittsburgh, Pa.). The coated plates were held overnight at 4°C, and 
blocked for 2 h at room temperature with NET buffer (0.15 M NaCl, 1 mM EDTA, 
0.05 M Tris, pH 7.4) containing 1% (w/v) bovine serum albumin (BSA) and 0.2% (v/v) 
NaN3. Plates were washed 5 times with NET buffer containing 0.05% (v/v) Tween-20 
prior to addition of each reagent (100 p 1/well). All the reagents were added at 100 
pl/well. Serum samples diluted 1:50 in NET buffer containing 1% BSA were added in
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triplicate to appropriate wells. Serum 1745 (Storz and Rott, 1980; Storz and Rott, 1981) 
was included as positive control in the test while RBCV-antibody free serum from a 
normal calf (Storz and Rott, 1980; Storz and Rott, 1981) was used as negative control. 
Plates were incubated for 30 min at room temperature and washed as described above. 
Horseradish peroxidase (HRPO) conjugated, affinity-purified goat anti-bovine IgG 
(H+L) (Jackson Immunoresearch Inc., Avondale, Pa.) diluted at 1:20,000 was added for 
total immunoglobulin detection. A 1:400 dilution of HRPO-conjugated sheep anti- 
bovine IgM, a 1:30,000 dilution of HRPO-conjugated sheep anti-bovine IgGl, and a 
1:4,000 dilution of HRPO-conjugated sheep anti-bovine IgG2 (Bethyl Laboratories 
Inc., Montgomery, Tx.) were used for IgM, IgGl and IgG2 isotype quantitation, 
respectively. Plates were incubated for another 30 min and washed as described above. 
The substrate solution containing H20 2 and the chromogen 3,3’,5,5’- 
tetramethylbenzidine (Kirkegarrd & Perry Laboratories Inc., Gaithersburg, Md.) was 
added. Plates were incubated for 5 min, and then reactions were stopped by addition of 
100 pi of 0.10 M H2S 0 4. The optical density (OD) was measured with an ELISA plate 
reader (Dynatech MR 5000, Dynatech Laboratories Inc., Chantilly, Va.) at 450 nm. The 
OD450 values of triplicate wells were averaged for each test serum.
4.2.5 Statistical Assessments
The kinetics of total and isotype-specific antibody responses in each response group 
are presented as means ± standard error of the mean (SEM) of OD450 values. The
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antibody responses were compared by an analysis of variance of repeated measures 
designed with a split-plot arrangement of treatments. Pairwise comparisons of treatment 
and day differences were conducted with Scheffe’s test. Interaction effects were 
examined with pairwise t-tests of least square means for pre-planned comparisons of 
treatments at specific day levels. All tests were considered significant at a probability of 
P <0.05.
4.2.6 Immunoblot Assays
Purified RBCV-97TXSF-Lul5-2 (1 mg protein/ml) at a volume of 250 pi was 
mixed with an equal volume of 2x sample buffer (0.125 M Tris, 20% [v/v] glycerol, 
10% [v/v] 2-Mercaptoethanol, 4.6% [w/v] SDS) and heated to 100°C for 5 min. A 500- 
|il volume of this virus preparation was separated by electrophoresis in a 12% (w/v) 
polyacrylamide mini-gel (BioRad Laboratories, Richmond, Calif.) at 100 volts for 60 to 
75 min. Proteins in the polyacrylamide gel were then electrophoretically transferred to 
pure nitrocellulose protein transfer membranes (Schleicher & Schuell, Keene, Nh.) at 
100 volts for 90 min using an electrophoretic transfer cell (Mini-Trans-Blot, BioRad 
Laboratories). Blotted membranes were then blocked overnight at 4°C with 10% (w/v) 
nonfat-dry milk in NET buffer. The blot was mounted in a 28 chamber miniblotter 
apparatus (Miniblotter 28; Immunetics, Cambridge, Mass.). Twenty serum samples 
diluted 1:5 were tested on each blot in separate lanes for 1 h at room temperature.
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Again, serum 1745 and RBCV-antibody free serum from a normal calf were included as 
positive and negative controls, respectively (Storz and Rott, 1980; Storz and Rott, 
1981). Bound antibodies was localized after 1 h-incubation at room temperature with 
HRPO-conjugated, affinity-purified goat anti-bovine IgG (H+L) (Jackson 
Immunoresearch Inc.) diluted 1:5,000. All dilutions were made with 10% nonfat-dry 
milk in NET buffer. Antibody bound conjugate was detected using ECL Western Blot 
Detection System (Amersham Life Science Inc., Arlington Heights, II.). Finally, the 
blot was exposed to Hyperfilm™ (Amersham Life Science Inc.).
4.3 Results
4.3.1 Isolation of RBCV and Respiratory Tract Disease in Response Groups
The results of RBCV isolation and signs of respiratory tract disease were correlated 
in Table 4.1. Respiratory bovine coronaviruses were isolated from nasal samples of 72 
cattle which had mucopurulent nasal discharges, depression and rectal temperatures of 
40°C or above (response group 1). Fifty-six of them nasally shed RBCV on day 0 
(subgroup la, lb). Sixteen additional cattle became infected during transport 
(subgroup lc) while 12 cattle discontinued virus shedding on day 7 (subgroup la). Four 
calves continued to shed RBCV on days 14 and 21. Response group 2 contained 5 cattle 
which did not show adverse respiratory signs, but secreted RBCV in nasal discharges on 
day 0 or day 7, and 1 of them continued shedding through day 14. Ten cattle (response 
group 3) developed severe pneumonia and died from respiratory failure on days 7 to 11.
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Virus isolations on nasal swab samples proved that 6 of them shed RBCV on days 0 and 
7 while 3 had become infected by day 7. The pneumonic lung tissues of these 9 cattle 
contained RBCV infectivity reaching titers of 5.0 x  106 plaque forming units per gram. 
The remaining case was RBCV isolation-negative. However, RBCV-specific genomic 
portions were detected in the lungs by an RT-PCR assay (Chouljenko et al., 1998a). 
Eighteen of the 95 remaining cattle did not yield RBCV from sequential nasal swab 
samples, 11 of them (response group 4) had mild respiratory signs, while the other 7 
calves remained clinically healthy throughout the entire epizootic (response group 5).
4.3.2 Total and Isotype-specific Antibody Responses to RBCV Infections
Differences in the 5-week total and isotype antibody responses between subgroups 
la, lb and lc were not statistically significant, and Findings on these 21 cattle were 
combined for pertinent analyses. Overall kinetics of total and isotype antibody 
responses for response groups 1 and 2 did not show significant changes (Fig. 4.1 A, 
4 .IB, 4 .IF and 4.1G).
Levels of total antibodies to RBCV for all surviving cattle with active RBCV 
infections of the respiratory tracts (response groups 1 and 2) were initially low with 
O D ^ values of 0.29 ± 0.03 and 0.33 ± 0.05 for cattle with and without signs of 
respiratory distress (Fig. 4.1 A and 4 .IB). The increases in these levels were statistically 
significant between days 7 and 14, and then remained at high OD450 values reaching
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FIG. 4.1: Levels of total (A, B, C, D, E) and isotype antibodies (F, G, H, I, J) to 
respiratory bovine coronavirus in sera from cattle of response groups 1 (A, F), 2 
(B, G), 3 (C, H), 4 (D, I) and 5 (E, J) during the 1997 shipping fever epizootic.
• ,  total Ig and IgM; O, IgGl; ▼, IgG2. Data are means ± standard errors of the means 
(n = 21, 5, 9, 7 and 7 for A+F, B+G, C+H, D+I, and E+J, respectively).
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0.71 ± 0.04 and 0.68 ± 0.07. In comparison with those for response group 2, O D ^  
values of IgM isotype for response group 1 were higher on days 0 and 7; and these 
differences were statistically significant (Fig. 4. IF  and 4.1G). As the IgM levels began 
to decline after day 7, levels of IgGl and IgG2 isotype antibodies began to rise. 
Interestingly, calves of response group 1 had a more dramatic increase in IgG2 antibody 
level than cattle of response group 2 during days 14 and 35.
Nine RBCV isolation-positive cattle with fatal pneumonia in response group 3 had 
low immune responses on day 0 as OD450 values for total Ig, IgM, IgGl, and IgG2 
antibodies were 0.12 ± 0.02, 0.44 ± 0.13, 0.10 ± 0.01, and 0.33 ± 0.06, respectively 
(Fig. 4.1C and 4.1H). Increases in antibody levels were not detected during the 7- or 8- 
day course of respiratory tract disease pathogenesis except for a minimal initial IgM 
response.
Cattle in response group 4 started at a relatively high and stable level of total 
antibody with OD450 values of 0.42 ± 0.06, and 0.53 ± 0.03 on days 0 and 7 which 
showed statistically significant increases from response groups 1 and 2 (Fig. 4.1A, 4.1B 
and 4. ID). The total antibody level increased to 0.59 ± 0.05 on day 14 and were 
maintained throughout the testing period. Kinetics of isotype antibody responses 
reflected that of the total antibody response (Fig. 4.11). Compared with cattle of 
response groups 1 and 2, response group 4 cattle also had a higher IgGl level during the
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first 2 weeks, and the increases were statistically significant (Fig. 4 .IF, 4.1G and 4.11). 
The IgG2 level of response group 4 was significantly higher than that of response group 
1 during the first week, and was also substantially higher than that of response group 2 
in weeks 2 through 5.
Significant differences were not observed in the total, IgM and IgGl antibody 
responses between response groups 4 and 5 during the entire period of this epizootic 
(Fig. 4 .ID, 4 .IE, 4.11 and 4.1J). However, during the time of observation, cattle in 
response group 5 had the highest level of lgG2 isotype antibodies to RBCV of any 
response group (Fig. 4. IF, 4.1G, 4.1H, 4.11 and 4.1J). The level of IgG2 for these cattle 
started with an OD450 value of 0.84 ± 0.15 on day 0, increased during the following 2 
weeks to OD450 value of 1.12 ± 0.15 on day 14, and was then maintained.
4.3.3 Antigenicity of RBCV Structural Proteins
Antibody responses to specific viral structural proteins in immunobiotting assays 
revealed similar reactions among the cattle of each response group, and representative 
results from a single calf in each response group are presented. Figure 4.2 illustrates the 
immunobiotting reactions for calf 97TXSF-105 of response group 1 which shed RBCV 
in nasal secretions on day 7. Antibodies directed against viral structural proteins were 
not detectable in the serum samples collected on day 0 and day 7, but antibodies of 
rising levels reacting with HE and S were detected on day 14. Calf 97TXSF-3 of
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FIG. 4.2: Representative western blot analysis of sera from calf 97TXSF-105 of 
response group 1.
Lanes 1 through 6 were probed with serum samples collected on day 0, 7, 14, 21, 28 
and 35 post-arrival at OBB, respectively.
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response group 2 shed RBCV in respiratory secretions on day 7 without adverse clinical 
signs. The HE- and S-specific antibodies were detected on day 14 (Fig. 4.3). Sera from 
RBCV isolation-positive and fatal cases of response group 3 failed to react with any of 
the RBCV structural proteins (data not shown).
Western blot analysis of serum samples collected from RBCV isolation-negative 
calf 97TXSF-88 of response group 4 which had transient signs of respiratory distress 
was presented in Fig. 4.4. Strong antibody bindings of HE, S, and N viral proteins were 
detected on day 7 as cattle arrived in the feedyard, and were maintained for the 
following 4 weeks. Antibodies directed toward M glycoprotein were detectable at low 
level on day 14 and 21, waned on day 28, and disappeared on day 35.
Figure 4.5 presents immunoblot reactivities of sera from calf 97TXSF-4 of response 
group 5 that remained clinically healthy and RBCV isolation-negative throughout the 
epizootic. The sera contained high levels o f specific antibodies to HE, S and N viral 
proteins on day 0. The HE- or N-specific antibodies in the subsequent serum samples 
began to decline 3 weeks later, while the S antibody level was maintained or even 
increased during the next 5 weeks. The M glycoprotein-specific band became visible on 
day 7, and disappeared 2 weeks later.
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FIG. 4.3: Representative western blot analysis of sera from calf 97TXSF-3 of 
response group 2.
Lanes 1 through 6 were probed with serum samples collected on day 0, 7, 14, 21, 28 
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FIG. 4.4: Representative western blot analysis of sera from calf 97TXSF-88 of 
response group 4.
Lanes 1 through 6 were probed with serum samples collected on day 0, 7, 14, 21, 28 
and 35 post-arrival at OBB, respectively.
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FIG. 4.5: Representative western blot analysis of sera from calf 97TXSF-4 of 
response group 5.
Lanes 1 through 6 were probed with serum samples collected on day 0, 7, 14, 21, 28 
and 35 post-arrival at OBB, respectively.
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4.4 Discussion
Isolation results for RBCV and overt signs of respiratory tract disease divided the 
cattle of this experimentally assessed shipping fever epizootic into 5 response groups. 
The majority of cattle (response groups 1 and 2) nasally shed RBCV in the early stage 
of the epizootic. Their initial total antibody levels were low and rapidly increased 
during the first 2 weeks through brisk responses to HE and S antigens. Increase in IgM 
appeared first, and was followed by rises in IgGl and IgG2 as is characteristic for 
primary immune responses to antigens. With the appearance of HE- and S-specific 
antibodies, nasal RBCV shedding of most cattle was ceased. This relationship between 
the RBCV infections and antibody responses can be explained by previous findings in 
EBCV and human respiratory coronavirus infections which revealed that S and HE 
elicited virus-neutralizing antibodies (Deregt et al., 1989; Schmidt and Kenny, 1982; 
Schultze and Herrler, 1992). These findings confirmed a previous report (Heckert et al., 
1991) with the difference that antibody responses to N protein could not be detected 
during the primary immune responses to RBCV infection of these immunologically 
mature cattle. Based on this previous report (Heckert et al., 1991), our virus isolation 
results and the detected antibody levels, we concluded that most of these cattle became 
naturally infected with RBCV shortly before they were assembled at the OBB, and that 
virus spread was enhanced by stressful conditions during transport and associated 
crowding.
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During the primary immune responses to RBCV, a significantly higher IgM level in 
the first week and a substantially higher IgG2 level for the last 3 weeks were observed 
in clinically sick cattle (response group 1) as compared to cattle without adverse 
respiratory signs (response group 2). Seroconversion was observed in calves between 
the 14th and the 21st days after intranasal vaccination with modified-live virus of 
infectious bovine rhinotracheitis (IBR) (LeJan and Asso, 1980). The neutralizing 
activity in the serum was low at the 14th day, but increased by day 21, and persisted for 
2 or 3 months. Other investigators studied primary immune responses of seronegative 
cattle to IBR after intramuscular or nasal inoculations (Potgieter, 1975; Rossi and 
Kiesel, 1976). They demonstrated an early, transient and complement-dependent IgM 
antibody response followed by a complement-requiring IgG antibody response. Bovine 
complement component 3 (C3) activation was reported to be enhanced by bovine 
respiratory syncytial virus (BRSV)-specific IgM and IgGl, but not by IgG2 (Kimman et 
al., 1989a) . In the study of the pathogenesis of BRSV-associated disease, C3 was 
demonstrated in BRSV-infected parts of the lungs of dead calves, and was suggested to 
play a role in causing severe dyspnoea (Kimman et al., 1989b). We proposed that an 
early primary antibody response to RBCV infections included high levels of 
complement-binding but non-neutralizing antibodies on RBCV-infected cells, which 
consequently enhanced complement activation and binding as a possible pathologic 
mechanism of early disease enhancement. Besides its contribution to recovery from the
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respiratory tract disease by inducing lysis of RBCV and RBCV-infected cells, 
complement activation might also play a causative role in adverse respiratory signs by 
inducing inflammation. Activated complement can increase vessel permeability and 
smooth muscle contractibility, and activate neutrophils and mast cells. Additionally, 
massive destruction of RBCV-infected cells could cause severe tissue damage and 
aggravate respiratory tract disease.
Investigation of fatal cases (response group 3) revealed that the calves were 
immunologically naive to RBCV antigens. Antibody responses to any of the major viral 
structural proteins could not be detected with a sensitive immunobiotting assay. Lack of 
protective immunity or inability to develop HE- and S-specific virus-neutralizing 
antibodies against RBCV could have resulted in acute infections of lungs with fatal 
outcomes in synergy with Pasteurella haemolytica infections, typical for shipping fever 
pneumonia (Hoerlein, 1980; Yates, 1982).
Cattle with respiratory disease signs but not shedding RBCV (response group 4) had 
relatively high levels of total antibody against RBCV on day 0. Strong RBCV-specific 
antibody responses against HE, S and N viral proteins had been mounted by the time of 
their arrival in the feedyard. These findings mirrored the late phase of a primary 
antibody response to the RBCV infections. Failure in RBCV isolation attempts probably 
was due to sampling during declining virus excretion. Additionally, RBCV infectivity 
in nasal secretions might have been neutralized by secretory antibodies through
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formation of antibody-virus complexes. Secretory IgA against RBCV was detected in 
nasal secretions of these cattle (data not shown). These cattle may have played an 
important role in introducing the RBCV into the large group of susceptible cattle in this 
severe epizootic.
During the 5-week investigation, 7 cattle remained healthy and RBCV isolation- 
negative (response group 5). These cattle had the highest level of IgG2 antibody against 
RBCV for the entire period of the epizootic, and antigens recognized were HE, S and N 
viral proteins. The S-specific antibody was more stable and persistent than the HE- and 
N-specific antibodies during the later course of the epizootic. However, antibody 
reactions with M protein were sporadically detected throughout the sampling period. 
The serological response patterns of these RBCV-resistant cattle characterized a 
secondary antibody response to RBCV, the type of protective immunity induced by 
recovery from initial infection or by effective vaccination and subsequent challenge 
exposure. Consequently, it was inferred that these cattle had been infected with RBCV, 
and had recovered from the infections before they were assembled at the OBB. Solid 
immunity from the initial infection prevented RBCV reinfection throughout this 
epizootic. This result agreed with previous studies on colostrum-deprived newborn 
calves which had been experimentally-infected with EBCV and subsequently challenge 
exposed (Heckert et al., 1991).
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A major difference observed in immune responses between RBCV isolation- 
negative cattle with or without signs of respiratory tract diseases was the ratio of IgG2 
to IgGl which was higher for clinically normal cattle than sick ones. The bovine serum 
IgGl has a shorter half-life than IgG2 (Nansen, 1970). Studies on the phagocytosis of 
Staphylococcus aureus by bovine polymorphonuclear neutrophils (PMN) indicated that 
IgG2 was opsonic for bovine PMN, while IgGl was not opsonic, and even inhibited 
IgG2 opsonization (Guidry et al., 1993). In contrast to IgG2, IgGl caused neither 
adherence nor phagocytosis in vitro by freshly isolated bovine neutrophils and 
monocytes (McGuire and Musoke, 1980). Competitive inhibition tests indicated that 
binding of IgG2 exceeded that of IgGl, although IgGl and IgG2 shared a common Fc 
receptor on bovine PMN (McGuire et al., 1979; Worku et al., 1994). Re-exposure of 
cattle to IBR virus resulted in a booster effect on serum antibodies including a transient 
IgM response as well as a further, rapid increase in IgG (Potgieter, 1975; Rossi and 
Kiesel, 1976). However, secondary antibody responses seemed to be less responsive to 
complement enhancement of the neutralizing activity. We hypothesized that during the 
secondary antibody response to RBCV, free RBCV and RBCV-infected cells were 
opsonized by high titers of opsonic and RBCV-neutralizing IgG2, leading to enhanced 
phagocytosis, more efficient elimination of RBCV infectivity, and thus alleviation of 
clinical signs of respiratory tract disease.
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Interestingly, bovine PMN FcR for IgGl and IgG2 were interferon-y (INF-y) 
inducible (Worku et al., 1994). Bovine IFN-y enhances IgG2 production by directly 
affecting suitably stimulated B cells (Estes et al., 1994). The effect of IFN-y on bovine 
IgG2 is augmented by interleukin 2 (IL-2). IgM production is suppressed by the 
presence of IFN-y alone but this effect is antagonized by IL-2. Bovine IL-4 upregulates 
the production of IgGl, IgE and IgM, and expression of MHC class II, the low-affinity 
FcR for IgE (CD23), IL-2R, and surface IgM on bovine B cells (Estes et al., 1995). 
Future studies on cytokines and related factors should be defined for the humoral as 
well as cell-mediated immune responses of cattle to RBCV infection.
Remarkable differences were observed in the antibody responses to the major 
structural proteins of RBCV. The M protein was much less immunogenic than S, HE, 
and N viral proteins. This observation can be explained by the low molecular mass, 
structural conformation and inaccessible location of M within the viral envelope. Both 
HE and S were the viral antigens recognized during the initial stages of the bovine 
immune response to RBCV infection. The HE glycoprotein induced antibodies earlier 
than the S glycoprotein. The HE glycoprotein consists of 2 identical, disulfide-linked 
glycosylated subunits with an N-terminal signal region and a C-terminal anchorage 
region (Lai, 1990). The S glycoprotein contains an N-terminal signal sequence, a coil- 
to-coil structure, and a C-terminal hydrophobic membrane-anchoring domain, and
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exists as a more stable tetramer. The structure and abundance of the HE protein might 
favor exposure of epitopes with earlier induction of antibodies. The antibody response 
to N protein was pronounced during the later phase of the infection when RBCV 
shedding could not be detected by virus isolation attempts, but a modified polymerase 
chain reaction detected RBCV genomic regions in lung samples (Chouljenko et al., 
1998a). We hypothesized that the relatively late appearance of N-specific antibodies 
might depend on the quantity of N in the virions, its structural binding to the RNA 
genome, and its internal site within the viral envelope. Findings on cell-mediated 
immunity to mouse hepatitis virus revealed that CD8-bearing lymphocytes influenced 
recovery from infection with N protein as the major target for cytotoxic lymphocytes 
(Stohlman et al., 1993). Therefore, HE, S and N proteins should be the major viral 
antigens to be included in future vaccines for cattle to achieve efficient prevention of 
RBCV as well as EBCV infections.
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CHAPTERS 
INFECTION OF POLARIZED EPITHELIAL CELLS WITH 
RESPIRATORY AND ENTERIC TRACT BOVINE 
CORONA VIRUSES AND RELEASE OF VIRUS PROGENY*
5.1 Introduction
Bovine Coronavirus (BCV) infections induce severe diarrhea in neonatal calves and 
are referred to as enteropathogenic BCV (EBCV). They may also cause winter 
dysentery in adult dairy cattle (Mebus et al., 1973; Saif et al., 1988). Furthermore, the 
high rate of BCV isolations from nasal samples of feedlot cattle with signs of 
respiratory tract infections implies an etiological role in respiratory diseases (Storz et 
al., 1996; Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b). These isolates are 
considered respiratory BCV (RBCV). The BCV are spherical and enveloped, have a 
diameter of about 80 nm, and possess a single-stranded nonsegmented RNA genome 
with positive polarity (Spaan et al., 1988). Virions contain 5 major structural proteins: 
the nucleocapsid pro tein  (N), the transm em brane protein (M), the 
hemagglutinin/esterase protein (HE), the spike protein (S) and the envelope protein 
(Brown and Brierly, 1995; Cavanagh et al., 1990; Lai, 1990).
* Reprint for letter of permission by the American Journal of Veterinary Research is on 
page 214.
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Observations of the interaction of wild-type EBCV strains with cultured cells were 
limited, because they could not be adapted to a variety of bovine cells with the 
exception of the Mebus strain (Mebus et al., 1973; Storz et al., 1981). However, 
isolation and propagation of the wild-type EBCV was successful in the human rectal 
tumor cell-18 line (HRT-18) which was established from an adenocarcinoma of the 
lower gastrointestinal tract by Tompkins and coworkers (Laporte et al., 1979; St. Cyr- 
Coats and Storz, 1988; Tompkins et al., 1974). Monolayers of these polarized 
epithelioid cells exhibited several structural and functional features of epithelial cells 
that are targeted by BCV in natural infections (Doughri and Storz, 1977). The apical 
and lateral surfaces of the HRT-18 cells are modified by abundant filiform microvilli 
(Payne and Storz, 1990), and the lateral membranes possess a pronounced system of 
intercellular adhesions (Williams, 1983).
Research on the interaction of influenza viruses with epithelial cells of the 
chorioallantois of chicken embryos indicated that the release of progeny virus occurred 
exclusively by budding at the apical cell surface (Murphy and Bang, 1952). Release of 
the virus thus was directional, occurring at only one side of this epithelial cell layer. 
More recently, it was reported that the directional budding of several enveloped viruses 
occurred from either the apical or the basolateral surfaces of epithelial cells in culture 
(Jones et al., 1985; Rodriguez-Boulan and Sabatini, 1978; Roth et al., 1983). The major 
aim of this investigation was to assess the interaction of enteric and respiratory strains
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of BCV with the polarized epithelioid G clone of HRT-18 cells following directional 
exposure. Cytopathic changes induced under these polarizing cytological conditions, as 
well as the release of hemagglutinins (HA) and viral infectivities from different cellular 
domains were assessed.
5.2 Materials and Methods
5.2.1 Cells, Media and Polarizing Cultural Conditions
The G clone of HRT-18 cells was used at the 18th passage level for these 
investigations. Monolayers of G clone cells were grown on polyester membranes with a 
pore size of 400 nm. These membranes had been treated to facilitate culturing of cells, 
and were inserted into 6-well cluster plates (Costar, Cambridge, Mass.). Cells were 
cultured in DMEM with 44 mM NaHC03 buffer and penicillin (100 units/ml) - 
streptomycin (100 pg/ml). Medium supplemented with 5% fetal calf serum was used for 
cell propagation, and serum-free medium was used during virus propagation. Confluent 
monolayers of G clone cells on the inserts of the wells of the plates were washed 2 
times with serum-free Dulbecco's PBS (calcium and magnesium free) and exposed to 
1.4 ml virus preparation from apical or 2.8 ml virus preparation from basolateral 
surfaces. Volumes of 1.4 ml and 2.8 ml of the DMEM were added to the spaces of the 
opposite, uninoculated surfaces to balance the volumes. The volumes were 
recommended by the manufacturers of the inserts. Uninfected cells were used as 
negative control, while cells infected with vesicular stomatitis virus (VSV) were used as
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
133
positive control. Following an absorption period of 1 h at 37°C, excess inoculum was 
removed, and cells were covered with fresh DMEM. Infected cluster plates were 
incubated at 37°C and cytopathic changes were monitored by microscopic examination.
5.2.2 Processing for Scanning Electron Microscopy (EM)
Parallel confluent control and inoculated monolayers of G clone cells on inserts in 
the wells o f plates were treated with EM stock fixative (1.25% glutaraldehyde and 2% 
formaldehyde in 0.1 M sodium cacodylate buffer pH 7.4), washed in 0.1 M sodium 
cacodylate buffer with 5% sucrose at pH 7.4. Segments of about 5 mm2 are cut from the 
monolayers on the membranes with razor blades, and incubated in sodium cacodylate 
buffered solutions (pH 7) of 1% osmium tetroxide for 30 min, 1% tannic acid for 15 
min and again in 1% osmium tetroxide for 15 min, rinse in distilled water, dehydrated 
in a gradient alcohol series, critical point dried, mounted with carbon tabs, and sputter 
coated with gold-palladium. The samples were viewed with a Cambridge S-150 
scanning electron microscope.
5.2.3 Giemsa Staining
Parallel confluent monolayers of G clone cells on the membranes was fixed in 
Bouin’s fixative, stained in 1:10 dilution of Giemsa reagents in lx  Giemsa buffer 
(A.J.P. Scientific Inc., Clifton, N.J.), and mounted with CoverBond™ mounting media 
(Division of American Hospital Supply Co., Genearl Office, McGAW PARK, II.).
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5.2.4 Virus Strains
The 2 EBCV strains, L9 (cell-culture adapted strain) and LY138 (wild-type strain), 
used in these investigations had been passaged in cell cultures 80 and 2 times, 
respectively. Two additional wild-type strains of RBCV, LSU-94LSS-051 and OK- 
0514, were used at their 2nd and 3rd G clone cell passages, respectively. The viral 
infectious titers were 1.0 to 4.0 x 10® plaque forming units per ml (PFU/ml). The VSV 
propagated in chicken embryos and once in G clone cells, in which it had a titer of 2.0 x
105 PFU/ml, was used as a comparative virus control.
5.2.5 Directional Sampling of Virus Released from BCV-infected G Clone Cells
Fluid samples (200 pi) were taken at different intervals (0 h, 6 h, 12 h, 24 h) from 
both the top and the bottom of the infected G clone cell monolayers growing on inserts 
in cluster plates. After each sampling, the same volume (200 pi) of fresh DMEM was 
added to restore the original volume, so that the last samplings had the original volume 
of fluid in the inserts after a 30-h incubation. The whole fluid was removed as the last 
samples collected from the bottom wells of the infected monolayers 30 h after 
inoculation, while the fluid in the inserts was frozen with the monolayers at -70°C and 
thawed at room temperature. Then, the cells were scrapped off and placed with the 
media into sterile Eppendorf tubes. The cell suspensions were then centrifuged at 4°C 
with a speed of 1,500 x g for 20 min. Supernatant fluids were transferred to Eppendorf
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tubes and identified as the 30-h ceil free samples collected from the apical surfaces of 
the infected monolayers.
5.2.6 Harvest of BCV-infected G Clone Cell Monolayers
An amount of 1 ml of DMEM was added to the cell sediment, and the cell 
suspensions were treated with sound 2 times for 15 s at a power setting of 2 (Branson 
Sonifier Cell Disruptor 200, Branson Ultrasonics Co., Danbury, Conn.) to release 
intracellular virus.
5.2.7 Assessment of Pore Size of Inserts for Virus Passage
An exploratory experiment assessing the ability of RBCV to penetrate the 400 nm 
membrane pores was done as follows: virus preparations at volumes of 1.4 ml were 
placed into the polyester membrane inserts and 2.8 ml were placed into the bottom 
wells. Corresponding volumes of DMEM were added to the opposite sides to balance 
the volume. Plates were incubated at 4°C for 1 h. The fluids in the wells and on the 
membrane inserts were then titered for HA activities.
5.2.8 Assays for HA
The assay for HA was performed as reported (Storz et al., 1999b and c) with washed 
rat red blood cells prepared to 0.5% with PBS pH7.4, containing 0.05% bovine serum 
albumin.
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5.2.9 Plaque Assays
The plaque assay was performed according to recently published procedure (Lin et 
al., 1997b), using 6-well flat-bottom tissue culture plates with confluent monolayers of 
G clone cells.
5.3 Results
5.3.1 Observations on Surfaces and Intercellular Binding of Control G Clone Cell 
Monolayers
The G clone cell monolayers on the porous membranes were examined by scanning 
EM and light microscopy, which revealed high cell density and complete tight 
intercellular contact as unique characteristics. Figure 5.1 depicts the surface of the G 
clone cell monolayers with abundant microvilli and tight intercellular binding.
5.3.2 Cytopathic Changes Induced in G Clone Cells Following Directional 
Infection with RBCV and EBCV
Cytopathic changes consisting of cell fusion were detected at 12 h after apical
inoculation. These changes were abundant by 24 h while basolaterally inoculated
cultures had only minimal changes (Table 5.1). Infected cells formed polykaryons in all
cultures at 30 h after inoculation, irrespective of the route of inoculation. A difference
between cells inoculated with respiratory or enteric BCV isolates was not observed.
Cells inoculated with VSV as virus controls developed cytocidal changes at 12 h after
inoculation by either route, and complete cell detachment and lysis had occurred by
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FIG. 5.1: Scanning electron micrograph of a monolayer o f uninfected G clone cells.
The surface is illustrated with microvilli (white arrow), and tight intercellular 
arrangement (black arrow) (x 5700); bar = 4pm.
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Table 5.1: Cytopathic Changes in G Clone Cells Following Apical and Basolateral 
Exposure to Respiratory and Enteropathogenic Bovine Coronaviruses and
Vesicular Stomatitis Virus
Strains of BCV Exposure Sites Hours After Inoculation
0 6 12 24 30
RBC V-LSU-94LSS-051 -2 A - - + ++++ ++++
B - - - ± + -H -+
RBCV-OK-0514-3 A - - + ++++ ++++
B - - - ± ++++
EBCV-L9-80 A - - ± ++++ + + + +
B - - - ± + + + +
EBCV-LY138-2 A - - ± ++++ ++++
B - - - ± ++++
VSV* A - - + ++++ ++++
B _ - ± ++++ ++++
BCV: bovine coronavirus; RBCV: respiratory bovine coronavirus; EBCV: 
enteropathogenic bovine coronavirus; VSV: vesicular stomatitis virus; A: apical; B: 
basolateral, -: no cytopathic changes; ±: beginning cytopathic changes, consisting of cell 
fusion < 10% of the monolayers involved; ++++: complete fusion of over 90% of cells in 
monolayers; *: VSV induced rounding and rapid lysis of the G clone cells.
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30 h. Uninoculated control cells maintained a dense confluent monolayer of small 
cuboidal epithelioid cells on the polyester membrane inserts.
5.3.3 Hemagglutinin and Infectious Virus Release from G Clone Cells Directionally 
Inoculated with RBCV and EBCV
Hemagglutinins interacting with rat RBC were released into the apical medium
irrespective of apical or basolateral exposure with increasing titers reaching levels of 32
to 64 by 30 h (Table 5.2). The basolateral samples did not carry detectable HA for 30 h.
Experiments with directional placement of virus inocula permitted passage of BCV
isolates through the membranous inserts with a pore size of 400 nm within 1 h (data not
shown). The highest infectivity titers of 5.2 x 107 PFU/ml in the 12-h samples and 4.2 x
108 PFU/ml in the 24-h samples were present in the apical medium of G clone cells
apically or basolaterally exposed with either RBCV or EBCV (Table 5.3). Samples
collected from the basolateral medium of cells exposed by apical or basolateral routes
had minimal infectivity titers that were 4 or 5 logs lower than those of the apical
samples. The G clone cells inoculated with VSV released virus through apical and
basolateral surfaces with equal titers when exposed by either route (Table 5.3).
5.3.4 Hemagglutinins and Viral Infectivities in Homogenized G Clone Cells 
Directionally Inoculated with RBCV and EBCV
Cell cultures that were homogenized at 30 h after the different modes of
directional inoculation had HA titers of 16 to 128 and viral infectivity titers of 1.2 x 106
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Table 5.2: Hemagglutinin Titers Released by G Clone Cells Following Directional 
Exposure to 4 Strains of Respiratory and Enteropathogenic Bovine Coronaviruses
Strains of BCV Sites of HA Titers X Hours After Inoculation
Exposure Sampling 0 6 12 24 30
RBCV-LSU- A A <2 <2 16* 32* 64
94LSS-051-2 A B <2 <2 <2* <2* <2
B A <2 <2 <2* 16* 32
B B <2 <2 <2* <2* <2
RBCV-OK-0514 A A <2 <2 16* 32* 32
-3 A B <2 <2 <2* <2* <2
B A <2 <2 <2* 32* 32
B B <2 <2 <2* <2* <2
EBCV-L9-80 A A <2 <2 8* 32* 32
A B <2 <2 <2* <2* <2
B A <2 <2 <2* 16* 64
B B <2 <2 <2* <2* <2
EBCV-LY138-2 A A <2 <2 8* 64* 32
A B <2 <2 <2* <2* <2
B A <2 <2 <2* 32* 64
B B <2 <2 <2* <2* <2
*: samples were assayed for plaque forming infectivity in table 4.3; Other notes as table 
5.1. Hemagglutinin (HA) titers were expressed as hemagglutination units (HAU)/50 pi, 
reflecting the highest titer with complete agglutination.
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Table S3: Titers of Hemagglutinins and Viral Infectivities of Virus after 
Directional Inoculation of G Clone Cells with Respiratory and Enteropathogenic 
Bovine Coronaviruses and Vesicular Stomatitis Virus
Strains of BCV Sites of  
Exposure Sampling
12 Hours PI 24 Hours PI
HAU PFU/ml HAU PFU/ml
RBCV-LSU A A 16 5.2 x 107 32 4.2 x 108
-94LSS-051-2 A B <2 2.8 x 102 <2 6.4 x 103
B A <2 7.0 x 103 16 6.8 x 107
B B <2 1.3 x 104 <2 1.7 x 104
RBCV-OK-0514 A A 16 4.8 x 107 32 2.4 x 108
-3 A B <2 2.0 x 102 <2 9.6 x 103
B A <2 8.0 x  103 32 2.4 x 108
B B <2 1.0 x 104 <2 2.4 x 104
EBCV-L9-80 A A 8 4.0 x 107 32 1.6 x 108
A B <2 4.0 x 10* <2 4.0 x 103
B A <2 1.4 x 103 16 2.0 x 107
B B <2 3.6 x 104 <2 9.6 x 103
EBCV-LY138-2 A A 8 8.0 x  106 64 6.8 x 107
A B <2 <4.0 x 10‘ <2 9.6 x 102
B A <2 8.0 x 103 32 2.6 x 107
B B <2 1.8 x 104 <2 4.8 x 103
VSV A A <2 2.0 x 102 <2 1.0 x 10s
A B <2 <4.0 x 101 <2 8.0 x 101
B A <2 4.0 x 102 <2 1.4 x 105
B B <2 4.0 x 102 <2 1.2 x 104
PI: postinfection; PFU: plaque forming units; other notes as table 5.2.
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to 4.0 x 107 PFU/ml (Table 5.4). No significant difference in these titers was observed 
when RBCV or EBCV isolates were inoculated by the 2 different routes.
5.4 Discussion
Our results demonstrate that polarized epithelioid G clone cells had maximal 
susceptibility to BCV infections from apical domains and minimal susceptibility from 
basolateral surfaces, but infectious progeny BCV virions were asymmetrically released 
from the apical surfaces of these cells. VSV entered and exited the G clone cells 
through both apical and basolateral surfaces.
Monolayers of polarized epithelioid G clone cells behave both structurally and 
functionally like epithelial cells, the type of cells targeted by BCV in natural infections. 
Monolayers of parent HRT-18 cells are composed of cells oriented with a basally 
located nucleus and the bulk of the cytoplasm above the nucleus. Intercellular adhesions 
consisting of desmosomes and maculae adherens are found connecting the cells to each 
other in culture. Microvilli are present both at the apical surface of the cells exposed 
directly to the cell culture medium and also in lateral areas between cells not connected 
by intercellular junctions and adhesions (Williams, 1983). The apical surfaces of the 
parent HRT-18 cells are modified by abundant small filiform microvilli (Payne and 
Storz, 1990). The HRT-18 cells exhibit features of polarized epithelial cells 
characterizing both enterocytes of gastrointestinal tracts and ciliated epithelial cells of 
respiratory tracts (Tucker and Compans, 1993). Recently, the epithelial cells of the
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Table 5.4: Hemagglutinin Titers and Virus Infectivities in Harvest of G Clone
Cells
Strains of BCV Exposure Sites HAU PFU/ml
RBCV-LSU-94LSS-051-2 A 16 1.2 x  106
B 32 9.6 x  106
RBCV-OK-0514-3 A 32 6.8 x  106
B 128 4.0 x  107
EBCV-L9-80 A 32 3.0 x  107
B 32 3.0 x  107
EBCV-LY138-2 A 64 4.8 x  106
B 64 4.8 x  106
VSV A <2 2.0 x  104
B <2 3.6 x  104
Notes as table 5.3.
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respiratory tract of cattle were found to be highly susceptible to RBCV(Storz et al., 
1996; Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b).
The morphology and morphogenesis of wild-type strain LY138 of EBCV infecting 
enterocytes of experimentally inoculated calves were first investigated by Doughri and 
coworkers (Doughri et al., 1976). Uptake of EBCV occurred through fusion of viral 
envelopes with the plasmalemma of the brush border with abundant virus binding to 
microvilli, or by entry into intercellular spaces and interaction with the lateral cell 
membranes of adjacent intestinal epithelial cells.
The abundance and unique distribution of microvilli of G  clone cells point to 
specific mechanism by which BCV infection may be initiated in these cells. Since it is 
now evident that BCV is not absolutely restricted to binding to the apical plasma 
membrane domains, it is reasonable to conclude that BCV receptor molecules are 
expressed on microvilli of both apical surfaces and intercellular areas of G clone cells to 
mediate virus infection. However, fewer microvilli at lateral intercellular areas makes 
the G clone cells minimally susceptible to BCV when infected basolaterally. Then, 
progeny virions released from apical surfaces reinfect the target cells from this domain 
and cause C.P.E. which was delayed for about 12 h, when compared with apical 
exposure.
Recently, Schultze and Herrler found that infection of MDCK I cells with strain L9 
of EBCV and influenza C virus is restricted to the apical cell surface (Schultze and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
145
Herrler, 1995). Fuller et al found that VSV infects primarily through the basal surface of 
MDCK cells (Fuller et al., 1984). These findings seem to differ from our results. The 
different cell types used in the experiments may account for the observed divergence.
The MDCK cell is a well-characterized epithelial cell line and contains all the 
elements of a polarized cell. The cell exhibits features characteristic of native renal 
tubular epithelium, including sparse microvilli, junctional complexes and defined lateral 
spaces (Cereijido et al., 1978; Misfeldt et al., 1976). However, up to now, investigations 
have not indicated that MDCK cells have microvilli at lateral intercellular areas not 
connected by the tight junctions. These lateral areas of G clone cells may be accessible 
to BCV when infected basolaterally. In accordance, EBCV-LY138 had been detected 
w ithin the in tercellu lar space of adjacent in testinal epithelial cells 
(Doughri et al., 1976).
Doughri and coworkers found that release of wild-type strain LY138 of EBCV from 
infected cells in the jejunal and ileal mucosa of calves occurred by lysis and 
fragmentation of the apical plasmalemma and flow of the cytoplasm with its contents 
into the gut lumen (Doughri et al., 1976). Release also occurred by digestion and lysis 
of extruded infected cells or by fusion of virus-containing cytoplasmic vacuoles with 
the apical plasmalemma and liberation of their contents.
It was reported by Rossen et al (1995) that 2 members of the family Coronaviridae, 
the porcine transmissible gastroenteritis virus (TGEV) and mouse hepatitis virus
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(MHV-A59) both enter polarized epithelial cells through the apical membrane. 
However, the release of newly synthesized TGEV occurred preferentially from the 
apical domains of LLC-PK1 cells while MHV was released preferentially from the 
basolateral membrane of mTAL cells. A more recent analysis revealed that the envelope 
glycoproteins of enveloped viruses accumulated on the same membrane domain from 
which virus release occurred (Jones et al., 1985; Roth et al., 1983; Stephens and 
Compans, 1986). The glycoproteins that assemble at the plasma membrane are 
directionally transported to the surface from which virus buds when their genes are 
expressed in the absence of other virus-specific polypeptides. A hypothesis predicts that 
the site of insertion of the envelope glycoproteins determines the site of viral assembly. 
The glycoproteins of these enveloped viruses are directionally processed in the 
endoplasmic membranes for BCV to be released at the plasma membrane of the apical 
surfaces, because BCV is enveloped on endoplasmic membranes and is released 
preferentially from apical cellular domains. It is still not clear whether the envelope 
glycoproteins are the only targeted component that defines the domain from which BCV 
is selectively released.
The G clone cells are structurally and functionally similar to epithelial cells in 
intestinal and respiratory tracts with specific apical modification of villi and cilia. The 
specific pathway of BCV release reflects the characteristic intracellular transport and 
surface expression of viral proteins which provide important information about the
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mechanism by which membrane proteins are targeted to specific plasma membrane 
domains of the epithelial layers. Restricted specific routes of viral entry or release 
determine the pathogenesis of viral infection as well as the potential mechanisms 
utilized by virus to circumvent the epithelial barrier. Although BCV can enter target 
cells only through apical surfaces in the case of epithelial cells with functional tight 
junctional complexes, under pathogenic conditions when junctional complexes detach, 
BCV may infect the epithelial cells through both apical and lateral areas.
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CHAPTER 6 
COMPARISON OF FUSOGENIC PROPERTIES OF 
RESPIRATORY AND ENTERIC TRACT BOVINE 
CORONA VIRUSES
6.1 Introduction
Bovine coronaviruses (BCV) were isolated in 1970 as a cause of severe diarrhea in 
neonatal calves (Mebus et al., 1973), may also be responsible for winter dysentery of 
adult cattle (Saif et al., 1988). These viruses were referred to as enteropathogenic 
bovine coronaviruses (EBCV). The Mebus strain of EBCV was isolated by adaptation 
to a specific primary bovine fetal kidney (BFK) cell line (Mebus et al., 1973). It induced 
minimal cytopathic changes during multiple passages. Addition of trypsin to the culture 
medium activated a factor enhancing cytopathic expression and polykaryocytosis of the 
cell culture-adapted strain L9 (EBCV-L9) in bovine fetal brain (BFB) and thyroid 
(BFTy) cell cultures (Storz et al., 1981). The spike (S) glycoprotein, one of the 4 
envelope-associated structural proteins in EBCV, facilitates virus attachment to 
susceptible cells and cell fusion (Abraham et al., 1990b; Lai, 1990). Investigation on the 
polypeptide profile of EBCV-L9 propagated in human rectal tumor-18 (HRT-18) cells 
and bovine fetal spleen cells (D2BFS) revealed that trypsin cleaved the 190-kDa S 
protein into 110-kDa SI and 100-kDa S2 subunits which was required for cell fusion 
(St. Cyr-Coats et al., 1988b). The S2 subunit of the EBCV Quebec strain was identified
148
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to mediate cell fusion because S2 recombinant baculovirus induced large syncytia in 
Spodoptera frugiperda (Sf9) cells (Yoo et al., 1991). In contrast to EBCV-L9, wild-type 
EBCV could not be propagated in cultured bovine cells even in the presence of trypsin. 
However, wild-type EBCV strains could be isolated in the HRT-18 cell line, which was 
derived from human rectal adenocarcinoma (Laporte et al., 1979; Tompkins et al., 
1974). This process was enhanced by addition of trypsin to the culture medium (St. Cyr- 
Coats et al., 1988a; Storz et al., 1981).
Antigens of BCV were detected in nasal swab samples from calves with signs of 
pneumoenteritis (Heckert et al., 1990; Mostl et al., 1988; Saif et al., 1986). However, 
conventional virus isolation methods did not detect BCV from respiratory tract samples 
of adult cattle until the unique G clone of HRT-18 cells was used (Storz et al., 1996; 
Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b). Hundreds of coronaviral 
strains were isolated in G clone cell cultures from nasal samples of adult cattle 
experiencing acute respiratory distress and lungs of cases with fatal pneumonia (Storz et 
al., 1996; Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b). The G clone cell- 
dependent coronaviruses were identified as respiratory bovine coronaviruses (RBCV). 
Phenotypic properties of RBCV distinguishing them from EBCV were their ease of 
isolation in the 1st G clone cell passage and their high fusogenicity at neutral pH ranges 
without the need for trypsin enhancement (Storz et al., 1996; Storz, 1998; Storz et al., 
1999; Storz et al., 2000a and b).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
150
Virus envelope-cell membrane fusion and virus-induced cell fusion are directly 
related to the mechanisms of viral entry into host cells (Payne et al., 1990a and b). The 
extensive and trypsin-independent cell fusion induced by all the RBCV isolates 
prompted us to analyze this unique polykaryon formation. Two representative RBCV 
strains were selected from a collection of hundreds of wild-type RBCV isolates with 
identical properties for comparison with 2 well-defined prototype strains of EBCV. The 
formation of polykaryons during RBCV and EBCV replications in G clone cells was 
compared, and the integrity of cytoplasmic membranes and nuclei of the RBCV- 
induced polykaryons were monitored and related ultrastructural evidence for virus 
morphogenesis and replication within the polykaryons.
6.2 Materials and Methods
6.2.1 Cells and Virus Preparations
The G clone was established from the parent HRT-18 cells (Lin et al., 1997b; Storz 
et al., 1996). The G clone cells were used at the 24th passage and grown to confluence 
in 6-well cluster plates (Becton-Dickinson, Lincoln Park, N.J.) with DMEM containing 
44 mM NaHC03 and supplemented with 5% fetal calf serum. The highly cell culture- 
adapted strain EBCV-L9 was derived from EBCV-Mebus strain by sequential passages 
through different bovine and parent HRT-18 cells, and used at its 80th G clone cell 
passage (St. Cyr-Coats et al., 1988b; Zhang et al., 1991). The virulent wild-type strain 
EBCV-LY138 from intestinal samples of diarrheic, newborn calves was initially
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maintained by oral inoculation of conventional calves and induction of enteritis 
(Doughri et al., 1976). It was used at its 2nd G clone cell passage. Two wild-type strains 
of RBCV, LSU-94LSS-051 and OK-0514, were used at their 3rd and 4th G clone cell 
passages, respectively. Virus stocks were prepared from cells infected at a multiplicity 
of 0.1 plaque forming units (PFU) per cell, incubated for 4 to 5 days at 37°C in serum- 
free DMEM, subjected to 3 cycles of freezing-thawing, 2 pulses of sonication on ice for 
15 s at a power setting of 4 (Branson Sonifier Cell Disruptor 200, Branson Ultrasonics 
Co., Danbury, Conn.), and frozen at —70°C. Titers of infectious virus in these 
preparations ranged from 2.0 to 6.0 x 107 PFU/ml.
6.2.2 Analysis of Sequential BCV-induced Polykaryon Formation
Confluent monolayers of G clone cells were washed 2 times with serum-free 
Dulbecco's PBS (calcium and magnesium free) and inoculated with 0.5-ml virus 
preparation containing 1.0 to 3.0 x 107 PFU. Uninfected cells were used as negative 
controls. Excess inoculum was removed after absorption for 1 h at 37°C, and cells were 
covered with 3 ml fresh serum-free DMEM. Inoculated cluster plates were incubated at 
37°C, and cytopathic changes were monitored by phase-contrast microscopy (Zeiss, 
Germany).
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6.2.3 Testing of Membranes o f RBCV-induced Polykaryons by Trypan Blue 
Exclusion
Detached polykaryons were collected at 2-h intervals from the medium by 
centrifugation at 1,500 x g for 20 min, washed with and resuspended in PBS, or treated 
with methanol. Both types of preparations were stained with 0.4% trypan blue 
(GIBCOL BRL, Grand Island, N.Y.). Aggregates of uninfected G clone cells were 
created by detaching them from the monolayer with 0.25% trypsin treatment to serve as 
normal uninfected cell controls.
6.2.4 Demonstration of Nuclei within RBCV-induced and Detached Polykaryons 
by Giemsa Staining
Aliquots of floating polykaryons, obtained as described above, were cytospun onto 
glass slides (Shandon Southern Products Inc. Astmoor, Runcorn, Cheshire) at 1,100 
rpm for 5 min and air-dried. The preparations were treated with Bourn’s fixative (1.2% 
aqueous pricric acid, 40% formaldehyde), stained in 1:10 dilution of Giemsa reagents in 
lx  Giemsa buffer (A.J.P. Scientific Inc. Clifton, N J.) and mounted with Coverbond™ 
media (Division of American Hospital Supply Coporation General Offices, McGAW 
PARK, II.). Cellular aggregates of uninfected G clone cell culture were obtained as 
described above and used as negative controls.
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6.2.5 Detection of RBCV Antigen in Polykaryons by Indirect Immunofluorescent
Assay (IFA)
Floating polykaryons and cells removed from monolayers by trypsin treatment were 
collected from infected G clone cell cultures, cytospun onto glass slides, and stained by 
IFA. These specimens were fixed for 30 min with 3% paraformaldehyde in PBS for 
detecting plasma membrane-associated RBCV antigens. Parallel preparations were 
further treated for 5 min with acetone at -20°C for tracing cytoplasmic antigens. Anti-S 
monoclonal antibody (Mab) 43C2 (Hussain et al., 1991) and polyclonal BCV antiserum 
1745 (Storz and Rott, 1980; Storz and Rott, 1981) were used at 1:50 dilutions. 
Fluorescein isothiocyanate (FITC)-labeled affinity purified goat anti-mouse and anti- 
bovine IgG were diluted at 1:50 (Kirkegaard & Perry Laboratories Inc. Gaithersburg, 
Md.), and served as indicator antibodies. The antibody-treated cytologic preparations 
were then counter stained with Evans blue, and examined with a UV microscope 
(Olympus AH-2, Olympus Optical Co. LTD, Japan).
6.2.6 Processing of RBCV-induced Polykaryons for Ultrastructural Analysis
The procedures described by Payne et al (Payne et al., 1990b) were modified. 
Briefly, floating polykaryons were washed once with PBS, and fixed at 4°C overnight 
with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3). These preparations 
were sedimented, incubated for 1 h in a solution of 1% osmium tetroxide and 1% 
potassium ferrocyanide in 0.1 M sodium cacodylate buffer, washed in 0.1 M sodium
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cacodylate buffer, and stained en bloc for 1 h with 0.2% uranyl acetate in distilled 
water. The preparations was dehydrated in an ascending alcohol gradient, embedded in 
Epon-Araldite resins (Mollenhauer, 1964), and polymerized at 60°C. Sections of 60-90 
nm thickness were prepared, stained with uranyl magnesium acetate and lead citrate, 
and examined with a Zeiss EM-10C electron microscope (Leo electron microscopy Inc. 
Germany).
6 J  Results 
6.3.1 Comparison of EBCV and RBCV-induced Fusion in G Clone Cells
The EBCV caused minimal fusion of the G clone cells which was identical in 
cultures infected with the highly cell culture-adapted avirulent strain L9-80 and the 
wild-type virulent strain LY138-2 (Fig. 6.1 A). In contrast, the 2 RBCV strains, RBCV- 
OK-0514-3 and RBCV-LSU-94LSS-051-4, induced the earliest cell fusion involving 
about 10% of the cell monolayers at 12 h postinfection. Polykaryons lost anchorage to 
culture substrates and detached from the monolayers in synchrony with fusion. Most of 
the cells in monolayers infected by RBCV were recruited into floating, pluriform and 
outreaching polykaryons by 24 h postinfection (Fig. 6 .IB).
6.3.2 Properties o f RBCV-induced Polykaryons
Polykaryons collected at 12 h postinfection with RBCV-OK-0514-3 had plasma 
membranes excluding trypan blue (Fig. 6.2A). Polykaryons floating in the media 
progressively lost their membrane integrity after another 4-h incubation at 37°C, when
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FIG. 6.1: Cytopathic changes in G clone ceil cultures infected with 
EBCV-L9-80 (A) or RBCV-OK-0514-3 (B) at 24 h postinfection.
Limited fusions (solid arrow) in monolayers of EBCV-infected cultures, and large and 
interconnecting polykaryons (solid arrow) in RBCV-infected cultures (x 66).
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FIG. 6.2: Assessment of membrane integrity of the RBCV-induced polykaryons by 
trypan blue exclusion.
Polykaryons with intact outer membranes (A) were observed at 12 h postinfection with 
RBCV-OK-0514-3, cellular aggregates (B) of uninfected G clone cells (x 106).
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trypan blue penetrated into cellular compartments. Polykaryons treated with methanol 
permitted universal uptake of trypan blue (data not shown). Cellular aggregates of 
uninfected G clone cells maintained distinct contours of individually separated cells 
(Fig. 6.2B). The large rafts of polykaryons, which were observed with phase-contrast 
microscopy, consisted of aggregates of smaller polykaryons (Fig. 6.3A). Surprisingly, 
most of the nuclei in the polykaryons were degenerated, and the remaining intact nuclei 
were dislocated into peripheral cytoplasmic areas. The uninfected G clone cellular 
aggregates were stained as distinct cellular entities with defined plasmalemma, 
cytoplasmic matrices and individual nuclei (Fig. 6.3B).
Membranes of polykaryons fixed with paraformaldehyde had intense 
immunofluorescence of coronavirus S glycoprotein antigen detected by anti-S Mab 
43C2 (data not shown). Cytoplasmic fluorescence of similar intensity was evident after 
staining acetone-treated polykaryon preparations with this antibody. Fifty percent of the 
cells, which had not been recruited into polykaryons at 12 h postinoculation, had similar 
membrane and cytoplasmic fluorescence as detected with anti-S Mab. These cell 
preparations contained predominantly single cells, but few small fluorescing 
polykaryons with 2 to 4 nuclei were also observed. Tests with the polycloncal antiserum 
1745 gave identical results.
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FIG. 6.3: Structural features and morphology of nuclei in RBCV-induced 
polykaryons after Giemsa staining.
Multiple nuclei were present in peripheral areas of polykaryons (A) induced by RBCV- 
OK-0514-3 at 12 h postinfection, cellular aggregates (B) of uninfected G clone cells
(x 84).
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6.3.3 Ultrastructural Features of RBCV-induced Polykaryons
Polykaryons contained multiple, lobulated and misshaped nuclei with fuzzy 
margins, intense chromatin condensation and margination in conjunction with nuclear 
membrane separation (Fig. 6.4A). Round RBCV particles, measuring 70 to 80 nm in 
diameter, were observed in the cytoplasmic matrix of polykaryons (Fig. 6.4B). Two 
morphological viral structures were found: one consisted of electron-dense cores 
surrounded by narrow electron-lucent, fringed membranes, and the other was 
represented by cores with electron-lucent centers creating doughnut-like shapes. 
Occasionally, smooth-surfaced cytoplasmic vesicles and rough endoplasmic reticula 
were internally linked with fringed viral structures. Virion morphogenesis began with 
focal electron-dense thickening on the membranes and by budding into the cistemae of 
smooth-membraned vesicles. Well-defined, round structures of differing electron 
densities and varying sizes were in the cytoplasm of polykaryons, some of them 
contained dense core structures embedded in the matrices, while others did not. 
Granulofibrillar areas of lower electron-density were also observed. Increasing numbers 
of swollen mitochondria that had lost their cristae aggregated in perinuclear areas of the 
cytoplasm.
6.4 Discussion
The highly polarized epithelioid G clone of the parent HRT-18 cells (Lin et al., 
1997b) facilitated successful isolation of RBCV strains from nasal swab and pneumonic
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FIG. 6.4: Ultrastructural evidence for RBCV morphogenesis within RBCV- 
induced polykaryons at 12 h postinfection.
Chromatin margination (C), cytoplasmic vacuoles (CV), granulofibrillar areas (GFA), 
mitochondria (M), nucleus (N) and virions (V). Uranyl acetate-lead citrate stain 
(A: x 18,750, B: x 56,250); bar = 0.5 pm (A), = 0.17 pm (B).
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lung samples of cattle with acute respiratory tract diseases. The newly isolated RBCV 
replicated and induced extensive cell fusion in the. 1st passage in G clone cells without 
trypsin enhancement. The trypsin-independent fusogenic activity of RBCV emerges as 
an important characteristic that distinguishes them from EBCV (Storz et al., 1996; 
Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b). The EBCV cause enteritis by 
infecting enterocytes in the intestinal tracts of calves where trypsin or other proteolytic 
enzymes are present in functional quantities. The RBCV target not only cells of bronchi 
but also cells of broncheoii and parenchyma of lungs of cattle. Proteolytic enzymes in 
respiratory tracts do not have physiological roles in digestion processes as they function 
in the intestinal tracts (Cunningham, 1997). A trypsin-like serine protease was found 
along surfaces of the trachea and lower respiratory tract of some mammalian hosts, and 
is theorized to facilitate proteolytic cleavage of hemagglutinin for the influenza virus 
entry into epithelial cells along respiratory tracts, however, orthomyxovirus infections 
had not been detected in cattle and other ruminants species (Rott, 1979). Increasing 
evidence implicates that RBCV infections play etiological roles in acute respiratory 
tract disease of cattle (Storz et al., 1996; Storz, 1998; Storz et al., 1999; Storz et al., 
2000a and b). These RBCV infections pathogenetically are comparable to acute 
respiratory tract disease induced by influenza virus infections in human subjects, horses, 
swine, and poultry (Murphy and Webster, 1996; Rott, 1979).
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The RBCV-induced polykaryons lost anchorage to substrates and detached from the 
G clone cell monolayers in synchrony with fusion. The close intercellular associations 
between the epithelioid HRT-18 cells were destroyed during the polykaryon formation 
(Payne and Storz, 1990). This phenomenon differs from the behavior of polykaryons 
induced by murine or porcine coronaviruses in other cell systems which remain attached 
to substrates (Lai, 1990; Spaan et al., 1988; Wege et al., 1982).
Immunofluorescence techniques were used to correlate expression of viral antigens 
with cell fusion observed through phase-contrast microscopy. Cytoplasmic membrane 
expression of S antigens was predominant in the floating RBCV-induced polykaryons. 
Previous studies of EBCV-L9 infections indicated that EBCV antigens were expressed 
at the surfaces of infected HRT-18 and fibroblastic BFS cells and that viral antigens 
appeared in plasma membranes several hours prior to the onset of trypsin-enhanced cell 
fusion (Payne et al., 1990a and b). Our observations implied that RBCV replication and 
S antigen expression facilitate formation of polykaryons and adversely affect 
intercellular adhesion molecules, leading to their loss of anchorage to the substrates.
The viral structural protein responsible for trypsin-activated polykaryocytosis was 
expressed on the plasma membrane of HRT-18 cells infected with EBCV-L9 strain, and 
was identified as S glycoprotein (Payne et al., 1990a; St. Cyr-Coats et al., 1988b). The 
internal sequence KRRSRR was recognized as the probable protease-active site which 
cleaves S precursor into N-terminal SI and C-terminal S2 subunits (Abraham et al.,
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1990b). The internal hydrophobic domains and heptad repeat region of S2 were found 
to facilitate cell fusion by forming the coiled-coil structure of the oligomeric S protein 
(Yoo et al., 1991).
Comparisons of S genes specified by RBCV (OK-0514, LSU-94LSS-051) and 
EBCV (LY138, Mebus) strains (Chouljenko et al., 1998b) indicated that most of the 
RBCV-specific nucleotide differences were concentrated on the SI subunit and resulted 
in an amino acid substitution within the signal sequence and 2 clusters of amino acid 
changes within the N-terminus and the hypervariable region. Although the proteolytic 
cleavage site of the S precursor was conserved among RBCV and EBCV strains 
analyzed, amino acid changes of Ala 769 to Ser, and Asp 1026 to Gly within the S2 
subunit were found to be located next to the proteolytic cleavage site and within the 
heptad repeat, respectively. We hypothesize that these mutations alone or in conjunction 
with other RBCV-specific amino acid changes may create conformational changes 
important for exposing the fusogenic domains of the S2 subunit and for facilitating the 
high cell-fusing activity of these RBCV isolates.
Paramyxoviruses induced cell fusion at physiological pH ranges among cells 
infected at high multiplicity (fusion from without) or among cells infected at low 
multiplicity leading to viral replication (fusion from within) (Hsu et al., 1982). The 
fusion (FI) protein o f the paramyxovirus envelope triggers this membrane fusion 
activity. Ultrastructural evaluation of RBCV-induced polykaryons identified virions
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containing electron-dense cores as well as doughnut-like virus forms in the cytoplasmic 
matrix, within well-defined cytoplasmic structures of high electron density, membrane- 
bound cytoplasmic vesicles and smooth endoplasmic reticula. Virions were not seen on 
the outer surfaces of cytoplasmic membrane of detached polykaryons. Therefore, it is 
concluded that RBCV-induced polykaryons result from viral replication and thus 
represent fusion from within.
Floating, RBCV-induced polykaryons had intact plasma membranes with 
marginated multiple nuclei as indicated by trypan blue exclusion. The plasmalemma 
maintained integrity for several hours after detachment. Progressive lysis of 
polykaryons followed gradual membrane and mitochondrial damage as well as 
karyorrhexis. Cellular aggregates of control G clone cells consisted of individual cells 
with distinct plasma membranes and nuclei. The characteristic morphological changes 
observed in RBCV-induced polykaryons included loss of membrane integrity and 
nuclear degeneration with extensive chromatin condensation and margination. These 
findings may imply that viral replication within the RBCV-induced polykaryons initiate 
and accelerate apoptotic processes as mechanisms by which cell death occurs. Further 
assessment of DNA fragmentation, morphological changes, and changes in cell surface 
markers should relate the changes in polykaryons to events in apoptosis.
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CHAPTER 7 
HEMAGGLUTININ-ESTERASE SPECIFIED BY RESPIRATORY 
BOVINE CORONA VIRUSES HAS TEMPERATURE-SENSITIVE 
ACETYLESTERASE ACTIVITY
7.1 Introduction
Bovine coronavirus (BCV) is a member of the Coronaviridae family, and possesses a 
single, positive-stranded RNA genome of about 31 kilobases in length (Spaan et al., 
1988; Wege et al., 1982). Similar to coronaviruses in antigenic group II, this virus 
contains a 5th structural protein, the hemagglutinin-esterase (HE), in addition to the 
nucleocapsid (N), membrane (M), envelope (E) and spike (S) proteins. This 140- 
kilodalton (kDa) glycoprotein is a disulfide-linked dimer of 2 identical 65-kDa 
glycosylated subunits, and thus belongs to 65-kDa class I membrane protein (Brian et al., 
1995). It forms the short peplomere on the viral envelope (Brown and Brierly, 1995; 
Deregt et al., 1987; Hogue et al., 1989).
The BCV HE serves as a receptor-binding and receptor-destroying glycoprotein 
similar to the hemagglutinin-esterase-fusion (HEF) glycoprotein of influenza C virus 
(Deregt et al., 1987; Herrler et al., 1988; Hogue et al., 1984; King et al., 1985; Strobl and 
Vlasak, 1993; Vlasak et al., 1988a and b, 1989). It binds to the N-acetyl-9-O- 
acetylneuraminic acid residues of glycoproteins or glycolipids on the surfaces of 
erythrocytes and susceptible cells, which is considered to be the major receptor
165
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determinant of BCV (Herrler et al., 1985; Herrleret al., 1991; Vlasak et al., 1988a). The 
receptor-destroying enzyme (RDE) activity of BCV HE is the first example of such an 
enzyme identified on positive-stranded RNA viruses (Vlasak et al., 1988a and b). 
Enzymes with receptor-destroying functions had been identified as major structural 
components of negative-stranded RNA viruses such as orthomyxoviruses and 
paramyxoviruses (Hirst, 1950). The receptor-destroying functions are mediated by 
neuraminidases (NA) of influenza A and B viruses as well as paramyxoviruses which 
remove terminal N-acetylneuraminate from glycoconjugates (Klenk et al., 1955). In 
contrast, RDE of both influenza C virus and BCV have acetylesterase (AE) activities 
which hydrolyze an ester linkage to release the acetyl group from position C-9 of N- 
acetyl-9-O-acetylneuraminic acid, potentially eluting adsorbed virions (Herrler et al., 
1985; Vlasak et al., 1988a and b). The 9-O-acetyl residue is important for influenza C 
virus recognition of a glycoprotein receptor, a major determinant for the cell tropism 
(Herrler and Klenk, 1987).
Inhibition of the AE activity of BCV HE by diisopropylfluorophosphate resulted in 
some reduction of viral activity, indicating that binding of HE to N-acetyl-9-O- 
acetylneuraminic acid residue involved in infectious process (Vlasak et al., 1988a). 
Enzymatic removal of the N-acetyl-9-O-acetylneuraminic acid residue from cell 
membranes or treatment with HE-specific monoclonal antibodies inhibits BCV 
infections (Deregt et al., 1989; Schultze and Herrler, 1992). Additionally, cells infected
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with a recombinant baculovirus expressing the HE of BCV exhibited hemadsorption 
and esterase activities, both of which could be blocked by monoclonal antibodies with 
infectivity neutralization activity (Parker et al., 1990; Yoo et al., 1992). Consequently, it 
appears that the HE of BCV is important in virus infectivity. In addition to the S 
glycoprotein which has strong receptor-binding properties (Schultze et al., 1991a and b; 
Schultze and Herrler, 1992), binding of HE glycoprotein of the short peplomeres to N- 
acetyl-9-O-acetylneuraminic acid residue on the cell surface may function as a 
prereceptor interaction for BCV. However, the HE of mouse hepatitis virus strains A59 
and JHM is not expressed in productive infections, and thus is not essential for 
replications of these strains (Shieh et al., 1989).
Numerous coronaviruses recently were isolated from nasal swab samples and lung 
tissues of feedlot and other cattle with signs of acute respiratory tract disease including 
a severe form of shipping fever pneumonia (Storz et al., 1996; Storz, 1998; Storz et al., 
1999; Storz et al., 2000a and b). These virus isolates multiplied only in the G clone of 
human rectal tumor-18 (HRT-18) cells, and not in cultured bovine cells, such as 
Georgia bovine kidney (GBK) and bovine turbinate (BT) cells which were permissive 
for the known respiratory bovine viruses including bovine herpes virus-1 (BHV-1), 
bovine parainfluenza type-3 virus (PI-3), bovine respiratory syncytial virus (BRSV) or 
bovine viral diarrhea virus (BVDV). These viruses were identified as respiratory bovine 
coronaviruses (RBCV) based on their morphological features as determined by electron
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microscopy, their ability to induce cell-to-cell fusion after infection of G clone cells, 
and the nucleotide (n.t.) sequence of structural genes. Phenotypic and genotypic 
properties of RBCV differentiated them from the previously reported enteropathogenic 
bovine coronaviruses (EBCV) (Chouljenko et al., 1998b; Storz et al., 1996; Storz, 1998; 
Storz et al., 1999; Storz et al., 2000a and b). Distinguishing features are: (1) The RBCV 
were isolated in the 1st G clone cell passage at neutral pH ranges without the use of 
trypsin enhancement. Trypsin activation was required for the isolation of EBCV 
(Storz et al., 1981). (2) The RBCV have unusually high cell-fusing activities for the G 
clone cells. (3) The RBCV have a restricted hemagglutination pattern, and agglutinate 
only mouse and rat, but not bovine and chicken red blood cells (RBC). The EBCV 
agglutinates both rodent and chicken RBC (Storz et al., 1992). (4) Comparative analysis 
of wild-type RBCV and EBCV n.t. and amino acid (a.a.) sequences at the 3’ genomic 
portion (9.5 kilobases) revealed that RBCV-specific n.t. and a.a. changes were 
disproportionally concentrated within the HE gene, S gene and the genomic region 
between the S and E genes (Chouljenko et al., 1998b). Most of these RBCV isolates 
have RDE activities for rat RBC (Lin et al., 1995).
We hypothesized that differences in structural and functional properties of HE and 
other BCV structural proteins may cause altered tissue tropism and virus pathogenicity. 
The objectives of this investigation were to identify the enzymatic reaction associated 
with the RDE function of HE for RBCV, to characterize the AE activities of HE
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glycoproteins from wild-type strains of RBCV and EBCV in purified virus preparations 
and as transiently expressed gene products at specific body temperatures, and to 
compare their HE cDNA-predicted a.a. sequences.
7.2 Materials and Methods
7.2.1 Virus Strains and Virus Purification
The wild-type strains of RBCV, OK-0514 (OK) and LSU-94LSS-051 (LSU), were 
used at their 2nd to 4th passages. The EBCV wild-type strain LY138 (LY) was used at 
its 2nd and 3rd passages. All viruses were propagated in the G clone cell. Virus 
purification was performed according to Zhang et al. (Zhang et al., 1994). Briefly, the 
media of infected G clone cell cultures were clarified by low speed centrifugation 
following 3 freezing and thawing cycles. Supernatant fluids were collected and 
precipitated by 10% (w/v) polyethylene glycol. Suspensions of precipitates were loaded 
onto a 20% sucrose cushion, and further purified by a 20 to 60% sucrose gradient. The 
purified virus preparations were resuspended in TNE buffer (100 mM Tris-HCl, 
10 mM NaCl, 1 mM EDTA, pH 7.4) and stored at —70°C. Virus infective titers in the 
preparations for RBCV OK and LSU, and EBCV LY ranged from 3.0 to 4.0 x  109 
plaque forming units (PFU)/ml.
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7.2.2 Assays for Hemagglutinin (HA) and RDE
The assays for HA and RDE were performed as reported (Storz et al., 1999; 
Storz et al., 2000a and b) with washed rat RBC prepared as suspensions of 0.5% with 
PBS (pH7.4), containing 0.05% bovine serum albumin.
7.2.3 Cloning and Sequencing of the cDNA Specifying the HE Glycoprotein and 
Alignment of Predicted Amino Acid Sequences of Different HE Genes
Viral RNA extraction, cDNA synthesis and DNA sequencing were performed as
reported (Chouljenko et al., 1998b), using TRI reagent (Molecular Research Center,
Inc., Cincinnati, Oh.), Ready-To-Go You-Prime First-Strand Beads (Pharmacia Biotech
Inc., Uppsala, Sweden), PCR reagents, AmpliTaq and Gene-Amp PCR system 9600
(Perkin-Elmer, Norwalk, Conn.), TA-cloning kit (Invitrogen Inc., San Diego, Calif.),
restriction enzymes (New England Biolabs, Beverly, Mass.), and sequenase™
(Amersham Life Science, Arlington Heights, II.). A cDNA HE fragment was amplified
by polymerase chain reactions (PCR) using a specific primer pair 5F16/3B10 which
corresponded to the sequences upstream and downstream of HE gene, respectively. The
actual primer sequences are: 5F16: 5’AGAATGGCAGTTGCTTATG3’; 3B10:
5 ’GATTATGGTCTAAGCATCATG3’. The 1,272-base pair (bp) DNA fragment
obtained by RT-PCR was first cloned into the pCR™ II vector and subsequently cloned
into the unique Not I- and Hind HI- restriction endonuclease sites of the eukaryotic
expression plasmid vector pcDNA3.1/Zeo(+) (Invitrogen Inc.). The predicted a.a.
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sequences of the HE genes from EBCV LY, RBCV OK and LSU were aligned with the 
aid of the Sequence Analysis Software Package version 6.1 of the Genetics Computer 
Group of the University of Wisconsin and the MacVector Software (IBI, New Haven, 
Conn.).
7.2.4 DNA Transfection and Transient Expression of BCV HE Genes in COS-7 
Cells
The HE genes were transfected into COS-7 cells using Lipofectamine™ (Life 
Technologies Inc., Gaithersburg, Md.). Eighteen to 24 h prior to transfection, COS-7 
cells were plated at an appropriate cell density to obtain approximately 50 to 80% 
confluency the next day. Two pg of plasmid DNA and 10 pi of lipofectamine reagent 
were mixed for each transfection, and incubated for 30 min at room temperature to form 
DNA-liposome complexes which were placed onto the cells grown in a 35-mm well 
together with serum and antibiotics-free NTCT medium (Sigma Inc., St. Louis, Mo.). 
After incubation at 37°C for 7 to 9 h, the transfection mixture was replaced with 
DMEM (Sigma Inc.) with 10% fetal bovine serum, and the cells were further incubated 
for another 60 h. When transient expression of HE was assessed by indirect 
immunofluorescence assay (IFA), 0.5 pg of plasmid DNA and 2.5 pi of 
Lipofectamine™ were applied to COS-7 cells grown on a 12-mm coverslip (Fisher 
Scientific, Pittsburgh, Pa.). Then the transfected cells were fixed with methanol at 60 h 
post transfection (h.p.t.), incubated with polyclonal antiserum from BCV-infected cattle
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(Storz and Rott, 1980; Storz and Rott, 1981), and reacted with fluorescien 
isothiocyanate (FITC)-Iabeled affinity purified goat anti-bovine IgG (Kirkegaard & 
Perry Laboratories Inc., Gaithersburg, Md.), counter-stained with Evans blue, and 
examined with a fluorescence microscopy (Olympus AH-2, Olympus Optical Co. LTD, 
Japan).
7.2.5 Acetylesterase Assay for Acetate Release from Bovine Submaxillary Mucin
(BSM)
Cells in six 35-mm wells were transfected with each plasmid DNA as described 
above, and used for the AE activity according to Herrler at al (Herrler et al., 1985). 
Briefly, the cells were scrapped off after 69 h.p.t., washed with phosphate-buffered 
saline (PBS) and resuspended in 0.6 ml PBS. The cellular suspension was treated with 
sonication at a power setting of 5.5 for 10 pulses (Branson Sonifier Cell Disruptor 200, 
Branson Ultrasonics Co., Danbury, Conn.), and soluble proteins were collected from 
supernatant after low speed centrifugation. The supernatant amount was mixed in 30 pi 
with 50 pi BSM (type I-S, Sigma; 25 mg/ml in PBS), and incubated at 37°C and 39°C, 
while 10 pi of purified virus preparation was used. The mixture was assayed at specific 
time points for the presence of acetate with a commercial test kit (Boehringer- 
Mannheim Inc., Indianapolis, Ind.). Reaction controls consisted of a sample of BSM 
and the same amount of the supernatant from transfected COS-7 cell lysate or purified
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
173
virion preparation which reacted at 4°C. The values of the control samples were 
subtracted from those of the test samples.
7.2.6 Serine-esterase Assay for Nitrophenol Release from p-nitrophenyl Acetate 
(PNPA)
The serine-esterase activity was determined according to Vlasak et al (Vlasak et al., 
1988a). Thirty-five |xl of the soluble protein preparation or 5 p i of purified virus 
preparation were incubated with 1 mM PNPA in PBS at room temperature. The release 
of nitrophenol was measured at 405 nm for 10 min at intervals of 1 min. A sample of 
the PNPA incubated with untransfected or uninfected cellular preparation was used as 
the background level, which was subtracted from the test samples.
7.3 Results
7.3.1 Analysis of HA and RDE Activities of RBCV and EBCV
The HA and RDE activities of RBCV and EBCV were analyzed before and after 
virus purification, as shown in Table 7.1. Virus preparations of RBCV and EBCV 
agglutinated rat RBC with HA titers ranging from 64 to 128 per 50 pi, and their 
associated RDE titers were 4 to 8 before purification. The specific HA and RDE titers 
of the virus preparations increased to titers of 4096 and 1024, respectively, after the 
virus purification procedure.
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Table 7.1: Hemagglutinin and Receptor-destroying Enzyme Activity of  
Respiratory and Enteropathogenic Bovine Coronaviruses
HA Titer RDE Titer
Before purification
RBC V-OK-0514-3 64 4






RBCV: respiratory bovine coronavirus; EBCV: enteropathogenic bovine coronavirus; 
Hemagglutinin (HA) titers were expressed as hemagglutination units (HAU)/50 pi, 
reflecting the highest titer with complete agglutination; Receptor-destroying enzyme 
(RDE) titers were indicated as the highest dilutions with complete elution of adsorbed 
virions, that was the deaggregation of previous aggregation.
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7.3.2 Transient Expression of HE on Transfected COS-7 Cells
The HE genes from RBCV OK and LSU, and EBCV LY were cloned into the 
transient expression vector pcDNA3.1/Zeo(+) under the control of cytomegalovirus 
immediate early promoter (pCMV) and transiently expressed in COS-7 cells 
(Fig. 7.1 A). All 3 HE proteins were expressed in similar amounts as indicated by the 
IFA with BCV-specific polyclonal antibody. Fluorescent signals were detected in the 
cytoplasm and perinuclear sites of approximately 5% of COS-7 cells at 69 h.p.t. 
(Fig. 7 .IB).
7.3.3 Serine-esterase and AE Enzymatic Activities of Purified Virus Preparations 
and Extracts of Transfected COS-7 cells
High levels of serine-esterase activity were detected in purified virus preparations at
room temperature using the synthetic serine-esterase substrate PNPA (Fig. 7.2A). The
RBCV OK and LSU, and EBCV LY virus preparations with identical PFU titers
released equivalent amounts of nitrophenol from PNPA. The COS-7 cellular extracts
containing HE specified by RBCV OK and LSU, and EBCV LY strains hydrolyzed
PNPA effectively (Fig. 7.2B). The COS-7 cellular extracts containing HE of RBCV OK
exhibited a lower rate of time-dependent serine-esterase activity than those of RBCV
LSU and EBCV LY.
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FIG. 7.1: Cloning and expression of HE gene in COS-7 cells.
(A) The PCR-amplified HE gene was cloned into pcDNA3.0/Zeo(+) vector. (B) 
Expression of HE genes from RBCV-OK-0514-3 (a), RBCV-LSU-94LSS-051-4 (b), 
and EBCV-LY138-2 (c) was detected after transfection into COS-7 cells using indirect 
immunofluorescence assay. The G clone cells infected with RBCV-OK-0514-3 were 
used as positive control (d).
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FIG. 7.2: Serine-esterase activities associated with purified RBCV and EBCV, and 
expressed HE proteins from RBCV and EBCV.
p-nitrophenyl acetate was incubated at room temperature with purified RBCV-OK- 
0514-3, RBCV-LSU-94LSS-051-2, and EBCV-LY138-3 (A); and expressed HE 
proteins from RBCV-OK-0514-3, RBCV-LSU-94LSS-051-4, and EBCV-LY138-2 (B). 
Data are means ± standard errors of means (n=3).
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The AE functions of HE proteins were further tested in a 60 min-assay by 
monitoring the release of acetate from a natural esterase substrate, BSM, at 37°C and 
39°C (Fig. 7.3). Purified preparations of RBCV OK and LSU, and EBCV LY released 
similar amounts of acetate over time at 37°C (Fig. 7.3A, 7.3B and 7.3C). Purified 
EBCV-LY preparation hydrolyzed 9-O-acetylated sialic acids in BSM at a higher level 
at 39°C than it did at 37°C. In contrast, purified RBCV OK and LSU preparations had 
reduced AE activities at 39°C in comparison to the AE activities at 37°C. Cellular 
extracts from COS-7 transfected with HE genes were also assayed for their AE 
activities. At 37°C, release of acetate from BSM by these COS-7 cellular extracts 
containing the HE of EBCV LY increased for up to 60 min (Fig. 7.3F). In contrast, the 
ability of expressed HE of RBCV OK and LSU to hydrolyze 9-O-acetylated sialic acids 
in BSM at this reaction temperature increased over time for 40 min, and subsequently 
declined to minimal levels of activities at 60 min (Fig. 7.3D and 7.3E). The expressed 
HE of EBCV LY rapidly decreased acetate liberation after 30-min reaction time at 
39°C, while the AE activity of the expressed HE of RBCV OK and LSU was further 
reduced after 40 min (Fig. 7.3D, 7.3E and 7.3F).
7.3.4 Comparison of HE cDNA-predicted A.A. Sequences Specified by RBCV and
EBCV
Comparison of the deduced a.a. sequences of RBCV OK and LSU, and EBCV LY 
strains revealed specific a.a. differences in HE (Fig. 7.4). The HE a.a. sequence of
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FIG. 7.3: Acetate release from bovine submaxillary mucin (BSM) by purified 
RBCV and EBCV, and expressed HE proteins from RBCV and EBCV.
Purified RBCV-OK-0514-3 (A), RBCV-LSU-94LSS-051-2 (B), EBCV-LY138-3 (C); 
and expressed HE proteins from RBCV-OK-0514-3 (D), RBCV-LSU-94LSS-051-4 (E), 
and EBCV-LY138-2 (F) were incubated with BSM at 37°C (□ ) and 39°C (0). Data are 
means ± standard errors of means (n=3).
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20 37-40 49 53 66 103 133A.A. 1 5 8 18
RBCV OK P V D FGDS T R G* V V
RBCV LSU P V D FGDS T R D V L*
EBCV LY P V D FGDS N R D V V
<4— ------------------►
A.A. 297 344 350 357 367 379 392 396 400  415 424
RBCV OK R D Q D P T I R*
RBCV LSU M* D Q D P T I G
EBCV LY R D Q D P N L G
FIG.7.4: Comparison of the predicted amino acid sequences of the HE proteins 
specified by different bovine coronavirus strains.
The compared strains included newly isolated respiratory bovine coronavirus (RBCV) 
strains OK and LSU, and prototype enteropathogenic BCV (EBCV) wild-type strain LY, 
Amino acids (a.a.) 1-18 are the predicted signal peptide, and a.a. 396-415 are the 
predicted intramembrane-anchoring sequence. *demarcates RBCV strain-specific a.a. 
changes in comparison to the EBCV LY. Boxed a.a. are unique for RBCV.
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EBCV LY differed from those of both RBCV OK and RBCV LSU at positions 49, 379 
and 392. Both a.a. substitutions at positions 49 and 379 were from Asn (LY) to Thr 
(OK, LSU), while the a.a. substitution at position 392 was from Leu (LY) to lie (OK, 
LSU).
7.4 Discussion
We examined and compared the structure and function of HE glycoproteins 
specified by RBCV and EBCV strains. We documented that the HE of RBCV had AE 
activity, which mediated the RDE function, a characteristic of BCV. Moreover, we 
showed that the enzymatic activities of HE could be measured by transient expression 
of HE genes in COS-7 cells. This transient expression system allows the functional 
characterization of HE proteins in the absence of any other BCV components. We found 
that the HE of RBCV can be differentiated from that of EBCV on the basis of 
temperature sensitivity, and identified unique RBCV-specific a.a. changes, which may 
cause the observed AE enzymatic activities.
Overall, the serine-esterase activity assayed by the PNPA method indicated that 
transiently expressed HE was enzymatically active, but this assay did not detect any 
differences between HE of RBCV and EBCV. In contrast, the AE activity tested with 
BSM as substrate, which mimics the natural enzymatic function of HE, indicated that 
the AE activity of RBCV-specified HE obtained from either purified virus preparations 
or through transient expression in COS-7 cells was more temperature-labile than that of
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EBCV. Specifically, the AE activities of purified EBCV LY virus preparations were 
stable at both 37°C and 39°C, while reduced AE activity of purified RBCV OK and 
LSU was observed at 39°C as compared with that at 37°C. In contrast, transient 
expression of HE in COS-7 cells indicated that HE of EBCV LY was stable at 37°C, but 
was temperature-labile at 39°C, while HE of RBCV OK and LSU was not stable at both 
37°C and 39°C. This property infers that HE interaction with other viral structural 
components may stabilize its structure and enzymatic functions. Multiprotein 
interaction between S and HE glycoproteins was first suggested by experiments with 
monoclonal antibodies against HE of EBCV-L9 which inhibited both hemagglutination 
and AE activities (Storz et al., 1991; Zhang et al., 1991).
The HE cDNA-predicted a.a. sequences specified by RBCV contained 3 a.a. 
substitutions. Two substitutions constituted nonconservative a.a. changes of the smaller 
polar Asn to the small nonpolar Thr. These substitutions were located 9 a.a. 
immediately downstream from the conserved esterase active site (FGDS^), and 18 a.a. 
upstream from the predicted intramembrane-anchoring sequence. The third RBCV- 
specific a.a. change involved the conservative a.a. substitution of IIe392 (RBCV) from 
Leu392 (EBCV). These specific a.a. changes may be responsible for the altered AE 
activities of RBCV. Future experiments with site-directed mutagenesis should
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determine whether these a.a. changes are specifically associated with the function of 
RBCV HE.
The coronavirus HE genes have 30% a.a. sequence homology with HEF 
glycoprotein of influenza C virus, and may have been derived by a recombination 
between an HEF mRNA of influenza C virus and the genomic RNA of an ancestral 
coronavirus during a mixed infection (Luytjes et al., 1988). Importantly, coronavirus 
HE has both receptor-binding (Deregt et al., 1987; Hogue et al., 1984; King et al., 1985) 
and AE-mediated receptor-destroying functions which are similar to the HEF of 
influenza C virus (Herrler et al., 1985; Herrler et al., 1991; Vlasak et al., 1988a and b). 
The influenza C virus HEF glycoprotein mediates viral attachment to cells through its 
receptor-binding activity for 9-O-acetyl-N-acetylneuraminic acid and viral penetration 
through its fusion activity (Herrler et al., 1988; Strobl and Vlasak, 1993; Vlasak et al., 
1989). The AE of this viral protein, which hydrolyzes an ester linkage to release acetate 
from the viral receptor determinant, 9-O-acetyl-N-acetylneuraminic acid, allowing 
release of mature virus from infected cells or from erythrocytes.
The receptor-destroying activity of influenza A and B viruses is mediated by an NA 
which catalyzes the cleavage of the a-ketosidic linkage between a terminal N- 
acetylneuraminate and an adjacent D-galactose or D-galactosamine, and releases N- 
acetylneuraminate from the glycoconjugates on the cell surface (Gottschalk, 1957; 
Palese et al., 1974). Another potential role of NA was suggested to permit transport of
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the virus through mucin layer present in the respiratory tract, facilitating the virus 
interaction with the target epithelial cells. Some NA (N1 and N9 subtypes) have both a 
receptor-binding site and an NA active site (Hausman et al., 1993; Laver et al., 1984). 
However, the receptor specificity and function of this receptor-binding activity is still 
unknown. The precise role of HE glycoprotein in coronavirus evolution, replication and 
pathogenesis remains a mystery. The coronavirus HE has been suggested to serve as a 
second viral attachment protein in addition to the S glycoprotein peplomere 
(Parker et al., 1989; Vlasak et al., 1988b). Theoretically, a remarkable selective 
advantage is provided by the HE to coronaviruses in infections of mucous membrane. 
The HE could facilitate virus release and spread, virus migration through the mucus 
layer, and ultimately vims infection of epithelial cells through its specific and reversible 
binding to the substrate, cleavage and rebinding.
The EBCV primarily causes severe diarrhea in neonatal calves and winter dysentery 
of adult cattle by infecting absorptive epithelial cells of the small intestine 
(Doughri et al., 1976; Mebus et al., 1973; Saif et al., 1988). The temperature at this site 
equals the body temperature of around 39°C of cattle, typically higher than the 
temperature of the epithelial surface of air passages which is about 37°C. We 
hypothesize that observed AE activities of HE described in this paper may directly or 
indirectly contribute to RBCV infections of respiratory tracts of cattle. The AE of the 
RBCV strains may have lost their stability at 39°C because these viruses evolved
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through replication in respiratory tissues. Conversely, it is possible that conformational 
changes leading to less thermostable AE activity of the RBCV strains may increase the 
ability of these viruses to replicate in respiratory tissues. Additional studies are required 
to resolve these possibilities.
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CHAPTER 8 
CONCLUSION AND PERSPECTIVES
Respiratory tract diseases remain an economically important problem in the beef 
and dairy cattle industries of this country. Shipping fever pneumonia represents the 
most serious component of the bovine respiratory disease complex. This disease is 
hypothesized to be attributed to multifactorial causes whereby stressful conditions favor 
initial virus infections of respiratory tracts which are often complicated by bacterial 
infections, leading to potentially fatal pneumonia (Hoerlein, 1980; Yates, 1982). 
Numerous attempts had been made to identify etiological infectious agents and their 
mechanisms of pathogenesis, and to induce typical shipping fever pneumonia by 
respiratory exposure of cattle for decades (Baldwin et al., 1967; Briggs et al., 1998; 
Collier, 1968; Friend et al., 1977; Hoerlein et al., 1961; Whitely et al., 1992; Yates, 
1982). Although vaccines and antibiotics were developed to protect cattle from 
respiratory tract infections with known viruses and bacteria, not all bovine respiratory 
tract disease problems were controlled, and shipping fever pneumonia remains 
particularly prevalent among beef cattle recently transported to feedlots (Storz et al., 
1996; Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b).
During the last 5 years, a total of 411 coronavirus strains were isolated from 
respiratory tract samples of 388 cattle in virtual absence of other respiratory virus
189
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infections during the early stages of disease epizootics that were investigated. These 
cattle originated from 11 different states, and included cattle involved in 3 major 
shipping fever epizootics of 1993, 1997 and 1998, cattle from livestock shows, hospital 
cases and cattle on winter pastures. This surprising finding strongly suggests that 
coronavirus has recently emerged as a major infectious factor of acute respiratory tract 
diseases in the vaccinated cattle population with apparent control of the known virus 
infections. The etiological involvement of coronavirus in shipping fever pneumonia and 
other acute bovine respiratory tract diseases were virtually not recognized in the past 
because either this virus infection did not exist previously, or proper technologies were 
not available for detecting this virus infection.
The pathogenic mechanism for the coronavirus infection of respiratory tracts of 
cattle derived from the unique phenotypic and genotypic properties of this virus. One 
important phenotypic characteristic of RBCV is its trypsin-independent fusogenic 
activity in the G clone cells (Storz et al., 1996; Storz, 1998; Storz et al., 1999; Storz et 
al., 2000a and b). The RBCV-induced polykaryons result from viral replication and S 
protein expression on plasma membranes. Ultrastructural analysis of the polykaryons 
may imply the associated apoptotic processes as mechanisms by which cell death 
occurs. Studies on the genetic properties of RBCV S protein suggest that RBCV- 
specific amino acid changes may create conformational changes important for exposing 
the fusogenic domains of the S2 subunit and for facilitating the high cell fusing activity
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of RBCV. Another significant property of RBCV is the high AE activity at 37°C which 
equals the temperature at respiratory tracts of cattle, while the AE function of EBCV is 
much more active at 39°C, the body temperature of cattle. Restricted apical routes of 
RBCV entry into or release from highly polarized epithelioid G clone cells are also 
proposed as potential mechanisms utilized by the virus to circumvent the epithelial 
barrier in vivo. When the tight junctional complexes are intact between the target 
epithelial cells, RBCV can enter the cells only through apical surfaces, leading to 
localized infection. However, under pathogenic conditions when junctional complexes 
detach, RBCV may infect the epithelial cells through both apical and lateral areas, 
causing potential systemic infection. Recently, evidence implicated that RBCV 
infections play etiological roles in acute respiratory tract disease of cattle (Storz et al., 
1996; Storz, 1998; Storz et al., 1999; Storz et al., 2000a and b). These RBCV infections 
pathogenetically are comparable to acute respiratory tract disease induced by influenza 
A virus infections in human subjects, horses, swine, and poultry (Murphy and Webster, 
1996; Rott, 1979). Interestingly, orthomyxovirus infections have not been observed in 
cattle and other ruminants species (Rott, 1979).
Pasteurella haemolytica was the bacterial species predominantly cultivated from 
pneumonic lung samples of the dead cattle. It was evident that the RBCV infection 
occurred first. Secondary P. haemolytica infection played important and sequentially 
interactive roles in the pathogenesis of the severe pneumonia of the calves. Respiratory
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tract defenses of cattle were weakened by the high loads of RBCV infections through 
the AE function of HE glycoprotein during the early phase of respiratory tract disease 
episodes. The HE binds to the 9-O-acetylated neuraminic acid residues of 
glycoconjugates on the surfaces of target cells and glycocalyx in mucus layer, which is 
considered to be the major receptor determinant of coronavirus (Herrler et al., 1985; 
Herrler et al., 1991; Vlasak et al., 1988a and b). The AE activity of HE hydrolyzes an 
ester bond to release the acetyl group from the substrates, resulting in elution of 
adsorbed virions and chemical changes in glycokalyx with loss of viscosity. Through 
this specific and reversible binding, cleavage and rebinding, HE could theoretically not 
only facilitate virus migration, infection, release and spread but also enhance adhesion 
of P. haemolytica through weakening mucosal resistance barrier.
For the first time, antibody responses of cattle against RBCV infections from the 
onset of a naturally occurring severe shipping fever epizootic to complete recovery of 
affected cattle or fatal outcomes were defined. Cattle nasally shedding RBCV at the 
beginning of the epizootic experienced characteristic primary immune responses with 
specific antibodies for HE and S proteins. The dead cattle had only IgM responses to 
RBCV infections. Cattle remaining negative in RBCV isolation tests entered this 
experiment with antibody against HE and S. Protection against respiratory tract disease 
was apparently afforded by high levels of opsonic and virus-neutralizing IgG2. The HE 
and S glycoproteins were recognized earliest by the bovine immune system while the N
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protein induced antibody responses during the later stage of initial infection and the 
early stage of reinfection. The membrane (M) glycoprotein was the least immunogenic 
of the major viral structural proteins.
Koch’s postulates have not been proven for a disease as complex as shipping fever 
pneumonia (Hoerlein, 1980; Thomson, 1980; Yates, 1982). Based on Evans’ criteria for 
causation and ideas of Thomson (1980), the etiological significance of different virus 
infections in shipping fever pneumonia were evaluated (Evans, 1976; Storz et al., 
2000a). As a causative factor in the pathogenesis of shipping fever pneumonia, the 
following criteria have to be met: (1) The viral factor is present in lung tissues and other 
sites of respiratory tracts of affected cattle. (2) The virus can be isolated in cell cultures 
at high rates from respiratory samples during the pathogenesis of shipping fever 
pneumonia. (3) Virus specific immune responses are observed in cattle that recover 
from shipping fever pneumonia. (4) The virus is not isolated from clinically normal 
cattle, but it may be detected in cattle with other forms of respiratory tract disease. (5) 
Cattle with significant levels of antibodies against the virus do not develop shipping 
fever pneumonia which occurs in cattle without such immune protection in specific 
epizootics. (6 ) Elimination of the virus factor prevents or decreases the severity of 
shipping fever pneumonia.
According to our findings reported in this investigation and other related 
experiments, we established that all of Evans’ criteria of causation were met when
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applied to the RBCV infections in the 1997 and 1998 epizootics (Storz et al., 1999; 
Storz et al., 2000a and b). High rates of RBCV shedding occurred during the early 
phase of genesis of shipping fever pneumonia among these cattle, and high RBCV titers 
were detected in their lungs of fatal cases. Pasteurella haemolytica was isolated from 
lung samples. The fatal outcomes of the combined infections of lungs with RBCV and 
P. haemolytica were influenced by the bacterial components which induced terminal 
necrotizing lesions. The RBCV shedding subsided during the convalescent phase, and 
treatment with antibiotics accelerated recovery of some of the cattle. Our findings 
furnish strong support for the conclusion that RBCV played an etiological role in the 
pathogenesis of shipping fever pneumonia which was previously not recognized, and 
represents a virtual missing link in the pathogenesis of this disease.
Future investigation should be aimed: (1) to further compare the structural and 
functional differences of structural and nonstructural genes and their products between 
the RBCV and EBCV strains, and relate them to the tissue specificity of RBCV; (2) to 
study the local, systemic, humoral as well as cell-mediated immune responses of cattle 
to RBCV infection; and (3) to develop effective vaccines based on the immunogenic 
properties of specific RBCV structural proteins.
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